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Abstract
Several features of the PAI suggest it would be a useful broadband measure of
emotional and personality functioning for assessments pursuant to closed head injury
(CHI). These features include brevity, readability, inclusion of validity indicators, and
breadth / relevance of measured constructs. Unfortunately, there is currently a paucity of
peer-reviewed literature to provide an empirical foundation underlying the use of this
instrument following CHI. The overarching goal of this dissertation is to provide
requisite empirical data by examining the PAI profiles of 99 individuals referred for
neuropsychological evaluation consequent to alleged CHI, for whom there was no
indication of suboptimal effort on symptom validity tests. In particular, the goals were to
describe PAI profiles associated with CHI, to address the issue of neurological content at
the item level, and to evaluate the correspondence between objective cognitive
performance and scores on cognitively loaded PAI scales, particularly SCZ-T. Data
analyses showed that a considerable minority of the CHI sample produced clinically
significant scores on scales representing somatic dysfunction, depression, anxiety, and
thought disturbance. The study also demonstrated distinct PAI profiles in association
with injury severity, with more prominent elevations on various scales (particularly
SOM, ANX, ARD, and SCZ) consequent to injury of lesser severity, consistent with prior
literature on the MMPI. Interpretive strategies and conundrums specific to CHI were
discussed. The issue of neurological content at the item level was addressed via rationalempirical selection of a subset of PAI items representing neurological content.
Endorsement of the neurologically relevant items appeared to be influenced by response
bias, depression, and cognitive functioning. Depression was the most potent predictor of
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the sum of scores on these items, regardless of injury severity. Although elevations on
SCZ-T were associated with scores on various neuropsychological measures, the pattern
of obtained correlations suggested that elevations on SCZ-T were not entirely attributable
to cognitive sequelae of CHI, particularly for mild CHI.
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Chapter I
Introduction
The Minnesota Multiphasic Personality Inventory (MMPI; Hathaway &
McKinley, 1940) and its revision, the Minnesota Multiphasic Personality Inventory - 2
(MMPI-2; Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989), have been the
most widely used and extensively researched self-report measures of personality and
emotional functioning in the practice of professional psychology (Greene, 2000). The
MMPI-2 is commonly used in forensic neuropsychological practice (Essig, Mittenberg,
Petersen, Strauman, & Cooper, 2001). In this practice setting, some proportion of the
individuals completing the MMPI-2 can be expected to suffer from bona fide cognitive
impairment, such as that arising from traumatic brain injury (TBI). Because several items
on the MMPI-2 are lengthy and complicated, validity of the obtained profile may be
compromised when administered to individuals with cognitive deficits. Indeed, the
impact of reduced intellectual functioning, memory, and attention / concentration on the
validity scales of the MMPI-2 validity scales have been demonstrated in a mixed
neurological sample (Mittenberg, Tremont, & Rayls, 1996). Moreover, there was no
theoretical basis for the selection of items included in specific MMPI scales (Greene).
Consequently, several items that appear to tap neurological sequelae of TBI, as well as
psychiatric symptomatology, were incidentally included (Gass, 1991). This presents a
further risk to the validity of inferences drawn about psychopathology from the
personality profiles of individuals with neurological dysfunction.
The Personality Assessment Inventory (PAI; Morey, 1991) is a more recent
measure of psychopathology that was developed on the basis of current theoretical
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models of psychopathology. Only an elementary school reading level is required for
accurate understanding and completion (Morey), the items being shorter and less
complicated than those included on the MMPI-2. The inventory includes fewer items
than the MMPI-2, facilitating ease of administration to cognitively impaired populations.
Relative to short and specific measures of psychopathology such as the Beck Depression
Inventory - II (BDI-II; Beck, Steer, & Brown, 1996), the PAI offers several advantages
including its sampling of a wide range of psychiatric symptoms and its inclusion of
validity scales. Although the PAI would appear to be a useful measure of
psychopathology following TBI, its use has not been sufficiently investigated and
validated in this population. In general, the goal of this study is to provide information
that may bridge this gap by evaluating the PAI profiles of individuals who have sustained
the most frequent variant of TBI, closed head injury (CHI). Empirical studies germane to
the use of the MMPI and MMPI-II in neurological populations are reviewed herein, given
that this body of literature underlies the rationale, methodology, and hypotheses of the
current study.
The MMPI in Medical and Neurological Disorders
As reviewed in Greene’s (2000) interpretive manual, the MMPI was constructed
using an empirical criterion keying strategy, whereby items comprising each clinical
scale were selected for their ability to discriminate criterion groups. For example, the
items in the Hypochondriasis (Hs) scale were selected because they were found to
discriminate between normal controls and patients deemed hypochondriacs in empirical
studies that administered a large item pool to both groups. Analogous comparisons
between normal controls and various criterion groups were the basis for selection of items
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composing the other clinical scales on the MMPI: Depression (D), Hysteria (Hy),
Psychopathic Deviate (Pd), Masculinity-Femininity (MF), Paranoia (Pa), Psychasthenia
(Pt), Schizophrenia (Sc), Hypomania (Ma), and Social Introversion (SI). Because item
selection proceeded via empirical methods, a conceptual or logical reason for inclusion of
an item in a particular scale cannot be assured.
The specific content of the items comprising the clinical scales has been of
particular concern to neuropsychologists since many items appear to lack content validity
when administered to neurological populations. Specifically, many items on the MMPI
appear to represent valid physical and cognitive manifestations of various medical and
neurological conditions. In some medical populations, endorsement of these items in the
pathological direction would be of doubtful psychopathological significance (Cripe,
1999; Gass, 1991). For example, memory complaints may differentiate between
depressed patients and normal controls, or between schizophrenic patients and normal
controls. However, the acknowledgement of memory problems should not necessarily be
construed as reflecting depressive or psychotic processes in a variety of neurological
conditions, since this symptom could be the direct result of disease processes. For similar
reasons, the inclusion of an item representing speech abnormalities in the schizophrenia
and mania scales is problematic when used in particular neurological populations. This
issue is best described as medical or neurological content bias. In psychometric terms,
bias refers to differential ability of a variable to predict a given criterion; it points to
systematic error in prediction of the external criterion from the predictor (Anastasi &
Urbina, 1997). Items with medical or neurological content may predict membership to
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particular psychiatric groups in medically healthy individuals, but to a lesser degree in
individuals with substantial medical illness or neurological compromise.
Several authors recognized the medical and neurological content of individual
items composing the MMPI clinical scales and questioned the accuracy of traditional
profile interpretation in medical or neurological patients (Bomstein & Kozora, 1990;
Chelune & Moehle, 1986; Cripe, 1989; Dikmen & Reitan, 1977; Gass & Russell, 1991;
Lezak, 1995; Prigatano, 1987; Reitan & Wolfson, 1993). The classic Conversion V
profile, with clinical elevations on the somatically loaded Hs and Hy scales and a lesser
elevation on the D scale, is generally interpreted as indicating a person who “is
converting personally distressing troubles into more rational or socially acceptable
problems: that is, the person is converting psychological problems into physical
symptoms” (Greene, 2000, p. 144). Its prevalence was reported in patients with
complaints of lower back pain (Hanvik, 1951), but use of scores on the neurotic triad to
differentiate functional and organic contributions to disability has not been supported in
the literature (Love & Peck, 1987). Scores on the neurotic triad also tend to be elevated
in patients who present for medical treatment of headache (Ziegler & Paolo, 1995).
Additionally, physical symptoms secondary to spinal cord injury have been shown to
impact MMPI profiles (Rodevich & Wanlass, 1995).
Some studies characterized MMPI elevations in mixed neurological samples. For
example, Cullum and Bigler (1988) found mean MMPI elevations above a T score of 65
on scales D, Pt, and Sc in patients with left-hemisphere, right-hemisphere, or more
diffuse damage secondary to TBI or cerebrovascular accident. The profiles were
interpreted as demonstrating anxiety and depression, unrelated to lesion laterality.

4
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Interestingly, MMPI elevations tended to increase with time since injury, and the authors
suggested this might be due to increased awareness over time leading to enhanced
emotional reactions to acquired deficits. Alternately, they suggested it could be due to
depression and frustration induced by problems or unmet goals as time went on. In
another sample with lateralized or bilateral cerebral dysfunction, the highest MMPI
elevations were observed on the neurotic triad and lesser elevations were observed on
scale Sc (Dikmen & Reitan, 1977). Elevations were more closely linked to functional
abilities (e.g., verbal abilities) than to lesion laterality. The authors concluded that the
MMPI may be insensitive to emotional problems specific to neurological populations,
and that observed elevations may reflect bona fide neurological symptoms. They
questioned traditional profile interpretations for neurological patients. It was concluded
that use and interpretation of the MMPI with brain-injured subjects should be more
selective, and that further research on the use of the MMPI in this population was
warranted.
Other investigators have directed their focus towards characterizing the MMPI
profiles of individuals with a specific neurological disorder. For example, Bomstein and
Kozora (1990) identified neurological content bias applicable to epilepsy in the Sc scale.
Additionally, Baldwin (1952) showed that MMPI elevations were related to disability and
varied with remission or exacerbation status in multiple sclerosis (MS). Marsh, Hirsch,
and Leung (1982) subsequently demonstrated clinically significant elevations on scales
Hs, D, Hy, and Sc in their sample of patients with MS. Deletion of items believed to
represent symptoms of MS significantly reduced elevations on scales Hs, Hy, and Sc,
with a trend towards reduction on scale D. Marsh and colleagues recommended removal

5
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of items plagued by neurological content when the MMPI was used in MS populations, as
well as the development of analogous correction scales for each neurological disorder. In
another study, MS patients endorsed items on scales Hs, D, Hy, Pt, and Sc that reflected
MS symptoms more frequently than items on these scales that did not reflect MS
symptoms (Meyerink, Reitan, & Selz, 1988). On the basis of these findings, the authors
suggested that physical illness was an independent factor that influenced the pattern of
MMPI item endorsement in MS (i.e., one unrelated to personality or psychopathology),
and that this factor needed to be taken into account when devising interpretations. They
speculated that similar findings were plausible in head injury. Deletion of MS-related
items continues to be recommended in the recent literature, on the basis of substantial
reductions on scales Hs, D, Hy, Pt, and Sc (see Nelson, Elder, Tehrani, & Groot, 2003).
Despite the lengthy history of concerns voiced over the use of the MMPI in
medical and neurological populations, this test continues to be amongst the most popular
measures used for the evaluation of personality and emotional functioning in
neuropsychological evaluations. In fact, one recent survey showed that 77% of
responding neuropsychologists administered the MMPI in the course of forensic
evaluations (Essig et al., 2001). A review of forensic neuropsychological reports
similarly found the MMPI had been used in the majority of evaluations (Lees-Haley,
Smith, Williams, & Dunn, 1996). Continued use of the test could be due, at least in part,
to the lack of analogous measures with comparable degrees of empirical study in
neurological populations. Indeed, the MMPI has traditionally been the most widely
taught and researched broadband measure of emotional functioning, the assessment of
which plays an important role in neuropsychological evaluation. Rather than dispense

6
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with its use altogether, there have attempts to clarify the impact of neurological content
on the MMPI and to devise appropriate correction factors and/or content scales that
quantify this impact.
Neurocorrection Factors in General
Several authors have devised and recommended the use of neurocorrection factors
in neurological disorders (Alfano, Finlayson, Steams, & Nielson, 1990; Alfano, Paniak,
& Finlayson, 1993; Gass, 1991; Marsh et al., 1982; Nelson et al., 2003). On the surface,
the principle is simple enough. If endorsement of select items reflects only bona fide
medical symptoms and fails to tap the psychopathology that is the construct of interest,
this confound should be removed. Therefore, neurologically sensitive items should be
deleted from the measure and the profile should be scored accordingly, without the
unwanted confound. Using this approach, two MMPI profiles can be generated: one
scored in the usual fashion and one scored following deletion of neurologically relevant
items (Gass, 1991). Comparison of the two profiles might permit some estimate of the
neurologic contributions to clinical scale elevations on the traditional profile. Moreover,
spurious inflations erroneously deemed psychopathological in nature are averted.
Presumably, the neurocorrected profile might prove a more useful or accurate measure of
the construct of interest, namely psychopathology.
In line with this reasoning, Alfano and colleagues (1990) used a content-oriented
approach to identify neurologically relevant items on the MMPI. Eighteen medical
specialists in the neurosciences were asked to identify items they believed were
“potentially tapping valid symptoms or manifestations of neurologic damage or
dysfunction” (Alfano et al., p. 70). Inter-rater agreement was achieved, among at least 12

7
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of the 18 specialists, for 44 neurologically related items that primarily impacted scales
Hs, Hy, and Sc. In their mixed neurological sample of 120 patients with verified
neurological damage, clinically significant MMPI elevations on the H§, D, Hy, Pt, and Sc
scales were obtained for 39.1%, 59.1%, 44.3%, 39.1%, and 43.5% of the profiles,
respectively. Single-point codetypes involving Hs, D, and Sc were common, as were 1-2
(Hs-D), 1-3 (Hs-Hy), 2-7 (D-Pt), and 2-8 (D-Sc) two-point codetypes. Deletion of the 44
neurologically relevant items resulted in substantial changes to the mean MMPI
elevations of the group. Likewise, the codetypes, from which interpretive hypotheses are
traditionally derived, were significantly altered for individual profiles as a result of item
deletion. The study illustrates the risk of neurological content spuriously elevating
MMPI scores, which could inadvertently be mistaken as evidence of psychopathology.
In a similar vein, Cripe identified 85 MMPI items and 111 MMPI-2 items that
could conceivably tap neurological dysfunction in a mixed neurological sample, using a
rational method based on content of the items (see Cripe, 1987; 1996; 1999). These items
have been termed the Cripe Neurologic Symptom (CNS) items. The items were divided
into subgroups delineating more homogeneous aspects of neurological and cognitive
functioning. Specifically, the 17 subscales are: attention / mental control, appetite,
fatigue / energy, health, headaches, incontinence, memory, motor, pain, seizures / blank
episodes, sensory, sexual, sleep disturbance, speech / language, vertigo / nausea, and
vocational functioning. Greene (2000) provided normative data for CNS item
endorsement on the MMPI-2 for clinical use. A neurocorrection approach, with deletion
of items, is not advocated. Rather, the CNS items collectively function as a
supplementary scale that quantifies responses to neurologically sensitive questions.
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Both Cripe (1996) and Alfano et al. (1990) sought to identify all items that could
potentially reflect neurological dysfunction. Presumably, this results in the identification
of a pool of items, with some heuristic value, that generalizes easily. The CNS scale and
the Alfano et al. neurocoirection factor could be used across a variety of neurological
disorders with varying degrees of success. However, the range of neurological symptoms
manifested in a specific condition is likely narrower. As a result, many researchers have
focused their efforts on delineating MMPI profiles characteristic of TBI and devising
neurocorrection factors that are specific to this population.
Neurocorrection in TBI
In TBI, elevations on the Hs, D, Hy have most consistently been reported, while
elevations on Pt and Sc have been noted less consistently (Cattelani, Gugliotta, Maravita,
& Mazzucchi, 1996; Cicerone & Kalmar, 1997; Cripe, 1999; Diamond, Barth, & Zilmer,
1988; Gass & Russell, 1991; Leininger, Kreutzer, & Hill, 1991; Novack, Daniel, & Long,
1984). These scales do include many items that could be considered to reflect
neurological dysfunction (Alfano et al., 1990; Cripe, 1996; Gass & Russell, 1991; Lezak,
1995; Reitan & Wolfson, 1993).
If one assumes that neurological content is inflating scores on this constellation of
clinical scales, one might expect that more severely injured individuals would exhibit
higher elevations on these scales than less severely injured individuals. In fact, this
prediction receives little empirical support in the literature. Individuals with posttraumatic amnesia of less than 24 hours showed higher elevations on Hs, Hy, and Pd than
individuals with post-traumatic amnesia of more than 24 hours (Novack et al., 1984).
Similarly, individuals with Glasgow Coma Scale (GCS) of 13 or more had higher
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elevations on Hs, Hy, and Pt than did individuals with GCS below 13 (Leininger et al.,
1991). Analogous findings have been reported by others, who emphasize that the
presence of litigation substantially influences MMPI findings (Berry, Wetter, Baer,
Youngjohn, Gass, Lamb et al., 1995; Hoffman, Scott, Emick, & Adams, 1999; Suhr,
Tranel, Wefel, & Barrash, 1997; Youngjohn, Davis, & Wolf, 1997). The apparent
increase in severity of psychological distress and complaints in TBI of milder severity is
sometimes described as the paradoxical effect of injury severity (cf. Youngjohn et al.).
Furthermore, increased MMPI elevations are reported in more chronic cases (Fordyce,
Roueche, & Prigatano, 1983). These findings suggest that elevations on the MMPI do
not merely reflect artificial inflations arising directly from physiological sequelae of the
injury. A myriad of emotional and psychosocial factors could be important contributors.
Nonetheless, it is important to delineate the impact of neurological symptoms, if any, on
the elevations in an attempt to disentangle them from pre-existing psychopathology,
emotional responses to the injury, neuropsychiatric manifestations arising directly from
the injury and/or exaggeration consequent to litigation. This is an empirical question
warranting study, to inform the clinical interpretations we derive from use of the
personality inventory.
Gass (1991) noted the implications of the criterion-keyed methodology used for
construction of the MMPI. Specifically, items were retained because they differentiated
between normal controls and psychiatric patients, without regard to their significance in
other populations that were not sampled. These items might also discriminate between
normal controls and TBI patients, without necessarily reflecting greater psychopathology
in the latter. Indeed, Gass notes that the content of several items on the MMPI could
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reflect bona fide medical symptoms, including those in neurological patients. He
questioned the accuracy of traditional MMPI interpretations in neurological patients,
since interpretive norms were derived from psychiatric samples, rather than neurological
samples. As a result, the psychopathological significance of scores on clinical scales that
have been inflated by endorsement of bona fide medical symptoms appears questionable
at best.
Consequently, Gass (1991) sought to identify MMPI items sensitive to the
sequelae of closed head injury, using an empirical method. In pursuit of this goal, he
compared the frequency of item endorsement in the MMPI-2 standardization sample to
that in a closed head injury sample. His sample included 75 patients without known
premorbid psychiatric history, all of whom had sustained brain damage that was verified
by standard neurodiagnostic examination performed by neurologists. Forty percent had
been unconscious for more than 7 days, reflecting the relatively severe nature of injuries
sustained by this sample. Of the 370 items included in analyses, 23 were endorsed by
more than 25% of the TBI sample and demonstrated significant discriminative power.
Principal components analysis with oblique rotation of these items generated a two-factor
solution. The first factor, accounting for 24.8% of the variance, was interpreted as
reflecting neurologic complaints. The content of the specific items included
concentration, cognitive inefficiency, and psychomotor abnormalities. Endorsement of
all 14 neurologically relevant items could inflate T scores on the HS, D, Hy, Pt, and Sc
scales by 10 to 20 points. Although these 14 items seemed applicable across a range of
chronicities, three items were endorsed more frequently in those who had sustained their
injuries in the prior year. The second factor accounted for 3.7% of the variance and was
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interpreted to represent psychiatric elements. The authors cautioned psychologists to
consider the content underlying the clinical scales when attributing elevations to
psychiatric or neurological causes. They noted that the more homogeneous HarrisLingoes and Content Scales are helpful in this regard. The authors recommended use of a
neurocorrection technique, in which neurologically relevant items are omitted from the
standard protocol. The neurocorrection factor includes 14 items that had loadings greater
than 0.30 on the first factor representing neurologic complaints.
The generalizability of the correction factor derived by Gass (1991) was evaluated
in a subsequent study by examining an independent sample of outpatients who had
sustained mild CHI (Gass & Wald, 1997). Thirteen of the 14 items were found to
discriminate between the MMPI-2 standardization sample and this cross-validation
sample. All 13 of these items were endorsed by at least 25% of the sample who had
sustained TBI. These findings from this cross-validation study provided further support
for the identified neurologically relevant items relevant to CHI.
Alfano and colleagues (1993) sought to evaluate neurological content bias on the
MMPI, using a combination of construct-oriented and empirical methods. They
examined the response patterns of 102 subjects who had sustained moderate to severe
CHI on the 44 items they had earlier identified as containing neurologic content (Alfano
et al., 1990). Of the 44 items, only 24 items were endorsed by more than 30% of thenpatient population. Responses on these 24 items were subjected to factor analysis,
resulting in a two-factor solution. The first factor, termed the neurobehavioural factor,
accounted for 25% of the overall variance. Thirteen items exhibited high loadings on the
neurobehavioural items, and the content of these items was germane to attention /
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concentration, sensorimotor function, work problems, and sexual satisfaction. Deletion
o f these 13 items resulted in substantial reductions to mean elevations on several clinical
scales (e.g., 8 or 9 T scores on the Sc scale and 5 T scores on the D scale), as well as
alteration of code type for several individual profiles. Endorsement of all items could
lead to inflations of 6T to 22T on Hs, D, Hy, Pt, and Sc. The second factor included 10
items with loadings over 0.41 and was deemed to represent emotional or somatic
complaints. Like Gass (1991), Alfano and colleagues (1993) recommended examination
of a neurocorrected profile following deletion of items tapping neurological content.
However, they noted that external validation of the neurocorrected profile would be
useful, as would documentation of a correlation between the neurobehavioural factor and
neuropsychological functioning.
The factor analysis solution generated in the Alfano and colleagues’ (1993) study
warrants closer examination. Principal components analysis with varimax rotation
produced a seven-factor solution that accounted that 61.9% of the variance, when
extracting factors with eigen values greater than 1. The authors noted that the scree plot
suggested a solution of no more than three factors, but this data was not presented. On
the basis of “conceptual coherence”, they selected a two-factor solution that accounted
for 33.2% of the variance. Arguably, the derivation of the factor solution is somewhat
arbitrary. To some degree, this is inherently true for all factor analyses. However, it is of
particular concern in this case, considering the reduction from seven factors to two, with
considerable loss in the total variance explained by the solution. One might suspect that a
more multi-faceted solution, with several factors accounting for only a small proportion
of variance, would have represented the data in a more comprehensive fashion.
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However, in the absence of the actual factor loadings for the seven-factor solution, this
possibility is rather speculative.
The findings of the Gass (1991) and Alfano et al. (1993) are remarkably similar in
several respects. Both identified a set of items ostensibly tapping neurological symptoms
that were endorsed more frequently in CHI than in normal populations. Both factor
analyses generated a first factor that appeared to reflect neurobehavioural issues in CHI.
In both studies, the neurobehavioural items that composed the derived neurocorrection
factors demonstrated the potential to substantially inflate scores on Hs, D, Hy, Pt, and Sc.
There is also overlap with regard to specific items included in the respective
neurocorrection factors. Of the 14 items in Alfano and colleagues’ neurocorrection
factor, eight had been included in Gass’ analogous factor.
Other researchers have used a rational method to identify neurologically relevant
items related to TBI on the MMPI-2 (van Balen, van Limbeek, & de Mey, 1997).
Specifically, selection of items was based on the opinion of 40 professionals, including
neuropsychologists, neurologists, psychiatrists, and physiatrists. Interestingly, the
specific items and number of items deemed neurologically relevant varied according to
the discipline of the professionals.
In an unpublished dissertation, Artzy (1996) recommended use of correction
factors derived from analyses on a sample of 172 individuals who had sustained CHI.
The first correction factor included 42 items that appeared to represent post-concussive
symptoms and chronic pain, while the second correction factor included 18 items that
appeared more germane to brain injury per se. At the level of individual items, 60 items
discriminated between the CHI sample and the MMPI-2 normative sample, of which 18
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also discriminated between the CHI sample and a chronic pain sample (as cited in Brulot,
Strauss, & Spellacy, 1997). Unfortunately, full details of this unpublished dissertation
were not available for review.
Appendix A shows neurologically relevant items identified in the following
studies: Gass (1991), Gass and Russell (1991), Alfano and colleagues (1993), Artzy
(1994; as cited in Greene, 2000), and van Balen and colleagues (1997). Items identified
by 3 of the 5 studies are bolded. [Appendix A does not include specific item content in
the final dissertation due to concerns surrounding test security and copyright issues.]
Although many items overlap, agreement is less than perfect. Differences in sample
characteristics (e.g., severity of injury, litigation status, and comorbid conditions such as
chronic pain) may account for these differences. Note, also, that specific instructions
given to raters in studies using a rational / content approach could substantially influence
which items are identified or selected for further consideration. Alfano et al. instructed
raters to select items “potentially tapping valid symptoms or manifestations of neurologic
damage or dysfunction” (Alfano et al., 1990, p. 70). Gass and Russell (1991) asked raters
to select “actual physical (not emotional) effects commonly produced by head injury”,
where “commonly refers to at least 25% or 1 out of 4 patients who sustained brain
damage secondary to closed head injury”. The differences between instructions, with
regard to emphasis on physical effects and observed frequency, are substantial enough to
result in different item pools. Despite less than perfect item agreement across the five
studies, Greene (2000) demonstrated very strong correlations amongst the five
neurocorrection scores in the large Caldwell psychiatric sample.
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It is also important to note that several of the items found to discriminate between
TBI patients and normal controls, particularly those identified by Artzy (1996), seem to
have little neurological content. For example, “I like collecting flowers or growing house
plants”, “I used to keep a diary” and “I think I would like the kind of work a forest ranger
does” (as cited in Greene, 2000) bear no obvious relationship to central nervous system
injury. Although the precise methodology used in that study is unknown, the items were
presumably identified pursuant to a strictly empirical approach in which responses to
ALL items were compared across the target groups. While it is possible that these items
tap genuine differences in endorsement patterns between the groups used in that
particular study, it is also possible that the findings are artifactual or the result of inflated
Type I error. In prior studies, factor analyses have been used to exclude content that
appears to tap aspects less directly related to neurological injury. Alternately, this
problem may be avoided in future studies by limiting analyses to items selected on some
rational basis such as content analysis of expert raters. Endorsement frequency should
also be considered when selecting items of interest. The suggestion has been that a
minimum of 30% endorsement in a clinical population should be used for this purpose
(Golden, Sawicki, & Franzen, 1984, as cited by Alfano et al., 1993), although Gass
(1991) has used a minimum endorsement frequency of 25%. Finally, the unusual items
described earlier highlight the need for replication across independent samples.
Greene (2000) also notes that rational or content methods have generally
identified a greater number of neurologically relevant items than empirical methods.
That is, of all the items that could be neurologically sensitive, only a few are actually
found to discriminate between neurological patients and normal groups. He concludes
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that correction factors based on the rational method of item selection “overestimate” the
number of such items, “which suggests that head-injured patients do not exhibit all of the
symptoms that are expected of them” (p.276). It should be noted, however, that this does
not necessarily point to flaws in the methodology of the studies or use of the derived
neurological scales. One plausible explanation for this apparent discrepancy is that not
all patients exhibit the entire spectrum of symptoms that might be induced by their
condition, since any head injury sample would be quite heterogeneous symptomatically.
The end result is that some neurological symptoms that could inflate MMPI scores for
particular individuals might not discriminate a neurological sample as a group. This is
particularly likely to be the case in a heterogeneous group such as CHI. Perhaps a more
useful way to conceptualize the discrepancy is that rational and empirical methods
generate lower-bound and upper-bound limits for profile correction.
With one notable exception (Dunn & Lees-Haley, 1995), there has been little
debate that it is important to consider the influence of neurological content in the
interpretation of MMPI profiles. On the other hand, the implications of this research and
the ensuing recommendations have been more controversial. The use of derived
neurocorrection factors in clinical settings has been questioned and refuted by many
(Arbisi & Ben-Porath, 1999; Brulot et al., 1997; Dunn & Lees-Haley, 1995; Edwards,
Dahmen, Wanlass, Holmquist, Wicks, Davis, & Morrison, 2003; Glassmire, Kinney,
Greene, Stolberg, Berry, & Cripe, 2003; Greene, 2000).
For example, Greene (2000) argues against the use of neurocorrection factors
because deletion of the items assumes that these items are independent from premorbid
medical and psychiatric status and from psychological reactions to injuries. He calls into
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question the validity of these assumptions. He states that these items should not
necessarily be attributed to current injuries. In addition, Greene critiques the deletion of
items because it alters the psychometric properties of the MMPI. He adds that valid
interpretation of the neurocorrected profile would require external validation of the
neurocorrected profile across samples and settings. The interested reader can refer to
various other sources outlining logical and empirical problems with use of
neurocorrection for the MMPI, including unwarranted underestimation of psychiatric
disorders, the failure to devise prorated norms, and the lack of evidence for incremental
validity of the neurocorrected profile (Arbisi & Ben-Porath, 1999).
Gass and Russell (1991) appear to have anticipated arguments that would later be
levelled against the deletion of neurologically relevant items. They commented that
complete deletion of the items could overcorrect for the neurologically relevant items,
thereby underestimating psychopathology. Therefore, they elected to omit neurologically
related items, but prorate scores for the number of omitted items, based on each
individual’s responses on clinical scale items that were not neurologically related. In this
study, they asked three board-certified neurologists to identify items that represented
common physical effects of CHI. Their sample excluded subjects with known premorbid
psychiatric history. For the prorated neurocorrected profiles, significant reductions
continued to be evident for mean elevations on scales Hs, D, Hy, Pt, and Sc, with
codetype changes for many individuals. Injury severity was unrelated to total number of
endorsed neurologically related items. Moreover, cross-sectional analyses showed an
increase in reporting of neurologically related items with increasing time since injury.
Prorating the scores appears to provide some protection against the unwarranted deletion
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of items that could reflect psychopathology, as pointed out by Greene (2000).
Nonetheless, this approach can still be criticized for modifying the psychometric
properties of the MMPI without empirical demonstration that the neurocorrected profile
is a better predictor of external validity indicators pertinent to psychopathology,
consistent with the aforementioned objections of various researchers.
Dunn and Lees-Haley (1995) pointed to elevated rates of neuropsychological
complaints in litigants who have not sustained TBI. They further pointed to the
emotional distress and psychopathology that could be experienced secondary to the TBI.
In deleting the MMPI items sensitive to neurological dysfunction, there is an implicit
assumption that these items are directly related to physical injury. Symptoms that are not
causally related to the injury could also be deleted. Therefore, the authors sought to
determine whether Gass’ (1991) neurological items were endorsed more frequently in 59
CHI litigants than in 102 non-CHI litigants (including some involved in motor vehicle
accidents). Only five of the 14 items were endorsed more frequently by the CHI group.
These items related to difficulty reading, memory problems, difficulty with balance when
walking, skin numbness, and muscle weakness. Moreover, deletion of these five items
did not result in substantial or clinically meaningful changes in the profiles. On the basis
of these findings, the authors did not recommend neurocorrection in the evaluation of
CHI in forensic settings.
Although the arguments presented by Dunn and Lees-Haley (1995) are valid, the
implications of the data they present are less clear. If the goal is to detect items that
reflect bona fide medical or neurological symptoms causally related to TBI, considerable
care should be taken to ensure that only valid personality profiles are included in
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analyses, particularly if litigation samples are used. They excluded profiles with 31 or
more unanswered items, F scales greater than 89T, and F - K scores greater than 16,
consistent with criteria used by Gass (1991). Evidently, the profiles were not screened
for consistency. Moreover, there does not appear to have been any attempt to exclude
subjects with exaggerated or feigned neurological deficits, introducing a confound that
was ill-recognized and inadequately addressed in earlier neuropsychological studies.
Furthermore, if the goal is to isolate bona fide neurological symptoms, sufficient
representation of individuals who have sustained moderate to severe TBI lends credence
to the findings. Unfortunately, injury variables were not reported for this CHI group, but
one might infer a high proportion of mild TBI subjects involved in litigation. The authors
did specifically note enhanced representativeness of their sample to the milder injuries
often seen for forensic neuropsychological evaluations. Overall, their sample and
treatment of the data seems inappropriate for addressing the impact of bona fide medical
symptoms on the MMPI. Nonetheless, their point that neuropsychological complaints
(including those endorsed on the MMPI) are observed in many litigation samples and
cannot be assumed to be caused by CHI is an important one.
Brulot et al. (1997) sought to determine the relationship of derived
neurobehavioural factors to injury severity, neuropsychological performance, and
depression. Correlations between the Gass (1991) and Alfano et al. (1993)
neurocorrection scores and injury severity (i.e., LOC and GCS) were very low, which
casts doubt on a direct dose-response relationship to injury parameters. Furthermore,
significant correlations between neurobehavioural scores and performance on tests of
memory and attention were not obtained. This was surprising, particularly since the
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included tests are amongst the most sensitive to the sequelae of TBI. Specifically,
measures used in analyses included: the Buschke Selective Reminding Test, Digit
Symbol, Paced Auditory Serial Addition Task, Rey Complex Figure Test Delayed Recall,
Symbol Digit Modalities Test, Stroop, Trail Making Test, and Brown-Peterson
Consonant Trigrams. Therefore, the derived neurobehavioural factors did not appear
sensitive to severity of injury or prototypical neuropsychological deficits. Moreover,
scores on the factor were substantially associated with scores on the MMPI-2 Depression
Content Scale, which includes only 2 items from the correction factors. The authors
questioned the validity of deleting items associated with psychopathology, if the purpose
of MMPI administration is to evaluate psychopathology in this population. The authors
concluded that neurocorrection of MMPI profiles was ill-advised, and encouraged
neuropsychologists to seek corroborating information about psychopathology from a
variety of sources. In fact, they stated that the traditional MMPI protocol should remain
intact and that interpretation should proceed via the traditional methods.
Glassmire and colleagues (2003) discerned that the high correlation between the
neurocorrection scores and depression reported by Brulot et al. (1997) suggested poor
discriminant validity of the neurocorrection items. Therefore, they sought to
simultaneously evaluate sensitivity and specificity of the correction items to CHI, using
Receiver Operating Characteristic (ROC) analysis in CHI patients, normal controls, and
psychiatric samples. Scores on the neurobehavioural correction factors showed large
effect sizes in discriminating between CHI patients and normal controls, although effect
sizes were small in discriminating between CHI patients and psychiatric patients. ROC
analysis showed adequate sensitivity and specificity in discriminating between CHI
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patients and the MMPI-2 standardization sample, with Gass’ (1991) correction factor
demonstrating the best diagnostic efficiency. In contrast, there was poor specificity when
discriminating between CHI and psychiatric patients, with a high rate of false-positive

errors for psychiatric patients. There was a strong correlation between scores on Welsh A
and the neurobehavioural factor, and the lack of specificity of the neurobehavioural factor
was attributed to its relationship to generalized distress. The authors recommended that
future researchers attempt to identify items that discriminate CHI patients from
psychiatric patients or patients with other neurological disorders. Given the lack of
specificity of the correction items to CHI, deletion of the items is not recommended.
Rather, an interpretive approach similar to that used with the Content scales is
recommended. Specifically, the authors advocated the inclusion of supplementary scales
sensitive to the sequelae of CHI, elevations on which should preclude neuropsychologists
from inadvertently attributing inflated scores to psychopathology without considering the
potential impact of neurological symptoms.
The article by Gass and Russell (1991) illustrates the use of supplementary scales
on the MMPI to enhance accuracy of clinical interpretations based on the MMPI. The
authors noted that the highest Harris-Lingoes scores in the profiles of their CHI sample
pertained to physical or cognitive functioning: D4 (Mental Dullness), Hy3 (LassitudeMalaise), Sc2 (Lack of Ego Mastery - Cognitive), Ma2 (Psychomotor Acceleration), Sc3
(Bizarre Sensory Experiences), and D3 (Physical Malfunctioning). With regard to
Harris-Lingoes scores relating to the Depression scale, scores on D4 (Mental Dullness)
and D3 (Physical Problems) were higher than scores on D1 (Subjective Depression), D2
(Psychomotor Retardation), and D5 (Brooding). With regard to the Hysteria clinical
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scale, the Hy3 (Fatigue and Malaise) score was higher than Hyl (Denial of social
anxiety), Hy2 (Affection Needs), Hy4 (Somatic Complaints), and Hy5 (Inhibition of
Aggression) scores. With regard to the Schizophrenia scale, Sc2 (Cognitive Inefficiency)
and Sc3 (Bizarre Sensory Experiences) were higher than Scl A (Social Alienation), SclB
(Emotional Alienation), Sc2B (Lack of Will Power), and Sc2C (Defective Inhibition).
Consequently, Gass and Russell recommended using the Harris-Lingoes scores to clarify
the content of items contributing to scores on scales Hs, D, Hy, Pt, and Sc. As an
example, they suggest that a diagnosis of depression would be more appropriate if D1
(Subjective Depression) were elevated.
Others have specifically evaluated whether use of the MMPI Content scales
provides incremental validity over the clinical scales in the evaluation of moderate to
severe TBI (Palav, Ortega, & McCaffrey, 2001). The authors note that the criterionkeyed construction of the MMPI led to the development of clinical scales that
discriminate between patients and controls, resulting in heterogeneous content that is not
necessarily related to the construct in question in an obvious or rational fashion. They
further note that use of empirically-derived clinical scales to discriminate groups has
received substantial empirical validation in the literature, and that the reduction in face
validity may make these scales less susceptible to intentional distortion. By contrast, the
items that compose the content scales were selected by rational methods and show high
content validity, likely increasing their correspondence to self-reported psychological
symptoms of importance to the patient. The items that compose each content scale are
far more homogeneous in content than those in the clinical scales. Therefore, it was
hypothesized that the more homogeneous content scales could add information that
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would clarify the responses of the patient and independently contribute to the prediction
of psychological symptom report. Indeed, hierarchical regression analyses indicated
incremental validity of the Content scales over the clinical scales in predicting selfreported symptoms on the Symptom Checklist-90-Revised (SCL-90-R) for patients with
confirmed TBI. Consequently, examination of both clinical scales and content scales was
recommended in the interpretation of MMPI profiles following TBI.
Likewise, Greene (2000) recommends inspection of scores on the CNS items and
subscales to determine the specific nature of self-reported complaints. He states that “the
clinician then can explore whether these specific symptoms are the result of the
neurological impairment, the reaction to living with die impairment, prior or comorbid
psychiatric problems, or more likely some combination of all of these factors” (Greene, p.
282). Normative data on the CNS items are included in the manual, as are T scores
derived from Caldwell’s clinical data set. Review of the CNS scores allows the clinician
to determine whether the client is endorsing an unusual number of neurological
symptoms that could be inflating clinical scale scores, in comparison to the MMPI-2
standardization sample or a psychiatric sample. Use of the data from Caldwell’s clinical
sample might, to some degree, circumvent the difficulty of low specificity to CHI and
high false-positive errors in psychiatric disorders, as reported for the Gass (1991) and
Alfano et al. (1993) items (Glassmire et al., 2003).
A follow-up study from Cripe and colleagues examined the specificity of CNS
items to neurological disorders (Cripe, Maxwell, & Hill, 1995). When considering the
total number of CNS items endorsed, scores were similar in a mixed neurological group,
a psychiatric group, and a chronic pain group. Therefore, the total number of CNS items
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was unable to differentiate between the groups. Furthermore, inspection of mean scores
on the MMPI clinical scales failed to show obvious group differences. Discriminant
function analyses that relied only on clinical scales L through SI correctly classified only
30% of neurological patients (with overall correct classification rate of 56%),
demonstrating the inherent difficulty of using the MMPI in the differential diagnosis of
psychiatric and neurological factors. In contrast, discriminant function analyses using 37
variables from the m an scales, research scales, and Cripe’s CNS scales correctly
classified 78% of the sample into their respective groups. The implication is that a
complex weighting system, considering the pattern of item endorsement of each
individual, would be necessary to correctly determine group membership of neurological,
psychiatric, and chronic pain patients. The CRIMAX is a formula, based on this
discriminant function analysis, that can be used in attempts to predict group membership
from pattern of item endorsement.
In his chapter, Cripe (1999) describes his perspective on the use of the MMPI in
mild CHI and its utility in differential diagnosis of neurological and psychiatric factors
impacting upon clinical presentation. Cripe notes that medical and neurologic patients
can generate an MMPI profile with elevations on a variety of scales, merely as a result of
their endorsement of bona fide medical symptoms. Endorsement of these symptoms,
however, does not unequivocally represent psychopathological processes. The profile
could easily be misconstrued. On the other hand, he notes that elevations on particular
scales are not invariably related to specific disorders. Elevations on particular MMPI
scales can occur in a wide variety of disorders and for a wide variety of reasons.
Therefore, it is virtually impossible to identify the reason for an elevation on a given
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clinical scale. He makes the point by referring to the item that reads “my memory seems
to be all right”. Considering the variety of possible reasons for endorsement of each item,
and the consequent elevations across clinical scales, it is perhaps not surprising that
accuracy of classification into psychiatric and neurological groups on the basis of clinical
scale scores is less than optimal.
Cripe (1999) concluded that “the safest and most logical assumption to make if a
medical or neurological patient elevates on scales 1,2 ,3 ,7 or 8 is that the patient has
some awareness of his / her problems and is reporting the problems within the limitations
and constrictions of the MMPI item pool” (p. 300). His point is that elevations reflect
only the patient’s awareness and communication of symptoms. Elevations do not permit
the determination of distress associated with these symptoms, validity of the symptoms,
or adjustment to the symptoms. Conversely, he notes that the absence of MMPI
elevations does not necessarily represent the absence of objective symptoms or
maladjustment, as it could merely be the result of impaired awareness. He advocates
understanding of the difficulties of MMPI interpretation in mild TBI, and decreased
reliance on it for the purpose of differential diagnosis and personality / emotional
evaluation in this population. If it is to be used, Cripe recommends item analysis, rather
than cookbook or computer-generated interpretations.
Interestingly, Cripe (1999) points to the outdated conceptualization of
psychopathology underlying the MMPI. He opines that Morey’s (1991) newer
Personality Assessment Inventory (PAI), which is psychometrically and conceptually
sound, appears to provide more clinically useful information than the MMPI. However,
he cautions that several items on this instrument are also likely to tap neurological
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symptoms. He specifically mentions sensitivity of the somatic and depression scales to
symptoms of mild TBI.
The PAI as a Broadband Self-Report Measure of Psychopathology
Development of the PAI
The development of the PAI and its features are most thoroughly detailed in the
technical manual (Morey, 1991), and description herein relies upon that source unless
otherwise noted. The PAI is an objective self-report measure of psychopathology
applicable to a range of mental disorders seen in a variety of clinical settings, intended to
provide information relevant to diagnosis and treatment planning. Each item is scored on
a 4-point Likert scale to better quantify the frequency or severity of symptom dimensions
than do dichotomous response formats. Item selection proceeded by a conceptualempirical approach. That is, after having decided which disorders or facets of
psychopathology should be evaluated by the measure, constructs relevant to each disorder
were determined on the basis of contemporary literature. Items were subsequently
written to portray those constructs from the perspective of the client. Further refinements
to the item pool were conducted on the basis of psychometric properties including
internal consistency, specificity, internal validity, transparency, and bias. Overall, the
construct validational approach substantially underlies the development process of the
PAI.
The final inventory includes 22 nonoverlapping scales comprised of 344 items.
There are four validity scales, five treatment scales, two interpersonal scales, and 11
clinical scales. The validity scales include Negative Impression (NIM), Positive
Impression (PIM), Inconsistency (ICN), and Infrequency (INF). The latter includes items
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that have extremely high or low rates of endorsement but appear independent from social
desirability and psychopathology. It should be noted, therefore, that the INF scale of the
PAI is qualitatively dissimilar to the F scale of the MMPI. Its primary purpose is to
identify random responding (Morey, 1996), unlike the MMPI F scale that often suggests
malingering due to endorsement of very unusual and highly pathological symptoms
(Greene, 2000). Treatment scales pertain to Aggression (AGG), Suicidal Ideation (SUI),
Stress (STR), Nonsupport (NON), and Treatment Rejection (RXR). STR evaluates the
impact of recent stressors on major areas of life functioning, while NON evaluates
perceived quality and level of social supports. RXR evaluates variables that may predict
motivation for emotional and psychological change, such as in psychotherapy. The
interpersonal scales are Dominance (DOM) and Warmth (WRM). The clinical scales are:
Somatic Complaints (SOM), Anxiety (ANX), Anxiety-Related Disorders (ARD),
Depression (DEP), Mania (MAN), Paranoia (PAR), Schizophrenia (SCZ), Borderline
Features (BOR), Antisocial Features (ANT), Alcohol Problems (ALC), and Drug
Problems (DRG). The constructs evaluated by each of the clinical scales is generally as
implied by the scale label. Mean clinical elevation (MCELEV), the mean of scores on all
11 clinical scales, is routinely provided via computer scoring.
Of the 22 scales, 10 include conceptually derived subscales that evaluate concepts
subsumed by the overarching construct representing the clinical scale, thereby clarifying
interpretation of the full scales. For example, there are three depression subscales (DEPC, DEP-A, and DEP-P) that tap cognitive, affective, and physiological aspects of
depression, respectively. More specifically, items that compose the DEP-C subscale
appear to evaluate thoughts that reveal hopelessness and worthlessness, in addition to
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difficulties concentrating. The DEP-A subscale items depict feelings of sadness and loss
of interest / pleasure, while DEP-P is composed of neurovegetative symptoms often
observed in depression, such as appetite and sleep disturbance.
Subscales pertaining to SOM are labelled Conversion (SOM-C), Somatization
(SOM-S), and Health Concerns (SOM-H). The SOM-C subscale demonstrates the
impact of sensory and motor symptoms in particular, while the SOM-S subscale evaluates
a wide variety of physical complaints including pain, fatigue, gastrointestinal problems,
or vague physical symptoms. As the name “Health Concerns” implies, SOM-H reflects
general concerns about medical status and health problems.
The SCZ clinical scale is similarly subdivided into three subscales that tap aspects
relevant to schizophreniform processes, without necessarily suggesting a diagnosis of
schizophrenia. In particular, Social Detachment (SCZ-S) quantifies social alienation and
isolation, while the Thought Disorder (SCZ-T) subscale quantifies thought disorders
marked by confusion or poor concentration, the etiology of which could be depression,
brain injury, or a psychotic disorder. Psychotic Experiences (SCZ-P) is the subscale
representing psychotic processes such as positive symptoms including hallucinations,
which are more often pathognomonic signs of schizophrenia or other serious psychotic
disorders.
The clinical subscales for the ANX scale represent Cognitive (ANX-C), Affective
(ANX-A), and Physiological (ANX-P) aspects of anxiety. Components of the ARD
clinical scale pertain to Obsessive-Compulsive (ARD-O) tendencies, Phobias (ARD-P),
and Traumatic Stress (ARD-T). The overarching MAN scales includes three clinical
subscales reflecting Activity Level (MAN-A), Grandiosity (MAN-G), and Irritability
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(MAN-I). PAR includes Hypervigilance (PAR-H), Persecution (PAR-P), and
Resentment (PAR-R). BOR is the only clinical scale with four subsumed subscales,
namely Affective Instability (BOR-A), Identity Problems (BOR-I), Negative
Relationships (BOR-N), and Self-Harm (BOR-S). The overall ANT clinical scale is
sensitive to antisocial features, including Antisocial Behaviors (ANT-A), Egocentricity
(ANT-E), and Stimulus-Seeking (ANT-S). Finally, Aggressive Attitude (AGG-A),
Verbal Aggression (AGG-V), and Physical Aggression (AGG-P) compose the AGG
clinical scale.
Confirmatory factor analyses were used to provide support for each of the
hypothesized subscales, with comparative fit indices above 0.97 for each subscale.
Maximizing internal consistency within the subscales was one goal during psychometric
refinement. Therefore, there is reason to believe that the various subscales include more
homogeneous content, and that they represent some conceptual variable of relevance that
will aid in clinical interpretation.
Raw scores are converted to T scores by reference to the normative sample, which
was comprised of 1000 subjects cross-stratified by age, gender, and race to match census
data and achieve a representative sample. Data are also provided for a clinical sample of
1265 patients from 69 clinical sites throughout the US. Primary diagnoses of the clinical
sample were as follows: affective disorders (22.2%), alcohol-related disorders (18.9%),
adjustment disorders (10.3%), personality disorders / social conditions (10.3%), drugrelated disorders (7.7%), anxiety disorders (7.0%), schizophrenia (5.4%), organic
disorders (2.2%), and somatization disorders (1.9%).
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Utility of the PAI
The PAI is rapidly gaining popularity for use in a variety of clinical settings, as
well as being incorporated into doctoral-level training programs (Piotrowski, 2000). A
growing body of literature supports the adequacy and utility of this measure, particularly
in forensic-correctional contexts (Douglas, Hart, & Kropp, 2001; Edens, BuffingtonVollum, Colwell, Johnson, & Johnson, 2002; Edens, Hart, Johnson, Johnson, & Olver,
2000; Rogers, Ustad, & Salekin, 1998; Salekin, Rogers, & Sewell, 1997; Walters,
Duncan, & Geyer, 2003; Wang et al., 1997). Supporting findings have also been reported
for post-traumatic stress disorder (McDevitt-Murphy, Weathers, Adkins, & Daniels,
2005), substance abuse (Kellogg et al., 2002; Parker, Daleiden, & Simpson, 1999; Ruiz,
Dickinson, & Pincus, 2002; Schinka, 1995), eating disorders (Tasca, Wood, Demidenko,
& Bissada, 2002), and chronic pain (Zhong, 2004). A majority of board-certified experts
in forensic psychology deemed the PAI an acceptable instrument for use in determining
an individual’s mental state at the time of an offense, competency to stand trial, and
likelihood of malingering (Lally, 2003). Rogers and colleagues (Rogers, Sewell, Morey,
& Ustad, 1996) described the PAI as a psychometrically rigorous measure with broad
clinical applicability, listing the distinguishing features of this inventory as:
its ease of reading comprehension (4th grade), its eschewing of commonly used
dichotomous alternatives (true-false) and adoption of quantitative responses (i.e.,
“false, not at all true”, “slightly true”, “mainly true”, and “very true”), its
selection of symptoms and associated features that represent the full spectrum of
syndromes / disorders, its true integration of subscales into the validation and
clinical interpretation, and its use of nonoverlapping scales to maximize

31

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

discriminant validity”, (p. 629-30)
Issues of Response Bias
Because the accuracy of interpretations derived from any self-report measure of
emotional functioning and/or psychopathology relies heavily on forthright responding
from die informant, detection of response biases should be an important component of
such evaluations. In many neuropsychological contexts, and particularly forensic
contexts, an external incentive for injury and disability are extant. Financial incentives
may include Worker’s Compensation benefits pursuant to a workplace injury, or
judgments arising from civil tort actions pursuant to motor vehicle accidents. Therefore,
detection of response bias is of crucial importance in the forensic contexts in which
neuropsychologists are most often retained (Bush, Ruff, Troster, Barth, Koffler, et al.,
2005).
Several free-standing instruments have been designed to detect sub-optimal effort
on neurocognitive measures. These measures are purported to be sensitive to the feigning
or exaggeration of cognitive deficits in particular. For example, the Test of Memory
Malingering (TOMM; Tombaugh, 1996), ostensibly a lengthy measure of visual memory,
was intended to detect the feigning or exaggeration of amnesia. Other measures utilized
to evaluate effort on and compliance with cognitive instruments were derived from
traditional neuropsychological measures that are sensitive to genuine neurocognitive
impairment. Examples would include Reliable Digit Span (RELDS; see Greiffenstein,
Baker, & Gola, 1994; Heinly, Greve, Bianchini, & Love, 2005) and Recognition Hits on
the California Verbal Learning Test (CVLT; see Curtis, Greve, Bianchini, & Brennan,
2006; Millis, Putnam, Adams, & Ricker, 1995).
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Evidence for symptom validity tests, in general, derives from analogue studies
utilizing simulators asked to feign a specific disorder and real-world known-groups
designs contrasting the performance of patients believed genuine to those of individuals
suspected of poor effort. In die known-groups design, probable malingerers have often
been so designated on the basis of poor performance on tests of motivation that lead to
questionable validity on cognitive measures, although Slick et al. (Slick, Sherman, &
Iverson, 1999) have provided more comprehensive criteria upon which to base this
determination. Poor performance on either the TOMM (Curtis et al., 2006) or RELDS
(Heinly et al., 2005) has been deemed as providing adequate independent evidence of
poor effort on neurocognitive instruments for the purpose of determining malingering
status (i.e., criteria B1 or B2 of the Slick criteria). On the other hand, a low score on
Recognition Hits of the CVLT has been described as sufficient for meeting the B6
criterion of the Slick criteria for the purpose of determining malingering status (Curtis et
al.), thereby requiring additional evidence of response bias prior to provision of a clinical
diagnosis of malingering, although the use of this score for detection of malingering has
received substantial empirical support (Curtis et al.; Greiffenstein et al., 1994; Millis et
al., 1995).
In forensic neuropsychological contexts, response bias should usually be
considered with regard to both cognitive and psychiatric symptomatology (cf. Bush et al.,
2005; Iverson, 2006; Larrabee, 2000). Although exaggeration of psychopathology and
neurological deficits can co-occur, some evidence suggests that they reflect independent
factors (Greiffenstein, Gola, & Baker, 1995), with only minimal correlations between
scores on psychopathology indices of malingering and measures of cognitive effort
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(McCaffrey, O'Bryant, Ashendorf, & Fisher, 2003). Thus, the detection of exaggeration
proceeds separately for neurocognitive and psychiatric domains via the analysis of
separate scores reflecting a particular purported purpose (i.e., detection of either
psychiatric or cognitive feigning), as recommended by Berry and Butcher (1998).
Furthermore, there is reason to believe that traditional measures of malingering
included on measures of psychopathology, including F, are generally more sensitive to
exaggerated claims involving very peculiar or psychotic symptoms than to exaggerated
cognitive or somatic complaints more typical for personal injury litigation (Boone & Lu;
1999; Dearth et al., 2005; Greiffenstein, Baker, Gola, Donders, & Miller, 2002;
Greiffenstein et al., 1995; Larrabee, 1998; Larrabee, 2003a; McCaffrey et al., 2003; Ross,
Millis, Krukowski, Putnam, & Adams, 2004). This is particularly concerning, given prior
studies in which probable malingerers produced higher elevations on MMPI-2 scales Hs,
Hy, D, Pt, and Sc than did individuals who have sustained moderate to severe TBI who
were not pursuing litigation, with effect sizes greater than 0.75 on these clinical scales,
compared to 0.30 for the F scale (Larrabee, 2003b). Indeed, increased elevations on a
variety of MMPI-2 clinical scales (e.g., Hs, Hy, D, Pt, and Sc) have been reported in the
presence of malingering and/or compensation-seeking in personal injury contexts in
several studies (Berry et al., 1995; Hoffman et al., 1999; Lamb, Berry, Wetter, & Baer,
1994; Larrabee, 1998; Larrabee, 2003a; Suhr et al., 1997). These findings reinforce the
need to evaluate for both psychiatric and cognitive response bias, using a comprehensive
multi-measure approach.
The Fake Bad Scale (Lees-Haley, English, & Glenn, 1991), more specifically
designed to tap exaggeration observed in personal injury contexts, has proven a fairly
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useful measure in the evaluation of exaggerated neurocognitive deficits (Dearth et al.,
2005; Greiffenstein et al., 2002; Larrabee, 2003a; Miller & Donders, 2001; Ross et al.,
2004; Slick, Hopp, Strauss, & Spellacy, 1996; Tsushima & Tsushima, 2001). However,
concerns about elevated rates of false positive errors in medical and psychiatric patients
have been raised (Butcher, Arbisi, Atlis, & McNulty, 2003; Greiffenstein et al., 2002;
Iverson, Henrichs, Barton, & Allen, 2002).
During development, two scales incorporated into the PAI were intended to detect
potentially problematic degrees of negative response bias: NIM and Malingering (Morey,
1996). A high score on NIM suggests that the individual has portrayed themselves in a
more negative light than would most objective observers, although malingering is not
necessarily indicated. Morey noted that a pervasively negative view of one’s self and
others is inherent to many psychiatric conditions, including depression. Therefore,
psychopathology is confounded with NIM. Scores on NIM are higher in clinical
populations, and the NIM score correlates with DEP scores. Nonetheless, invalidity of
the profile is strongly indicated by scores above 9 IT, whether these elevations are due to
careless responding, malingering, or pervasively negative representations. The accuracy
or usefulness of information that might be gleaned from such a profile is presumably nil
or negligible, and the risk of inaccurate interpretations is high, regardless of the reason
for the elevation, according to Morey.
A cutoff of 92T on NIM correctly classified 86.5% of simulated malingerers
asked to feign a severe psychiatric disturbance and 94.1% o f the clinical sample in the
first validation study (Morey, 1991). A subsequent simulation study demonstrated that
NIM correctly identified 90.9% of profiles simulating schizophrenia, 55.9% o f profiles
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simulating depression, and 38.7% of profiles simulating generalized anxiety disorder,
using a cutoff of 8 for raw scores on NIM (Rogers, Omduff, & Sewell, 1993). The
finding that NIM is more sensitive to feigning of severe psychiatric symptomatology,
such as psychotic symptoms, parallels findings regarding F on the MMPI. In addition,
sophisticated simulators (i.e., clinical psychology graduate students permitted one week
for preparation) were more effective than naive simulators in producing higher elevations
on the Depression scale while continuing to evade detection (Rogers et al., 1993).
A follow-up study sought to discriminate between the profiles of simulated
malingerers and clinical patients with the target disorders (Rogers et al., 1996). Naive
simulators (i.e., undergraduates) tended to produce elevations across several scales, while
sophisticated simulators tended to produce selective elevations consistent with the target
disorder. Although NIM scores were generally higher for naive simulators, the NIM
scores for sophisticated simulators feigning generalized anxiety and major depression
were comparable to those of patients diagnosed with those conditions. Use of the
optimum cutting score for NIM resulted in the identification of only 2/3 of naive
simulators, and was essentially useless in the detection of sophisticated simulators
feigning anxiety or depression. In conjunction with prior findings, the authors concluded
that response bias scales composed of very unusual symptoms were not very useful in the
detection of feigned mood disorders, and that a new approach was necessary.
Rogers et al. (1996) observed that simulators had more difficulty generating
profiles that accurately represented the pattern of scores across scales and subscales
usually seen in clinical patients. For example, individuals feigning psychotic disorders
tend to endorse too many positive symptoms on the SCZ-P scale, in combination with too
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few symptoms of cognitive inefficiency on the SCZ-T scale. Therefore, they examined
whether discriminant function analyses could discriminate simulators from clinical
patients on the basis of 20 clinical scales and subscales. An overall hit rate of 92.2% was
found for the calibration sample, whereas an overall hit rate of 80.4% was found for the
cross-validation sample. Use of standardized canonical coefficients may hold some
promise in the detection of exaggerated and/or feigned psychopathology, particularly
mood disorders. The authors caution that use of the Rogers Discriminant Function (RDF)
should be restricted to screening purposes, considering the lack of replication in a knowngroups design and the misclassification of approximately 20% of psychiatric patients in
the cross-validation sample. Arguably, this is an unacceptably high false positive rate for
use in clinical settings, given the seriousness of the consequences that could ensue.
Indeed, the cut-off may require adjustment for general clinical use.
Morey (1996) reported RDF scores for a variety of clinical and non-clinical
samples obtained for original validation purposes. Mean elevations for the “fake bad”
sample were above the recommended RDF cut-off, with mean scores from other samples
falling two to three standard deviations lower. Unfortunately, specificity rates, or some
indication of the number of clinical patients that exceed the cut-off, were not provided.
Interestingly, RDF scores were not substantially correlated with scores on NIM or F from
the MMPI, which Morey interpreted as suggesting that the function is tapping a relatively
distinct and independent aspect of negative response bias. The correlation with the
Malingering Index (MAL) of the PAI was somewhat higher.
MAL is the second indicator of negative response bias included on the PAI
(Morey, 1996). Conceptually, it relies on the earlier-noted observation that simulators
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have difficulty reproducing across-scale patterns observed in actual patients. It includes
eight configural features that are observed more frequently in simulators than in clinical
samples, with some items being related to erroneous stereotypes about psychopathology
held by laypersons. For example, very high scores on the Depression scale are usually
associated with strong recognition of the need for psychological change and motivation
for therapeutic intervention, which manifests by very low scores on the RXR scale.
Therefore, one point is scored if extreme elevations on the Depression scale are
accompanied by RXR scores in the normal to high range. One point is scored for each of
eight configural feature present in the profile. A score of 3 on the Malingering Index
constitutes an elevation of two standard deviations above the mean of the clinical sample,
while a score of 5 is deemed to strongly suggest malingering, according to Morey.
Use of the PAI in TBI
Relative to the MMPI-2, several features of the PAI facilitate its administration to
and interpretation in cognitively impaired populations. It is shorter than the MMPI.
Indeed, the PAI includes 344 items (Morey, 1991), which is considerably fewer than the
567 items administered for the full version of the MMPI-2 and slightly fewer than the 370
items for the abbreviated version. All items on the PAI contain fewer than 14 words, and
only five items are in the passive voice (Morey, 1991). This contrasts with several
lengthy and/or complex items on the MMPI that could be challenging for individuals with
cognitive impairment secondary to TBI. This possibility is supported by prior literature
indicating that cognitive deficits observed in neuropsychological practice, such as
reduced memory, attention, and concentration, may lead to invalidity of MMPI profiles
(Mittenberg et al., 1996). The PAI requires only a grade 4 reading level, with the average

38

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

word length being 1.37 syllables (Morey, 1991), whereas many items on the MMPI-2
require an 8th or 9th grade reading level (Paolo, Ryan, & Smith, 1991). Review of the PAI
items confirms they are easy to comprehend without an advanced vocabulary, which is
beneficial for use in populations with limited education. The PAI retains several
advantages of the MMPI-2, such as the sampling of a wide range of behaviours that could
reflect psychopathology and the inclusion of validity indicators for frequency, response
bias, and consistency.
Despite apparent advantages for use in a TBI population, there is reason to
suspect that the PAI may be plagued by medical or neurological content bias, much like
the MMPI. Several examples of items that could tap neurological dysfunction in TBI,
independent of psychopathology, are listed in Appendix B for illustrative purposes. [In
the final dissertation, Appendix B is not reproduced in its entirety due to test security and
copyright issues.] Sensitivity of several PAI scales to medical or neurological issues has
been noted by some authors, although the basis for these comments appears to have been
anecdotal, based on educated conjecture, or derived from review of insufficiently
characterized patient groups. For example, Cripe (1999) commented on the sensitivity of
the somatic and depression scales to complaints pursuant to TBI. Morey (1996) stated
that moderate elevations could be expected on the SOM-C subscale for an individual with
mild sensorimotor impairments, such as those caused by minor cerebrovascular infarcts.
He further stated that elevations on the overall SOM scale could not differentiate between
organic and functional contributions to symptomatology. He also specified that
elevations of the SCZ-T scale are commonly seen in conjunction with cognitive
impairment, likely due to memory and concentration deficits. Additionally, Morey

39

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

opined that elevations on the DEP scale could reflect physiological symptoms associated
with organic conditions or a depressive reaction to said organic condition.
Based on the clinical experience of the author with this instrument, non-traditional
explanations (or alternative interpretive hypotheses) for elevations on a variety of
subscales may be considered in individuals who have sustained CHI. Elevations on all of
the somatic subscales could be directly attributable to medical and/or neurological
symptoms. High scores on DEP-P, reflecting what has been termed neurovegetative
symptoms of depression, could be due to physiological dysfunction secondary to brain
injury. The SCZ-T subscale may be elevated due to cognitive deficits arising from CHI,
whereas BOR-A may be elevated due to affective lability. In some individuals,
elevations on BOR-I may be secondary to considerable changes in vocational and family
roles consequent to the injury. AGG-V and AGG-P elevations could be secondary to
disinhibition. Note that these potential explanations are intended only as hypotheses that
are to be confirmed or disconfirmed via the clinical history or record review in individual
cases. Their commonality across individuals who have sustained TBI is not implied, nor
is an expectation of elevated mean scores on these subscales for any TBI group. Indeed,
the frequency of elevations on these scales following TBI has yet to be documented in
peer-reviewed literature, or replicated across independent samples.
Less than one page (p. 195) is devoted to issues specific to “organic mental
disorders / cognitive disorders” in Morey’s (1996) Interpretive Guide for the PAI. Less
than 30 individuals were included in the “organic” group used for development of the
PAI (Morey, 1991); it is unclear precisely what constituted inclusion criteria for this
“organic group”. Despite the range and heterogeneity of disorders that could be
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subsumed under this rubric, Morey stated that “a person with central nervous system
compromise will not obtain scale elevations merely as a function of the organicity; in
fact, over 40% of such patients obtain no clinical elevations above 70T (Morey, 1991)”
(p. 195). In the opinion of the current author, the possibility of neurological content at
the item level, and of spurious inflations at the clinical scale level, warrants empirical
investigation in neurological populations of various etiologies.
Even if the clinical scales are sensitive to or inflated by endorsement of medical
items, the subscales that include more homogeneous content may prove useful in
clarifying the source of elevations on clinical scales and refining resultant interpretations.
In this fashion, their use and interpretive value bears resemblance to the Harris-Lingoes
and Content scales of the MMPI-2. These subscales could be particularly useful in the
evaluation of patients who have sustained CHI. The DEP-A subscale isolates the
dysphoric mood and/or anhedonia required for diagnosis of a mood disorder. The score
is not inflated by neurovegetative disturbances (e.g., sleep and appetite disturbance) that
are often associated with depression, but could be causally related to neurological injury,
particularly in severe TBI. Likewise, the SCZ-T subscale might provide a convenient
tool to determine whether cognitive complaints are contributing to overall elevations on
the SCZ clinical scale.
While this author could speculate endlessly, empirical studies about the PAI
following TBI in the peer-reviewed literature are fairly sparse. There are few published
reports describing profiles commonly observed in this population, or reports linking
personality profiles to injury variables such as time since injury or injury severity.
Studies demonstrating correlations between post-injury cognitive complaints on the PAI
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and objective cognitive performance, or the lack thereof, are not available in the
literature. Potential neurological content bias has not been systematically investigated.
Although there is reason to believe that the PAI may be a more appropriate measure than
the MMPI-2 in select clinical evaluations following TBI, a more extensive empirical base
is required to enhance general clinical knowledge germane to appropriate uses of and
interpretation of the PAI in this population. Furthermore, generation of peer-reviewed
literature would be helpful in bolstering arguments of admissibility under Daubert, when
the measure is used in this population. (See Lees-Haley, Iverson, Lange, Fox, & Allen,
2002, for a discussion of potential Daubert challenges arising from interpretation of
MMPI profiles in TBI that are not generally agreed upon.)
Rationale for the Current Study and Hypotheses
The overarching goal of this dissertation is to provide information that is relevant
to the use of the PAI in CHI. This overarching goal can be parcelled into three sub-goals
that involve describing PAI profiles associated with CHI, addressing neurological content
at the item level, and evaluating the correspondence between objective cognitive
performance and scores on cognitively loaded PAI scales, particularly SCZ-T.
The first goal of the current study is to describe the personality profiles generated
by the obtained CHI sample. As a preliminary step, this can be accomplished by
computing mean PAI scores for the total sample to determine whether particular
complaints are common enough that mean elevations on select clinical scales or subscales
are within the range of clinical significance (i.e., T scores of at least 65). Complaints of
somatic dysfunction, depression, and cognitive disturbance are common in this
population, leading to the possibility that PAI scales germane to these domains would

42

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

show mean elevations in the clinically significant range. Other issues (e.g., affective
instability, irritability, verbal aggression) are expected to represent challenging areas of
functioning for a more limited subset of the CHI sample. The proportion of the sample
reporting problematic degrees of symptomatology in these domains may be too small to
produce considerable elevations in mean PAI scores for the total sample. However,
computation of PAI scores representing select percentile levels can provide an estimate of
the distribution of scores for any given clinical scale or subscale. In particular, 75th or
90th percentile scores greater than a T score of 65 for a given PAI scale would indicate
that the construct tapped by that scale represents a challenging area of functioning for a
considerable minority of the CHI sample.
In describing the PAI profiles of the obtained CHI sample, it is also of interest to
contrast PAI profiles following mild CHI (mCHI) to those following moderate to severe
CHI (sCHI). This comparison can be accomplished statistically via profile analysis,
although graphical representation of mean PAI scores according to injury severity will
facilitate description and interpretation. Based on findings with the MMPI, it would be
predicted that the mCHI sample would obtain higher PAI scores than the sCHI sample on
a variety of scales, particularly those representing symptoms of depression, somatic
dysfunction, and cognitive disturbance. In general, it is important to note that the first
goal is strictly and entirely descriptive. There is no explicit or implicit goal to attribute
observed elevations to causes of a neurological, medical, psychosocial, or emotional
nature, whether premorbid or reactive. Indeed, observed elevations could be due to any
of the above factors, or some combination thereof.
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The second goal is to determine whether neurologically relevant items can
discriminate between a CHI sample and a normal group. Prior studies have demonstrated
that MMPI items that appear to tap bona fide medical or neurological symptoms can, in
fact, discriminate between neurological samples and comparison samples. By extension,
one might infer that several items on the PAI could be tapping neurological or medical
symptoms directly caused by sustained injuries. True determination of neurological or
medical bias would require demonstration that inflated elevations on the clinical scales
lead to incorrect classification, or differential classification, of the CHI subjects in
relation to external criteria known to reflect psychopathology. Even in the absence of this
demonstration, however, several items ostensibly reflecting neurological dysfunction
might be found to discriminate the CHI subjects from a variety of other groups, using a
rational-empirical method.
The current study shall employ a combination of rational and empirical methods
to address the issue of neurological content in the PAI at the item level. Specifically,
clinical neuropsychologists deemed expert raters will be asked to select items they
believe could reflect common sequelae of “moderate to severe CHI”. The distributions of
scores for selected items can then be contrasted for the sCHI group and the normative
sample used for standardization of the PAI. For the purpose of identifying neurologically
relevant items that could reflect bona fide neurological or medical symptoms secondary
to CHI, analyses shall be restricted to those who sustained sCHI for several reasons.
First, the argument could be made that the majority of subjects who had sustained mCHI
more than one year prior should have completely recovered from a neurological
perspective and that residual complaints are more germane to psychiatric manifestations
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than to bona fide neurological dysfunction. Second, expert raters will be asked to
identify items that could reflect moderate to severe CHI to ensure their focus on
unequivocal documented neurological injury, rather than equivocal symptoms of
uncertain etiology (e.g., post-concussional symptoms) sometimes observed following
CHI of lesser severity. Despite this, item endorsement in the mCHI group will be
compared to that in the normative sample in an attempt to replicate neurological items
identified via comparison to the sCHI group, as in the cross-validation conducted by Gass
and Wald (1997).
A composite score representing endorsement of neurologically relevant items on
the PAI shall be constructed by summing the scores on all PAI items selected by the
expert raters that are found to discriminate between the normative sample and the sCHI
sample. This sum shall, hereafter, be referred to as the Neuro-Item Sum. The nature of
the Neuro-Item Sum, including the underlying constructs that influence endorsement of
neurologically relevant items, may be illuminated by consideration of the convergent and
divergent validity of the Neuro-Item Sum. In particular, group comparisons and
correlation analyses can be utilized to quantify the relationship of the Neuro-Item Sum to
a variety of demographic variables (i.e., age, education), injury parameters (i.e., injury
severity, time since injury), response bias indicators (e.g., NIM, PIM), and cognitive
scores. Since depression is associated with increased self-report of cognitive deficits
(Coleman, Sackeim, Prudic, Devanand, McElhiney et al., 1996; Larrabee & Levin, 1986)
and neurobehavioural factors derived from the MMPI correlate with depression (Brulot et
al., 1997), the relationship of the Neuro-Item Sum to DEP scores is also to be considered
in this context.
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The third goal is to evaluate possible relationships between objective
neuropsychological performance and scores on cognitively loaded scales and subscales of
the PAI. The SCZ scale, with its component SCZ-T subscale, contains items germane to
cognitive disturbance, including references to confusion, poor concentration, scrambled
thoughts, and tangentiality. Therefore, the magnitude of correspondence between
cognitive complaints on the PAI (particularly SCZ-T) and objective cognitive
performance shall be evaluated for the mCHI group and the sCHI group. The correlation
between objective test performance and cognitive complaints may be attenuated in the
sCHI group due to the prevalence of limited insight into cognitive deficits in this group.
Objective cognitive measures to be used for this purpose include tasks of attention,
concentration, and memory, in addition to a neuropsychological composite score
ostensibly sensitive to cognitive impairment secondary to CHI (i.e., the Average
Performance Rating described later). Furthermore, correlations with Full Scale IQ
(FSIQ) are to be computed to consider relationships to overall cognitive functioning.
Specifically, correlations between scores on SCZ and SCZ-T and the following cognitive
scores are to be computed: Arithmetic, Digit Span, Longest Digest Span Forward,
Longest Digit Span Backwards, Letter-Number Sequencing, Spatial Span, Longest
Spatial Span Forward, Longest Spatial Span Backwards, Consonant Trigrams Total, Long
Delay Free Recall on the California Verbal Learning Test - II (CVLT-II), Total Learning
on the CVLT-II (i.e., Trials 1 to 5 total), Verbal Fluency (FAS), Trails B, Coding from
the WAIS-III, Average Performance Rating, and FSIQ from the WAIS-III.
Although exaggeration of psychopathology and neurological deficits can co
occur, some evidence suggests that they reflect independent factors (Greiffenstein et al.,
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1995), with minimal correlations between scores on psychopathology indices of
malingering and measures of cognitive effort (McCaffrey et al., 2003). Traditional
personality indices designed to detect exaggeration of psychopathology are not always
optimally sensitive to the exaggeration of neurocognitive deficits that are more
commonly suspected in personal injury litigation (Boone & Lu; 1999; Dearth et al., 2005;
Greiffenstein et al., 2002; Greiffenstein et al., 1995; Larrabee, 1998; Larrabee, 2003a;
Lees-Haley et al., 1991; McCaffrey et al., 2003; Ross et al., 2004). The PAI does not
include a measure analogous to the Fake Bad Scale (Lees-Haley et al., 1991), one
specifically intended for use in the detection of exaggeration in personal injury contexts.
Inclusion of PAI profiles from individuals with suspect effort on
neuropsychological measures could lead to spurious elevations on PAI scales with
content germane to somatic or cognitive sequelae of CHI. When empirically selecting
neurologically relevant items, inclusion of the subjects feigning neurocognitive deficits
could confound or obscure legitimate differences between bona fide CHI and control
groups that might otherwise be identified on the basis of truthful symptom report. For
example, items that do not represent bona fide symptoms could empirically be found to
discriminate between the neurological and normal groups. Finally, inclusion of subjects
with suspect effort on neurocognitive measures could spuriously inflate observed
correlations between neuropsychological performance and PAI scales tapping cognitive
complaints. The purposes of the current study are to describe PAI profiles that are
presumed legitimate, to isolate item endorsement reflecting bona fide medical or
neurologic symptoms, and to evaluate the relationship of cognitively loaded PAI scores to
objective neuropsychological performance in a sample presumed to be putting forth
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adequate effort on objective measures and responding honestly on the PAI.
Consequently, all analyses herein will exclude subjects producing PAI profiles of
questionable validity according to negative response bias indicators derived from the PAI
(i.e., NIM, MAL, or RDF) and subjects for whom exaggeration of neurocognitive deficits
was suspected due to poor performance on free-standing or embedded measures of effort
(i.e., TOMM, RELDS, or CVLT-II Recognition Hits).
Hypotheses
The following hypotheses are provided in relation to the aforementioned goals.
Hypothesis 1:
In the whole sample, mean elevations in the clinically significant range will be observed
on several PAI scales and subscales reflecting common presenting complaints following
CHI, particularly those associated with DEP (DEP-A, DEP-C, and DEP-P), SOM (SOMC, SOM-S, and SOM-H), and SCZ-T.
Hypothesis 2:
As shown by PAI scores at the 75th and/or 90th percentile levels that are greater than a T
score of 65, a sizeable minority of the CHI sample (i.e., between 10% and 25%) will
report challenges in functioning that are tapped by the following scales: ANX (ANX-A,
ANX-C, ANX-P), ARD-T, ARD-P, BOR-A, BOR-I, MAN-I, AGG-V, and AGG-P.
Hypothesis 3:
Relative to individuals who have sCHI, individuals who have sustained mTBI will exhibit
higher scores on several PAI scales, particularly those associated with depression,
somatic complaints, and cognitive disturbance, a paradoxical prediction consistent with
findings in the literature based on the MMPI.
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Hypothesis 4:
The expert raters will select several PAI items for which endorsement in the pathological
direction could reflect common sequelae o f sCHI. These items are likely to be included
in clinical subscales germane to anxiety, somatic complaints, thought disturbance,
affective instability, irritability, verbal aggression, physical aggression, and depression,
particularly physiological symptoms of depression.
Hypothesis 5:
O f the neurologically relevant items selected by expert raters, only a subset will be found
to empirically discriminate between the sCHI group and a normal control group. The
nature of the Neuro-Item Sum will be clarified by its pattern of associations with
demographic variables, injury parameters, objective cognitive performance, scores on
response bias indicators of the PAI, and depression.
Hypothesis 6:
Scores on PAI subscales that tap cognitive complaints will be negatively correlated with
objective performance on measures of working memory, memory, set-shifting, and
measures sensitive to CHI sequelae. Given the limited insight about cognitive deficits
sometimes observed in sCHI, correlations between cognitive complaints and objective
test performance may be attenuated in the sCHI group relative to the mCHI group.
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Chapter II
Method
Measures
All subjects in the current study had undergone a comprehensive
neuropsychological evaluation for clinical and/or legal purposes. Given the retrospective
nature of the study, it was not possible to ensure that all subjects had completed precisely
the same neuropsychological battery, although considerable consistency across subjects
was achieved for the many of tests analyzed herein. Several psychological measures
could be characterized as central to the hypotheses and issues addressed in this study.
These central measures had been administered to the vast majority, if not all, of the
subjects. Indeed, completion of select measures, including the PAI, was required for
inclusion in this study. Other psychological measures used in this study could be
characterized as supplementary; it was less critical that all subjects had completed the
measure of interest. For example, when evaluating the correlations between elevations
on SCZ-T and objective neuropsychological measures, not all subjects had completed all
of the objective measures for which analyses were conducted. With regard to these
correlation analyses, the number of subjects for whom data was available can be
determined by reference to the associated table.
Central Personality and Neuropsychological Measures
For obvious reasons, completion of the PAI was required for inclusion in this
study. Only subjects who had completed both the TOMM and RELDS were included in
the current study, because it was crucial to consider and address the possibility of
neurocognitive feigning in this forensic sample. Since an inadequate score for
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Recognition Hits from the CVLT-II is suggestive of poor effort but should not be used in
isolation to diagnose malingering, completion of the CVLT-II was not mandatory for
inclusion in the study. Nonetheless, this score was available for most of the sample and
was utilized when it had been administered. [Due to test security concerns, these
measures are not described in further detail.]
Supplementary Neuropsychological Measures
Several measures were utilized from the Wechsler Adult Intelligence Scale -Third
Edition (WAIS-III; The Psychological Corporation, 1997a). These included FSIQ that
summarizes overall intellectual functioning and the Index Scores representing the four
factors of the WAIS-III, namely the Verbal Comprehension Index (VCI), the Working
Memory Index (WMI), the Perceptual-Organization Index (POI), and the Processing
Speed Index (PSI). These scores are standard scores, calculated in the customary fashion.
Individual subtests from the WAIS-III utilized in the current study were: Coding,
Arithmetic, Digit Span, and Letter-Number Sequencing. The Coding subtest is a task of
speeded symbol substitution that is sensitive to deficits in speed of information
processing. Arithmetic, Digit Span, and Letter-Number Sequencing are generally
characterized as measures of verbal attention and working memory. Arithmetic requires
mental computation of mathematical problems, whereas Letter-Number Sequencing
requires reorganization of letters and numbers while holding this information in short
term memory. Scores for individual subtests on the WAIS-III are scaled scores. The
Longest Digit Span Forward and Longest Digit Span Backwards were also recorded from
Digit Span, with these scores being the actual raw scores.
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The only score used from the Wechsler Memory Scale - Third Edition (WMS-III;
The Psychological Corporation, 1997b) was the one derived from the Spatial Span
subtest. This subtest, a measure of visual-spatial working memory, requires the repetition
of strings of spatial positions in forward and reverse orders. The overall score for Spatial
Span represents a scaled score, computed in accordance with standard WMS-III
instructions. The maximum numbers of spatial positions correctly recalled in forward
and reverse orders were also recorded, providing scores for Longest Spatial Span
Forward and Longest Spatial Span Backwards, respectively. The latter scores represent
raw scores that are not corrected for demographic variables such as age.
Consonant Trigrams is a task of short-term verbal memory and resistance to
interference that requires retention of consonants over a short delay period in which
mental arithmetic is completed. Scores reported herein are T scores for the total number
of consonants correctly recalled across all delay periods, scored in accordance with the
norms provided by Stuss and colleagues in 1998 (as shown in Spreen & Strauss, 1998).
Two scores, namely Trials 1 to 5 and Long Delay Free Recall, were derived from
the performance on the CYLT-II (Delis, Kramer, Kaplan, & Ober, 2000), a verbal
learning task. The score for Trials 1 to 5 is reported as a T score representing total recall
across learning trials. Long Delay Free Recall, a z-score, represents uncued recall
following the longest delay period on the CVLT-II.
Finally, verbal fluency (FAS) is a measure of speeded lexical retrieval. Scores
reported herein represent z-scores computed on the basis of norms provided by
Tombaugh, Kozak, and Rees in 1996 (as cited in Spreen & Strauss, 1998). Trails B is a
speeded alphanumeric sequencing task, with total time to completion having been
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converted to a T score equivalent by reference to the Heaton, Grant, and Mathews (1991)
norms.
Neuropsychological Composite Score
To quantify the severity of neuropsychological impairment at the time of
assessment, a neuropsychological composite score labelled the Average Performance
Rating (APR) was calculated for each subject. This was accomplished by computing the
average of T scores achieved on each of verbal fluency (FAS), Trails B, Coding from the
WAIS-III, and Total Learning on Trials 1 through 5 of the CVLT-II. The measures
comprised in the APR were selected to maximize sensitivity to the sequelae of CHI in
this sample. In the final sample used for analyses herein, 11 participants (5 with mCHI
and 6 with sCHI) had completed alphanumeric sequencing as part of the Delis-Kaplan
Executive Function System; in these cases, scaled scores for letter-number switching
were substituted for Trails B in computing the APR. Scores for Coding and Verbal
Fluency were available for all subjects. Eight subjects were lacking scores for Trials 1
through 5 on the CVLT-II; for these subjects, the computed value for the APR was based
on the scores for the other three component measures. The APR was not computed for
one subject because scores were available for less than three of the component measures.
Participants
The sample in the current study represents consecutive referrals to a private
practice in clinical neuropsychology for evaluation of potential sequelae arising from
CHI. All subjects were outpatients at the time of evaluation. Referral sources included
case managers, insurers, attorneys, and a variety of treating practitioners such as family
physicians, chiropractors, and speech language pathologists. This sample is
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predominantly forensic in nature in that civil litigation and/or compensation - seeking
was actively ongoing or an impending possibility for the vast majority, if not all, of the
subjects. Data were collected by retrospective file review.
Based on a priori inclusion criteria, all subjects were between the ages of 18 and
60 years of age at the time of assessment. Inclusion criteria were relatively broad to
maintain the representativeness of the sample to populations routinely evaluated in
clinical practice in outpatient settings, particularly in the context of third-party
evaluations. Subjects were not excluded due to prior history of learning difficulties,
chronic pain, substance abuse, litigation status, or pre-existing medical and/or psychiatric
difficulties. On the other hand, subjects whose performance was judged to be grossly
affected by a condition unrelated to the brain injury were excluded. Specifically, one
individual was excluded due a long-standing, well-documented history of premorbid
schizophrenia. When an individual meeting the selection criteria had completed more
than one neuropsychological evaluation, the earliest evaluation that included requisite
data (i.e., the PAI, the symptom validity tests, and a reasonable selection of
supplementary neuropsychological measures composing the APR) was selected for
inclusion.
All subjects sustained at least a mild brain injury, according to the criteria of the
Mild Traumatic Brain Injury Committee of the American Congress of Rehabilitation
Medicine (1993). Specific criteria included at least one of the following: any period of
loss of consciousness, any loss of memory (whether retrograde or anterograde), any
alteration in mental state, or the manifestation of focal neurological deficits. Individuals
who presented with loss of consciousness greater than one hour, post-traumatic amnesia
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of greater than 24 hours, and GCS less than 13 were deemed to have sustained a moderate
to severe brain injury, consistent with the aforementioned criteria. Furthermore, the
emphasis of the current study was on closed head injury in particular. The expectation
was that the majority of injured subjects would have sustained diffuse injuries
concomitant to axonal shearing typical of acceleration-deceleration brain injuries
sustained in motor vehicle accidents. Therefore, individuals who had sustained
predominantly focal, penetrating wounds were excluded. On the other hand, individuals
who presented with focal lesions superimposed upon more diffuse injuries (e.g., frontal
hematoma or contusion associated with acceleration-deceleration injury) were not
excluded.
Applying the aforementioned selection criteria to the consecutive referrals for
which ethics approval had been secured, data were amassed for a total of 139 CHI
subjects. Of these, 91 were deemed to have sustained mCHI, while 48 were deemed to
have sustained sCHI.
The sample was then refined by including only those with adequate performance
on free-standing and embedded measures of neurocognitive effort. Specifically, all
included subjects achieved scores of 45 or more on the 2nd trial of the TOMM, consistent
with the recommended cut-off for this measure (Tombaugh, 1996), and scores of at least
7 for RELDS (cf. Greiffenstein et al., 1994; Heinly et al., 2005). Additionally, the
CVLT-II had been administered to 130 of the original sample of 139. Of these, only
subjects who obtained raw scores of 11 or more for Recognition Hits on the CVLT-II
were included in the CHI sample. In total, 31 participants were excluded because scores
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achieved on one or more of these measures suggested the possibility of incomplete effort
on neurocognitive instruments.
The PAI profiles generated by the CHI sample were then screened for validity in
several respects. First, PAI profiles were screened to ensure that participants had
attended to and were responsive to item content. Specifically, profiles were excluded if
obtained scores were greater than a T score of 74 on INF or greater than a T score of 72
on ICN, as suggested by Morey (1991). Of the initial 139 subjects, 10 obtained scores
above the recommended cut-offs on either INF or ICN. Second, PAI profiles were
excluded if negative response bias was suspected, as evidenced by scores greater than 91
T on the NIM Scale of the PAI (Morey, 1991), raw scores of greater than 4 on the MAL
Index of the PAI (Morey, 1996), or scores greater than 1.50 (approximately 73 T) on the
RDF (cf. Morey, 1996). Relatively high cut-off scores, usually considered to indicate
definite invalidity, were selected since use of these cut-off scores has not previously been
investigated in TBI samples. Using the MMPI, other researchers have noted that a high
proportion of CHI cases are excluded on the basis of conservative validity criteria and
have consequently increased the cut-off scores used for sample selection (see Alfano et
al., 1993). In total, 6 of 139 profiles exceeded one or more of the cut-off scores for
negative impression management. Only nine subjects with adequate effort were deemed
to have invalid PAI profiles by the chosen standards for PAI validity (i.e., INF, ICN,
NIM, RDF, and MAL).
Applying all of the above criteria resulted in a total sample size of 99 subjects, 61
of whom had sustained mCHI and 38 of whom had sustained sCHI. Mechanisms of
injury for each of the groups are listed in Table 1. As can be seen, the majority of
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Table 1
Mechanisms of Injury for the Mild CHI (n = 61) and Moderate to Severe CHI (« = 38)
Groups

Injury Severity

Mild

Moderate to Severe

Mechanism of Injury

n

n

Auto collision

52

27

Pedestrian struck by auto

2

4

Motorcycle accident

2

2

Snowmobile accident

2

2

Dirt bike accident

1

0

Fall

1

1

Falling Object

1

0

Assault

0

2
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subjects alleged their injuries were the result of motor vehicle accidents. Demographic
data for each of the severity groups is presented in Table 2, as are group comparisons.
The groups did not differ significantly with regard to age. With regard to chronicity, the
presence of outliers inflated the mean and standard deviation time since injury for the
sCHI group, but use of non-parametric Mann Whitney U to compare the groups on this
variable failed to show any significant difference. The mCHI group presented with
slightly higher educational achievement than the sCHI group, although FSIQ did not
differ by injury severity. Group differences in gender composition are identified in Table
3. Although the total sample includes a comparable number of female and male subjects,
females are over-represented in the mCHI group and under-represented in the sCHI
group. Male subjects were evenly distributed between the injury severity groups.
Analyses
Goal 1: Describing the PAI Profiles of the Sample
Mean PAI scores were computed and plotted for the total CHI sample. PAI scores
representing the 10th, 25th, 50th, 75th, and 90th percentile levels were also computed.
Mean elevations on the PAI scales were illustrated separately for the mCHI and sCHI
groups. Profile analysis was employed to determine whether the PAI profiles of the
injury severity groups were parallel and flat, and to identify overall differences in the
levels associated with injury severity. Profile analysis requires that the smallest group
include more subjects than dependent variables as a minimum, and singularity is to be
avoided when selecting dependent variables to include in any given analysis (Tabachnick
& Fidell, 2001). Considering these statistical requirements, two separate profile analyses
were employed to compare the profiles of those who had sustained mCHI to those who
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Table 2
Demographic Data for the Mild CHI (n = 61) and Moderate to Severe CHI (n = 38)
Groups

Mild CHI

Moderate to Severe CHI

Variable

M(SD)

M(SD)

Months since injury

19(16.8)

Age in years

t

U

P

33.7 (76.8)

1029

.349

35.7 (11.0)

35.4 (12.6)

1116.5

.760

Years of education

14.1 (2.6)

12.1 (2.7)

3.602**

.001

Full Scale IQ

101.8 (15.1)

98.1 (11.1)

1.299

.197

* *p < 0 .0 1
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Table 3
Gender by Injury Severity

Male Female
Injury Severity

n

n

Total n by Severity

Mild

23

38

61

Moderate / Severe

24

14

37

Total n by Gender

47

52

Chi-Square

p

6.083*

0.014

*p < 0.05
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had sustained sCHI. The first profile analysis included all variables from the customary
PAI profile (i.e., eleven clinical scales, five treatment scales, and two interpersonal
scales) as dependent variables. The clinical subscales were analyzed separately in a
second profile analysis, independently from the clinical scales they comprise. Traditional
validity indicators on the PAI (i.e., INF, ICN, NIM, and PIM) were omitted from profile
analyses since validity scores were initially used to select subjects and elevations
potentially reflected methodological procedures, at least to some degree. It should also
be noted that RDF, CDF, MAL, and DEF could not be entered into profile analyses
because available scores were raw scores, which were not scaled in the same fashion as
the traditional PAI scores. Since univariate and multivariate outliers were detected and
profile analysis is sensitive to outliers, both profile analyses were repeated after excluding
outliers.
In file instance of significant findings for the omnibus profile analysis, further
analysis was required to isolate the source(s) of significant differences between the injury
severity groups. An infinite number of contrasts could be completed in profile analysis.
According to Tabachnick and Fidell (2001), interaction contrasts should be used to follow
up profile analyses that are significant for parallelism, levels, and flatness. However, in
this case, our interest is in determining whether the mCHI and sCHI groups produce
comparable scores for each of the PAI variables, which is akin to a simple effects
between-subject analysis. Indeed, the demonstrated method for follow-up analyses of the
latter variety is a series of one-way ANOVA analyses. In addition, we are interested in
determining whether elevations on particular PAI scales continue to differ by injury
severity when holding the levels constant (or controlling for overall differences in
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elevations across the groups). For the purpose of “holding the levels constant”,
controlling for MCELEV appeared more appropriate than controlling for the average
elevation on an arbitrary selection of PAI scales. The reason is two-fold: higher
elevations on the clinical scales consistently indicate greater pathology and MCELEV is a
clinically intuitive score that is obtained during routine scoring. Therefore, in the
instance that significant differences by injury severity were identified during earlier
ANOVA analyses, follow-up ANCOVA analyses were conducted to determine whether
differences remained significant after controlling for MCELEV.
Considering the exploratory nature of the study, comparisons of group means for all
available PAI scores are desirable. There are 8 validity scales, 11 clinical scales, 5
treatment scales, 2 interpersonal scales, and 31 clinical subscales, generating a total of 57
PAI scores warranting group comparison. The number of post-hoc comparisons is clearly
large enough to warrant some reduction in the per-comparison alpha level to minimize
family-wise Type I errors. On the other hand, use of a Bonferroni correction that
maintained a family-wise Type I error at only 5% was deemed to reduce power too much,
given the high number of comparisons and the particularly stringent critical alpha level
that would result. Therefore, we opted to select a critical per comparison alpha that
would maintain a family-wise Type I error rate of 15% when conducting follow-up
analyses for each of the profile analyses. This appeared to be a reasonable compromise
between the competing goals of correcting for the elevated number of comparisons and
permitting enough power to detect legitimate group differences. Since there are 18
variables in the first profile analysis, the critical probability level computed for follow-up
ANOVA analyses is 0.008. Since there are 31 clinical subscales included in the second
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profile analysis, the critical probability level for these follow-up ANOVA analyses is
0.005. Although there is a 15% probability of one Type I error in the group comparisons,
it should be noted that the resulting alpha levels are fairly stringent nonetheless, thereby
reinforcing the notion that the majority of detected group differences represent bona fide
differences between the injury severity groups.
Several scores from the PAI, including validity indices, were omitted from profile
analyses. Elevations on the validity scales for the injury severity groups could, at least in
part, reflect the methodology used herein, since validity scores were initially used to
select the sample. Consequently, scores on these validity indices and associated injury
severity comparisons are not entirely accurate from a descriptive perspective, nor are they
necessarily representative of larger mCHI or sCHI samples. Nonetheless, it is of interest
to consider potential differences in validity scores for the two samples for which profile
analyses and group comparisons were conducted herein. Therefore, group comparisons
were used to determine whether the mCHI and sCHI samples differed with regard to PAI
validity scores. Other scores omitted from the profile analyses were those that are not
scaled in the same fashion as customary PAI scores (e.g., CDF and MAL). The
possibility of differences according to injury severity for these variables was also
analyzed separately from the profile analyses by way of appropriate group comparisons,
namely t-tests or Mann-Whitney U.
Since females were over-represented in the mCHI group, it was desirable to
investigate the possibility that statistically significant differences observed for various
PAI scores were due to gender composition rather than injury severity. Consequently,
one-way ANOVA analyses were repeated separately for each gender, for each of the PAI
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variables found to differ in mCHI and sCHI as demonstrated by earlier ANOVA
analyses. The stringent alpha levels adjusting for multiple comparisons were not retained
for these analyses, since this method substantially reduced the number of participants in
select groups (particularly the females in the sCHI group) and the scales under
consideration were those previously deemed significant using a small per-comparison
alpha level. Rather, the primary interest was in determining whether trends in the
appropriate direction would be observed for each of the genders.
Goal 2: Evaluating Neurological Content of Individual PAI Items
Nine clinical neuropsychologists were asked to select items on the PAI that
represented common neurological sequelae of moderate to severe closed head injury.
Participating experts were employed in a variety of settings, including academic medical
centers, rehabilitation hospitals, private practices, and universities with graduate
programs in clinical neuropsychology. For the purpose of selecting items, the expert
raters were advised that a frequency of at least 25% would qualify as being “common”,
consistent with instructions provided by Gass and Russell (1991). Raters were also asked
to record whether responses in the affirmative or in the negative direction would be due
to CHI. Items that were selected by at least five of the nine expert raters were retained
for further empirical analyses. This leads to a minimum inter-rater agreement of 55%,
which is slightly lower than the 67% agreement minimum used by Alfano and colleagues
(1993), as well as Gass and Russell (1991). This level of inter-rater agreement was
deemed appropriate since many of the raters reported substantial difficulty choosing
symptoms that would be present in a considerable proportion of CHI subjects, given the
heterogeneity of presenting symptoms and chronicity. Retained items were subsequently
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subjected to empirical analyses to determine whether they indeed discriminated between
the CHI and normative samples.
Each item on the PAI is rated on a four-point verbal Likert scale. Although this type
of measurement may be presumed to quantify a continuous underlying dimension, the
actual scale of measurement for each item is more accurately considered ordinal.
Furthermore, for several of the selected neurological items, the distribution of ratings was
markedly skewed in the normative sample. Consequently, non-parametric methods for
group comparison were deemed the most viable option. For several of the selected
neurological items, expected frequencies for cells representing high scores were below
five, sometimes even after collapsing the Likert scale into binary options, rendering ChiSquare inappropriate. Therefore, for each of the selected neurological items, MannWhitney U analysis was utilized to determine whether scores were higher in the sCHI
group than in a normal control group.
For the purpose of comparing item endorsement in the CHI and normative samples,
observed frequencies for each possible score were provided by Morey (personal
communication, 2006), having been derived from the original standardization sample of
the PAI (N = 1000). Use of Mann-Whitney U, a statistic based on the sum of ranks, did
not appear appropriate to compare a group of 38 to a group of 1000. Therefore, a smaller
control group that closely represented item endorsement frequencies in the normative
sample, hereafter referred to as the “control group”, was constructed. Construction of a
representative control group, based on observed frequencies of item responses in the
normative sample, was employed for the purpose of statistical analyses in Gass (1991).
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The sample size of the control group in the current study was selected to be 50 to
approximate the size of the two CHI groups. Therefore, for a given item, if 10% of the
normative sample obtained a score of 0, 50% obtained a score of 1, and 40% obtained a
score of 2, the control group was constructed such that 5 subjects obtained scores of 0
(i.e., 10% of 50 control subjects), 25 obtained scores of 1 (i.e., 50% of 50 control
subjects), and 20 obtained scores of 2 (i.e., 40% of 50 control subjects). Since observed
frequencies for the normative sample were derived from a sample of 1000 individuals,
there are fractional values when observed frequencies are divided by 20 to determine
analogous frequencies for a sample size of 50. For example, if 17% of the normative
sample obtained a score of 0 for a specific item, the equivalent would be 8.5 subjects with
this score in a representative control group. Consequently, expected frequencies for the
control group of 50 were rounded to the nearest whole. When adjustments were
necessary due to rounding error, the higher of two possible scores was assigned to the
control subject. This adjustment leads to a more conservative test of group differences;
that is, findings of statistically significant group differences can be accepted with
confidence. This is the case because attribution of a higher score slightly increases scores
for the control group, this adjustment narrowing the gap between the control group and
the CHI groups who were expected to obtain higher scores on the neurological items.
The sum of rationally identified items empirically found to discriminate between the
sCHI and control groups was computed to quantify overall responses to these
neurologically relevant items. This sum shall be referred to as the Neuro-Item Sum.
Three of the CHI subjects had omitted responses for one of the neurologically relevant
items. In this instance, a prorated score rounded to the nearest whole was calculated and
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imputed as the total sum. The Neuro-Item Sum was first explored to determine its
statistical properties in the current sample. Group comparisons were utilized to determine
whether the Neuro-Item Sum differed significantly by gender or injury severity.
Furthermore, correlation coefficients were computed to evaluate possible relationships
between the Neuro-Item Sum and various continuous scores including demographic
variables (i.e., age, education), injury parameters (i.e., time since injury), response bias
indicators on the PAI (i.e., RDF, CDF, NIM, PIM, MAL, DEF), depression, and
cognitive performance (i.e., APR and FSIQ). Since significant correlations were obtained
for FSIQ and APR, correlation coefficients were also computed for the Index Scores
representing factors of FSIQ and the cognitive measures that compose the APR.
On the basis of observed correlations between the Neuro-Item Sum and scores
representing negative impression management, depression, and cognitive performance,
hierarchical regression analyses were conducted in an attempt to isolate independent
contributions of these variables in predicting the Neuro-Item Sum. The specification of
regression models was determined on a post-hoc basis; therefore, specific analyses are
described in greater detail following the computation of correlation coefficients used for
model specification.
Goal 3: The Relationship of Objective Neuropsychological Performance to
Cognitive Complaints on the PAI
Elevations on the SCZ and SCZ-T scales were correlated with scores achieved on
several objective neuropsychological measures, including Arithmetic, Digit Span,
Longest Digest Span Forward, Longest Digit Span Backwards, Letter-Number
Sequencing, Spatial Span, Longest Spatial Span Forward, Longest Digit Span
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Backwards, Consonant Trigrams Total, FSIQ, Long Delay Free Recall from the CVLT-II,
Total Learning (i.e., Trials 1 through 5) from the CVLT-II, Verbal Fluency (FAS), Trails
B, Coding, and APR. Correlation coefficients were calculated separately for the mCHI
and sCHI groups.
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Chapter III
Results
Data Exploration and Statistical Disclaimers
Data exploration and statistical considerations / disclaimers are described in
Appendix C.
Findings
Goal 1: Describing the PAI Profiles of the Sample
Mean PAI scores and standard deviations for the combined CHI sample are listed
in Table 4, as are scores representing the 10th, 25th, 50th, 75th and 90th percentile levels in
this sample. Note that scores reported for MAL, DEF, RDF, and CDF are raw scores, but
all others are T scores. The only mean PAI score to exceed a T score of 65 in the
combined CHI sample was SCZ-T. On the other hand, a considerable proportion of this
sample presented with complaints of somatic dysfunction, anxiety, depression, cognitive
disturbance, affective instability, identity problems, and anxiety-related disorders
(particularly traumatic stressors). Specifically, scores at the 75th percentile were greater
than a T score of 65 for the following PAI scales and subscales: SOM, ANX, ARD, DEP,
SCZ, SOM-C, SOM-S, SOM-H, ANX-C, ANX-A, ANX-P, ARD-T, DEP-C, DEP-A,
DEP-P, SCZ-T, BOR-A, and BOR-I. This indicates that at least 25% of the combined
CHI sample reported symptoms in these domains to a degree that is clinically relevant.
In addition, a smaller proportion (at least 10%) of this sample reported clinically
significant degrees of symptomatology germane to the following PAI scales and
subscales: NIM, PAR, AGG, SUI, STR, NON, ARD-O, ARD-P, MAN-I, PAR-H,
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Table 4
Mean Elevations on PAI Scales for the Combined CHI Sample (N= 99) and Scores
Representing Select Percentile Levels

Score at Given Percentile

PAI Scale

M (SD)

10

25

50

75

90

M A L1

0.65 (0.80)

0

0

0

1

2

DEF

2.60 (1.5)

0

1

3

4

5

R D F1

-1.42 (1.08)

-2.88 -2.04 -1.43 -0.65 -0.1

CDF

143.9 (13.7)

122.9 134.9 143.6 153.2 158,

ICN 1

51.5 (8.3)

40

46

52

58

64

IN F 1

52.2 (8.1)

44

47

51

59

63

N IM 1

57.1 (10.6)

44

47

55

62

77

PIM

48.4 (11.2)

31

41

50

54

61

SOM

64.1 (12.5)

49

53

63

72

81

ANX

58.1 (12.3)

44

48

55

68

75

ARD

57.0 (13.7)

42

45

55

67

77

DEP

64.5 (15.4)

45

52

62

74

86

MAN

49.6 (9.2)

36

43

49

55

63

PAR

50.8 (11.4)

37

43

48

58

68

SCZ

58.2 (12.0)

44

50

58

65

74

BOR

57.7(11.1)

44

50

57

64

74

ANT

49.2 (10.0)

38

42

47

55

62

70
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ALC

47.1 (7.4)

41

41

45

50

57

DRG

49.5 (8.7)

42

42

48

54

60

AGG

53.4 (13.5)

37

44

49

62

73

SUI

54.3 (14.9)

43

43

49

58

82

STR

57.9(11.4)

44

48

57

64

73

NON

50.3 (11.3)

37

39

48

58

67

RXR

48.1 (10.2)

33

40

48

55

61

DOM

49.9 (9.9)

36

44

51

56

63

WRM

49.9 (10.4)

37

42

51

56

62

SOM-C

63.0(13.5)

49

51

60

72

84

SOM-S

63.9 (14.3)

46

51

65

75

83

SOM-H

60.1 (11.1)

47

52

59

66

76

ANX-C

57.5 (11.8)

43

50

55

66

71

ANX-A

56.2 (12.9)

42

47

55

65

73

ANX-P

58.3 (12.5)

44

50

55

66

78

ARD-0

52.6 (10.5)

38

46

52

60

68

ARD-P

52.3 (11.0)

40

45

51

59

67

ARD-T

59.7 (15.8)

41

48

55

70

87

DEP-C

59.3 (14.5)

43

49

55

67

78

DEP-A

62.6 (15.5)

44

53

61

72

85

DEP-P

64.6 (13.6)

45

55

67

74

82

MAN-A

49.2(9.1)

38

42

48

54

60

MAN-G

47.6 (10.4)

35

40

47

54

63
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MAN-I

52.5 (10.9)

38

46

53

60

67

PAR-H

51.1 (11.8)

37

42

51

60

69

PAR-P

50.2 (11.1)

39

42

48

57

63

PAR-R

50.6 (11.3)

38

41

48

55

69

SCZ-P

48.5 (8.9)

36

43

46

53

60

SCZ-S

53.1 (12.5)

41

43

51

61

71

SCZ-T

66.3 (15.1)

46

55

67

78

84

BOR-A

58.9 (12.3)

42

48

60

66

78

BOR-I

57.8 (11.4)

44

50

56

65

74

BOR-N

55.4(11.0)

40

46

53

62

68

BOR-S

51.4(10.7)

37

41

49

60

64

ANT-A

50.0 (11.4)

39

41

45

57

66

ANT-E

47.5 (7.7)

39

42

45

52

59

ANT-S

49.8 (10.1)

37

43

48

53

62

AGG-A

52.3 (13.1)

34

42

51

59

70

AGG-V

51.4 (11.5)

34

42

51

59

68

AGG-P

55.3 (14.2)

42

43

52

63

79

1Extreme values on these scales were initially used to screen the sample; therefore, listed
values are not representative of larger, representative samples.
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PAR-R, SCZ-S, BOR-N, ANT-A, AGG-A, AGG-V, and AGG-P, as demonstrated by
scores at the 90th percentile that were greater than a T score of 65.
Two separate profile analyses were employed to contrast the profiles of those who
had sustained mCHI to those who had sustained sCHI. The first profile analysis included
the majority of scales on the customary PAI profile (i.e., eleven clinical scales, five
treatment scales, and two interpersonal scales) as dependent variables and used injury
severity as the grouping variable. Profile analysis showed that the profiles were neither
flat, F(17,81) = 13.711 ,/? = 0.000, rf = 0.742, nor parallel, F(17,81) = 2.531 ,/? = 0.003,
r f - 0.347. The levels test was also significant, F(l,97) = 5.113,/? = 0.026, rf = 0.05,
with the mild CHI group producing higher elevations on the PAI overall. Mean PAI
profiles according to injury severity are graphically represented in Figure 1.
The second profile analysis was conducted with the 31 clinical subscales of the
PAI as the dependent variables and injury severity as the grouping variable. Again, the
profiles were neither flat, F(30,68) = 9.926,/? = 0.000, rf = 0.814, nor parallel, F(30,68)
= 3.074,/? = 0.000, rf = 0.576. The mild CHI group tended to produce higher overall
elevations across the clinical subscales, F(l,97) = 9.077,/? = 0.003, rf = 0.086. Mean
elevations on the PAI clinical subscales are depicted separately for the mCHI and sCHI
groups in Figure 2.
Given the presence of univariate and multivariate outliers, as well as the
sensitivity of profile analysis to these outliers, both profile analyses were repeated after
exclusion of these outliers. Results were analogous, with the exception of a non
significant levels test for the customary PAI profile, F(l,93) = 3.697,/? = 0.058. Overall,
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Figure 1. Mean elevations on customary PAI profiles by injury severity
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Figure 2. Mean elevations on PAI subscales by injury severity
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it can be concluded that injury severity has a potent effect on the shape of the customary
PAI profile and that the profile is not flat for at least one of the injury severity groups.
Although the mCHI group tends to produce higher overall elevations on the PAI than the
sCHI group, this effect is comparatively smaller.
Follow-up one-way ANOVA analyses were utilized to isolate the source(s) of
group differences on the PAI. Mean PAI elevations for the mCHI and moderate to sCHI
groups are listed in Table 5, as are group comparisons employing ANOVA. The bolded
probability levels are those below the per-comparison alpha level computed to adjust for
multiple comparisons. Since MCELEV was higher for the mCHI group (M= 56.66; SD
= 7.27) than the sCHI group (M= 52.58; SD = 7.52), /(97) = 2.679, p = 0.009, ANCOVA
analyses were also used to determine whether PAI scores continued to differ by injury
severity after covarying for overall differences in MCELEV. As shown in Table 5, the
group with mCHI generated higher elevations on scales pertaining to somatic symptoms,
anxiety, anxiety-related disorders, depression, thought disturbance, and affective
instability. After covarying for MCELEV, the mCHI group continued to demonstrate
higher elevations than the sCHI group (p < 0.05) on the following clinical scales and
subscales: SOM (SOM-C and SOM-S), ANX (ANX-P), ARD and SCZ (SCZ-T).
For PAI variables omitted from profile analyses, mean scores, standard
deviations, and applicable group comparisons are presented in Table 6. The injury
severity groups had similar scores on CDF, MAL, and DEF. On the other hand, the
mCHI group showed higher scores on NIM, but lower scores on RDF, relative to the
sCHI group. Note that higher scores on NIM indicate increased likelihood of
exaggeration, while lower scores on RDF represent decreased likelihood of exaggeration.
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Table 5
Mean PAI Scores and Standard Deviations for the Mild CHI (n = 61) and Moderate to
Severe CHI (n = 38) Groups, as well as Group Comparisons

PAI Scale

Mild CHI

Moderate to Severe CHI

ANOVA

ANCOVA

M(SD)

M(SD)

F

p

F

p

Global PAI Scales
SOM

68

( 1 2 .1 )

57.8 (10.6)

18.3

0.000 10.5

0.002

ANX

61.3 (13.1)

52.9 (8.7)

12.4

0.001 4.8

0.031

ARD

60.5 (14.4)

51.4(10.5)

11.4

0.001 4.1

0.047

DEP

67.9 (16.0)

59.1 (12.9)

8 .2

0.005 1.4

0.243

MAN

50.77 (8.2)

47.6 (10.5)

2 .8

0.097

PAR

50.5 (10.9)

51.2(12.3)

0 .1

0.770

SCZ

61.8(11.5)

52.4 (10.5)

16.8

0 .0 0 0

BOR

59.2 (10.0)

55.3 (12.5)

2.9

0.089

ANT

48.1 (9.2)

50.8 (11.2)

1.7

0.195

ALC

46.3 (6.4)

48.5 (8.7)

2 .0

0.159

DRG

48.3 (7.4)

51.6 (10.4)

3.4

0.066

AGG

54.3 (13.4)

51.9 (13.7)

0.7

0.393

SUI

55.4 (15.6)

52.4 (13.7)

0.9

0.334

STR

59.2 (11.9)

55.7 (10.3)

2 .2

0.137

NON

50.4(10.1)

50.2 (13.1)

0 .0 2

0.904

RXR

46.1 (9.7)

51.4(10.2)

6.7

0 .0 1 1

9.1

0.003
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DOM

49.9(10.1)

49.8 (9.7)

0 .0 0

0.960

WRM

50.0 (10.9)

49.7 (9.6)

0 .0 1

0.915

PAI Clinical Subscales
SOM-C

67.1 (13.6)

56.3 (10.3)

17.6

0 .0 0 0

9.7

0 .0 0 2

SOM-S

69.0 (13.2)

55.9 (12.2)

24.3

0 .0 0 0

16.4

0 .0 0 0

SOM-H

61.7 (11.2)

57.6 (10.7)

3.2

0.077

ANX-C

59.7 (12.8)

53.9 (9.2)

5.9

0.017

ANX-A

59.1 (14.0)

51.5(9.5)

8.7

0.004

2 .0

0.165

ANX-P

62.1 (13.0)

52.2 (8.7)

17.4

0 .0 0 0

9.7

0 .0 0 2

ARD-0

54.2(11.0)

49.2 (9.3)

4.1

0.046

ARD-P

54.3 (11.5)

49.2 (9.3)

5.1

0.026

ARD-T

63.5 (16.6)

53.5 (12.2)

1 0 .2

0 .0 0 2

3.2

0.076

DEP-C

62.0 (15.1)

55.0 (12.5)

5.7

0.019

DEP-A

65.1 (16.2)

58.4 (13.6)

4.5

0.036

DEP-P

67.9 (13.5)

59.2 (12.0)

10.7

0 .0 0 2

3.9

0.053

MAN-A

50.6 (9.7)

46.8 (7.5)

4.2

0.044

MAN-G

47.3 (9.5)

48.1 (11.7)

0 .1

0.743

MAN-I

54.1 (10.2)

49.9(11.5)

3.7

0.058

PAR-H

50.0(11.1)

52.8 (12.7)

1.4

0.246

PAR-P

50.4(11.1)

49.8 (11.1)

0 .1

0.791

PAR-R

50.8 (11.1)

50.2 (11.7)

0.7

0.792

SCZ-P

49.6 (9.7)

46.8 (7.1)

2 .2

0.139

SCZ-S

54.0 (12.9)

51.6(11.9)

0.9

0.351
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SCZ-T

72.6(13.2)

56.1 (12.3)

38.4

0 .0 0 0

BOR-A

61.6(11.5)

54.6 (12.6)

8.3

0.005

BOR-I

58.5 (11.0)

56.7 (12.0)

0 .6

0.451

BOR-N

55.2 (10.0)

55.7 (12.6)

0 .0

0.852

BOR-S

52.7 (10.4)

49.3 (11.1)

2.3

0.136

ANT-A

47.8 (9.9)

53.5 (12.9)

6 .1

0.015

ANT-E

47.5 (8.1)

47.6 (7.1)

0 .0

0.973

ANT-S

49.9 (8.4)

49.7 (12.5)

0 .0

0.934

AGG-A

53.9 (13.5)

49.8 (12.1)

2.3

0.135

AGG-V

50.8 (11.3)

52.3 (11.9)

0.4

0.527

AGG-P

56.7 (12.8)

53.2 (16.0)

1.4

0.235

Note. Probability levels that are bolded are considered significant at the adjusted percomparison alpha level determined for the given analysis. For ANOVA analyses, p <
0.009 was required for significance for analyses with the global PAI scores on the
customary profile, whereas p < 0.0052 was required for significance for analyses with the
clinical subscales. The alpha level was not adjusted for multiple comparisons for
ANCOVA analyses; therefore, bolded probability levels represent p < 0.05.
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Table 6
Mean Scores and Standard Deviations for PAI Validity Scales, as well as Comparison of
Scores for the Mild CHI (n = 61) and Moderate to Severe CHI (« = 38) Groups.

Mild CHI

Moderate to Severe CHI

Group Comparison

PAI Scale

M(SD)

M (SD)

F

ICN

50.97 (8.5)

52.3 (8.1)

0.565

0.454

INF

52.0 (7.5)

52.6 (8.9)

0 .1 2 0

0.730

NIM

59.9 (10.9)

52.8 (8.4)

11.571 **

0 .0 0 1

PIM

47.1 (9.9)

50.3 (13.0)

1.939

0.167

MAL

0.77 (0.86)

0.47 (0.86)

DEF

2.52 (1.66)

2.63 (1.36)

0 .1 1 1

0.740

RDF

-1.67 (1.09)

-1.03(0.96)

8.837 **

0.004

CDF

144.37 (13.5) 143.13 (14.12)

0.191

0.663

U

952.0

P

0 .1 0 0

* * p < 0.01
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Since females were over-represented in the mCHI group, it was desirable to
investigate the possibility that differences on the PAI attributed to injury severity were
merely the result of gender composition. One-way ANOVA analyses were repeated
separately for each gender, for each of the PAI variables for which severity-related
differences had been identified by earlier ANOVA analyses. The results of these
analyses are shown in Table 7, while mean PAI profiles according to injury severity are
illustrated separately for each gender in Figures 3 through 6 .
For the males, the mCHI group displayed significantly (p < 0.05) higher scores on
the following scales and subscales: SOM, ANX, SCZ, SOM-C, SOM-S, ANX-A, ANXP, DEP-P, and SCZ-T, in addition to lower scores on RDF. There was a trend (p = 0.053)
toward higher NIM scores in those who had sustained mCHI relative to those who had
sustained sCHI. Group comparisons failed to demonstrate statistically significant
differences on ARD and ARD-T by injury severity. The fact that males with mCHI
produced mean elevations above 55 and 60 on ARD and ARD-T, respectively, suggests
that symptoms germane to these areas were reported by a small proportion of the sample.
However, the mean scores on these scales for males who had sustained mCHI appear
lower than those for females who had sustained mCHI. In general, it appears that the
failure to find severity-related differences in complaints of anxiety-related disorders
(particularly traumatic stressors) in males, despite the existence of this difference in
females, may indeed reflect gender differences. Likewise, there was no difference across
the injury severity groups for the clinical subscale reflecting affective instability, with the
mCHI group demonstrating a mean of only 60, for the male subsample. With regard to
DEP, the male mCHI group showed a higher mean score than the male sCHI group, but
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Table 7
Mean PAI Scores and Standard Deviations by Injury Severity, As Well As Group
Comparisons, Conducted Separately for Each Gender

PAI Scale

Mild CHI

Moderate to Severe CHI

M

M

SD

SD

F

P

Male
NIM

59.0

1 0 .8

53.4

8.5

3.964

0.053

RDF

-1.7

1.4

-1 .0

0.9

4.269 *

0.045

SOM

68.4

13.9

59.0

10.9

6.762 *

0.013

ANX

60.2

1 2 .2

51.9

9.6

6.777 *

0 .0 1 2

ARD

56.8

1 2 .8

51.1

1 1 .6

2.602

0.114

DEP

67.7

14.4

60.2

1 2 .6

3.603

0.064

SCZ

61.7

1 0 .0

53.1

10.4

8.428 **

0.006

SOM-C

65.9

14.4

56.8

10.4

6.170 *

0.017

SOM-S

70.7

14.8

57.0

12.7

11.574**

0 .0 0 1

ANX-A

57.1

1 1 .6

50.3

9.8

4.780 *

0.034

ANX-P

62.4

13.8

53.3

9.7

6.911 *

0 .0 1 2

ARD-T

60.8

15.9

55.2

14.3

1.624

0.209

DEP-P

69.1

12.3

61.4

1 2 .2

4.619 *

0.037

SCZ-T

73.3

1 1 .8

55.0

12.9

25.826 **

0 .0 0 0

BOR-A

60.2

11.7

55.8

13.7

1.387

0.245
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Female
60.3

1 1 .1

51.7

8.5

6.897 *

0 .0 1 1

RDF

-1.7

0.91

- 1 .1

1 .1

3.338

0.074

SOM

67.7

1 1 .1

55.6

1 0 .2

12.637 **

0 .0 0 1

ANX

62.0

13.8

54.5

7.1

3.746

0.059

ARD

62.8

15.0

52.0

8.5

6.417 *

0.014

DEP

6 8 .1

17.0

57.3

13.8

4.505 *

0.039

SCZ

61.9

12.5

51.2

10.9

8.004 **

0.007

SOM-C

67.9

13.3

55.6

10.3

9.837 **

0.003

SOM-S

67.9

1 2 .2

54.0

11.4

13.763 **

0 .0 0 1

ANX-A

60.3

15.3

53.6

9.0

2.409

0.127

ANX-P

62.0

12.7

50.2

6.7

10.807 **

0 .0 0 2

ARD-T

65.1

17.0

50.6

6 .8

9 419

**

0.003

DEP-P

67.2

14.3

55.4

1 1 .1

7.814 **

0.007

SCZ-T

72.2

14.2

58.1

11.4

00

0 .0 0 2

BOR-A

62.5

11.4

52.4

1 0 .6

8.416 **

0.006

**
o

NIM

Note. There were 23 males with mild CHI and 24 with moderate to severe CHI. There
were 38 females with mild CHI and 14 with moderate to severe CHI.
* p < 0.05; **/><0.01
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Figure 3. Mean PAI scores for males according to injury severity.
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Figure 4. Mean PAI scores for females according to injury severity.
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statistical significance was not quite achieved. Interestingly, the males did show a
difference in the depression subscale representing physiological symptoms often
associated with depression (i.e., DEP-P). It should also be noted that the absence of
significant differences between the injury severity groups for the global DEP scale was
not due to the absence of elevations in the males. In fact, the mean DEP score for the
males following mCHI was 67.7, a score that is comparable to the mean of 68.1
generated by the females following mCHI.
For the females, the mild CHI subjects obtained higher mean scores than the
moderate to severe CHI subjects on the following PAI scales: NIM, SOM, ARD, DEP,
SCZ, SOM-C, SOM-S, ANX-P, ARD-T, DEP-P, SCZ-T, and BOR-A. Group
differences approached significance for RDF and ANX, with group means in the
expected direction. Although the mCHI subjects produced higher scores on ANX-A than
did the sCHI subjects, this difference did not approach statistical significance.
Goal 2: Evaluating Neurological Content of Individual PAI Items
According to at least five of the nine expert raters, 24 of the items could reflect
common bona fide neurological sequelae of moderate to severe CHI. The specific items
were: 3,12,38,52,54,61,78, 86,92,112, 115, 123,147, 152,155,172,209,223,272,
276,278,283,299, and 318. Of these, there were three items from SOM-C, three items
from SOM-S, four items from SOM-H, four items from SCZ-T, one item from DEP-A,
one item from DEP-C, two items from DEP-P, one item from BOR-A, one item from
AGG-P, one item from AGG-A, one item from MAN-I, one item from BOR-S, and one
item from NIM. For all 24 items, the direction of the response (i.e., affirmative vs.
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negative) that could reflect neurological content was scored in the pathological direction
on the PAL
For each of the selected neurological items, mean scores and standard deviations
derived from the normative sample and the mixed clinical sample described in the PAI
Professional Manual are listed in Table 8 , along with the means and standard deviations
calculated for die control, mCHI and sCHI groups. Given the markedly skewed nature of
scores on individual PAI items, mean values should be interpreted with caution, although
they are presented for descriptive purposes. Several general impressions emerge from
visual examination of this data. Descriptive statistics for the control group closely
approximate those of the normative sample, reported to one decimal place, and negligible
deviations are presumably due to rounding of decimals. As expected, the mixed clinical
sample tends to obtain higher scores on these items than the normative sample. Scores on
the selected neurological items generally appear higher in the sCHI group than in the
normative sample. Only a subset of the items appears to have higher means in the sCHI
group than in the mixed clinical sample. Interestingly, the mCHI group appeared to have
higher mean scores than the sCHI group on several items.
Mann-Whitney U analyses were then used to determine whether the sCHI subjects
tended to obtain higher scores on the selected neurological items than the control group.
Results of these analyses are shown in Table 9, along with median scores presented for
illustrative purposes. There were significant group differences for 11 of the 24 items,
with the CHI subjects endorsing a higher level of symptomatology than the control group
for each of these items. Analogous analyses were completed to compare the mCHI group
and the control group, in an attempt to replicate group differences related to CHI using
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Table 8
Descriptive Statistics for Scores on Selected Neurological Items for Various Groups

Normative 1 Control2

Clinical3

Mild CHI4

Mod-Sev. C H I5

Item

M(SD)

M(SD)

M(SD)

M(SD)

M(SD)

3

0.5 (0.9)

0.54 (0.93)

1 .0

( 1 .2 )

2.43 (0.83)

1.97(1.13)

12

0.6 (0.9)

0.68 (0.96)

1 .2

( 1 .2 )

1.10(1.16)

1 .2 1

38

0.3 (0.6)

0.28 (0.61)

1 .0

( 1 .0 )

1.73 (1.10)

0.82 (0.93)

52

0.3 (0.7)

0.30 (0.74)

0.7 (1.0)

1 1 2

( 1 .0 0 )

0.95 (1.11)

54

0.7 (0.9)

0.74 (0.90)

1.4 (1.1)

1.75 (1.00)

1.05 (1.00)

61

0.5 (0.8)

0.50 (0.79)

1 .0

( 1 .1 )

1.10(1.05)

0.66 (1.05)

78

0.7 (0.8)

0.68 (0.77)

1 .2

( 1 .0 )

2.03 (0.92)

1.03 (0.94)

86

0.4 (0.7)

0.46 (0.76)

1 .0

( 1 .0 )

1.37(1.12)

0.79 (0.91)

92

0.3 (0.7)

0.28 (0.73)

0 .8

( 1 .1 )

1.80(1.02)

1.39(1.24)

112

0.9 (0.9)

0.90 (0.99)

1 .2

( 1 .1 )

1.77 (0.93)

1.37(1.00)

115

1 .0

( 1 .1 )

1.04(1.09)

1 .8

( 1 .1 )

2.13(1.10)

1.75 (1.20)

123

0.3 (0.7)

0.32 (0.74)

0.7 (1.1)

1.18(1.14)

0.50 (0.80)

147

0.5 (0.7)

0.48 (0.71)

1 .1

( 1 .0 )

1.88 (0.99)

1.05(0.93)

152

1 .2

( 1 .0 )

1.26(1.05)

1 .6

( 1 .1 )

2.03 (0.81)

1.73(1.10)

155

0 .6

(0 .8 )

0.56 (0.81)

1 .0

( 1 .1 )

1 8 8

172

1 .0

( 1 .0 )

1.02(1.04)

209

0.2 (0.5)

223

0.5 (0.7)

.

.

( 1 .1 2 )

( 1 .0 1 )

1.42(1.18)

1.4 (1.1)

1.83 (1.03)

1.40(1.08)

0.2 (0.57)

0.5 (0.9)

0.27 (0.67)

0.34 (0.53)

0.5 (0.71)

0 .8

( 1 .0 )

0.45 (0.70)

0.39 (0.68)
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272

0.3 (0.7)

0.34 (0.75)

0 .6

( 1 .0 )

1.63 (1.30)

0.55 (1.06)

276

1 .0

(0 .8 )

1.02(0.87)

1.5 (1.0)

1.75 (1.07)

1.21 (0.99)

278

0.5 (0.8)

0.58 (0.81)

0.8 (0.9)

1 .6 8

( 1 .0 2 )

0.79 (0.87)

283

0.1 (0.5)

0.14 (0.53)

0.3 (0.8)

0.38 (0.74)

0.24 (0.71)

299

1.3 (1.0)

1.32 (1.04)

1.7 (1.1)

1.43 (1.14)

1.16(1.05)

318

1.1 (0.9)

1.14(0.95)

1.7 (1.1)

2.68 (0.70)

1.97 (1.15)

1

Normative Sample (N = 1000) from the PAI Professional Manual
Control Group (N= 50) derived from expected frequencies in the full normative sample

3

Mixed Clinical Sample (N= 1246) from the PAI Professional Manual

4

Mild CHI Group (N = 61)

5

Moderate to Severe CHI Group (N = 38)
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Table 9

Scores of the Control Group (« = 50) on Selected Neurological Items Compared to Those
of the Moderate to Severe CHI (sCHI) Group (n = 38) and die Mild CHI (mCHI) Group (n = 60)

Control

sCHI

mCHI
Mdn A/Rank U

Item

Mdn

M Rank

Mdn

A/Rank U

3

0

31.99

2.5

60.96

324.5

.000**

3

75.54

297.5

12

0

39.22

1

51.45

686.0

.017**

1

60.55

1197.0 .050

38

0

37.84

1

53.26

617.0

.001**

2

73.17

440.0

.000**

52

0

38.14

0.5

52.87

632.0

.001**

1

67.76

722.0

.000**

54

0.5

40.63

1

48.55

756.5

.122

2

68.85

699.0

.000**

61

0

43.83

0

45.38

916.50 .741

1

64.05

987.0

.001**

78

1

40.61

1

49.62

755.5

.075

2

73.08

445.0

.000**

86

0

40.48

1

49.79

479.0

.055

1

67.17

800.0

.000**

92

0

34.58

1

57.55

454.0

.000**

2

74.57

356.0

.000**

112

1

39.30

1

51.34

690.0

.021*

2

67.35

789.0

.000**

115

1

38.30

2

52.66

640.0

.007**

3

68.07

746.0

.000**

123

0

41.54

0

48.39

802.0

.110

1

66.87

818.0

.000**

147

0

37.66

1

53.5

608.0

.002**

2

73.45

423.0

.000**

152

1

39.55

2

50.01

702.5

.048*

2

65.55

852.5

.000**

155

0

36.56

0

54.95

553.0

.000**

2

72.05

507.0

.000**

172

1

40.65

1

49.57

757.5

.088

2

65.93

874.5

.000**

209

0

41.34

0

48.66

792.0

.063

0

56.16

1406.5 .519

223

0

46.16

0

42.32

867.0

.409

0

54.38

1432.5 .635

272

0

43.66

0

45.61

908.0

.629

2

68.39

685.0

.000**

276

1

42.55

1

47.07

852.5

.381

2

65.15

921.0

.000**

278

0

41.79

1

48.07

814.5

.208

2

70.09

624.5

.000**

P

P

.000**
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283

0

43.52

0

45.79

901.0

.432

0

60.06

1226.5 .014*

299

1

46.18

1

42.29

866.0

.462

1

56.77

1424.0 .636

318

1

36.77

2

54.67

563.5

.001**

3

74.25

375

.000**

* p < 0.05. **Jp<0.01
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the sample with lesser injury severity. Results of these group comparisons, as well as
median scores, are also included in Table 9. As can be seen, all items found to
discriminate the sCHI group from the control group were also found to discriminate the
mCHI group from the control group, with the exception of item #3 that sits at a
probability level of exactly 0.05. Incidentally, it is evident that a greater number of
neurologically relevant items would have been found to discriminate between CHI and
normal samples had the mCHI sample been used as the comparison group, as opposed to
the sCHI group.
The 11 items that discriminated between the sCHI sample and the control group
are as follows: 3,12,38,52,92, 112,115, 147, 152, 155, and 318. Three items are
included in SOM-H, two are included in SOM-S, one is included in SOM-C, two are
included in SCZ-T, two are included in DEP-P and one is included in DEP-C. The
difference between a score of 0 and a score of 3 on all of these items produces a change
of at least 5 T for all clinical subscales, as well as the overarching DEP, SOM, and SCZ
clinical scales.
For each of the 11 items, the percentages of subjects obtaining scores of 0 , 1 , 2,
and 3 were calculated for the mCHI and sCHI groups. Analogous values for the actual
normative sample were provided by Morey. Data for all three samples are presented in
Table 10. Figures listed are valid percent, in that they include the percentage of scores
for respondents in the sample that had not omitted the particular item. As can be seen, at
least 30% of the sCHI sample achieved scores of 2 or 3 on the majority of item s. For the
two exceptions in which this did not occur (i.e., items 38 and 147), more than 60% of the
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Table 10
Percentages of Subjects Obtaining Given Scores on Neurologically Relevant Items for
the Normative Sample (N = 1000), the Moderate to Severe CHI (sCHI) Group (n = 38),
and the Mild CHI (mCHI) Group in = 60)

Normative

sCHI

mCHI

% Obtaining Score

% Obtaining Score

% Obtaining Score

0 ,1 ,2 ,3

0

Item

0

, 1 , 2 ,3

, 1 , 2 ,3

3

69.0,17.9, 6.0,7.2

10.5,31.6,7.9,50.0

3.3,11.7,23.3,61.7

12

59.7,23.5,9.0, 7.8

34.2,28.9,18.4,18.4

41.7,26.7,11.7,20.0

38

77.2,18.1,2.7,2.0

44.7,36.8,10.5, 7.9

16.7,26.7,23.3,33.3

52

81.7,10.2,4.9,3.2

50.0,18.4,18.4,13.2

30.5,40.7, 15.3, 13.6

92

84.0, 8 .8 ,3.5,3.7

34.2,21.1,15.8,28.9

10.0,33.3,23.3,33.3

112

44.8,32.8,13.8,8.6

18.4,44.7,18.4,18.4

6.7,36.7,30.0,26.7

115

42.1,26.3, 18.8,12.8

21.1,23.7,15.8,39.5

13.3, 13.3,20.0,53.3

147

62.2,29.3,6.2,2.2

31.6,39.5,21.1,7.9

6.7,35.0,21.7,36.7

152

28.6,34.7,20.9,15.7

16.2,27.0,24.3,32.4

3.4,20.3,45.8,30.5

155

60.3,27.5, 7.7,4.5

28.9,26.3,18.4,26.3

10.0,26.7,28.3, 35.0

318

23.3,36.3,25.7,14.7

15.8,18.4,18.4,47.4

1.7, 8.3,10.0, 80.0

Note. The percentages of the sCHI sample obtaining scores of 2 or 3 on the items are
bolded.
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sCHI sample obtained scores at least 1. Furthermore, more than 30% of the mCHI
sample achieved scores of 3 for both of these items.
The Neuro-Item Sum was calculated by summing scores on all 11 of the selected
neurological items that discriminated between the sCHI group and the control group.
This sum was then explored to determine its statistical properties. Distributions within
the mCHI sample, the sCHI sample, and the combined sample did not deviate
significantly from normal; no outliers were identified. Analogous exploration for data
from the control group showed marked positive skew for the Neuro-Item Sum.
The relationship of the Neuro-Item Sum to injury parameters, demographic
variables, and objective cognitive scores (i.e., APR and FSIQ) was then explored. NeuroItem Scores were higher in the mCHI group (M= 20.57; SD = 15.63) than in the sCHI
group (M = 15.63; SD = 7.58), t( 1,96) = 3.512, p = 0.001. ANCOVA analysis showed
*

that the difference in scores associated with injury severity remained significant after
controlling for MCELEV, although the effect size of injury severity was small, F(l,95) =
5.449, p = 0.022, x\2 = 0.054). The Neuro-Item Sum appeared equivalent in males (M=
18.45; SD = 7.66) and females (M= 18.84; SD = 6.74), t(1,96) = -0.272,p = 0.786.
Correlation coefficients between the Neuro-Item Sum and continuous demographic,
injury, and cognitive variables are provided in Table 11. Because significant correlations
were observed for FSIQ and APR, correlation coefficients were also computed for Index
Scores that compose FSIQ and for individual cognitive measures that compose APR.
According to these analyses, time since injury and demographic variables (i.e., age and
education) appeared unrelated to total scores on the selected neurological item s. For the
combined CHI sample, the only variables to correlate significantly with the Neuro-Item
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Table 11
Correlations Between the Neuro-item Sum and Demographic, Injury, and Cognitive
Variables for the Combined Sample (n = 98), die Mild CHI (mCHI) Group (« = 60) and
the Moderate to Severe CHI (sCHI) Group (n = 38).

Combined Sample

mCHI

sCHI

Variable

r ip )

rip)

rip )

Months since injury

-.003 (.973)

-.062 (.640)

.094 (.576)

Age in years

.1 1 0

(.282)

.089 (.498)

.130 (.437)

Education in years

.000 (.999)

-.069 (.599)

-.213 (.199)

APR

-.225 (.027) *

-.366 (.004) **

-.072 (.673)

Full Scale IQ

-.175 (.086)

-.371 (.003) **

-.006 (.971)

VCI

-.165 (.105)

-.290 (.026) **

-.176 (.290)

POI

-.186 (.070)

-.388 (.002) **

.046 (.788)

WMI

-.094 (.394)

-.122 (.379)

-.133 (.485)

PSI

-.252 (.013) *

-.414 (.001) **

-.127 (.447)

Trails B

-.181 (.095)

.290 (.032) *

-.028 (.882)

Coding

-.251 (.013) *

-.456 (.000) **

-.127 (.448)

Verbal Fluency

-.105 (.305)

-.274 (.034) *

CVLT-II Trials 1 to 5

-.076 (.475)

-.062 (.648)

.126 (.458)
-.092 (.611)

Note. APR = Average Performance Rating; VCI = Verbal Comprehension Index; POI =
Perceptual Organization Index; WMI = Working Memory Index; PSI = Processing Speed
Index; CVLT-II = California Verbal Learning Test - II.
* p < 0.05. **/?<0.01
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Sum were the Coding subtest and the neuropsychological composite score, namely the
APR. A wider range of cognitive scores correlated with the Neuro-Item Sum when
analyses were restricted to those with mCHI. No significant relationships were observed
between Neuro-Item Scores and objective cognitive performance in the sCHI group.
The relationship between scores on the Neuro-Item Sum and various PAI
response bias indicators is shown in Table 12 by correlation coefficients in the combined
sample, the mCHI group, and the sCHI group. Correlations with DEP are also listed in
Table 12. The pattern of correlations suggests a strong relationship between scores on the
Neuro-Item Sum and depression regardless of injury severity, and a relationship between
the Neuro-Item Sum and negative impression management that is attenuated in the sCHI
group relative to the mCHI group. The positive correlation between NIM and the NeuroItem Score is particularly noteworthy, given the initial screening for extreme scores on
this PAI variable. NIM is known to elevate in conjunction with depression, which was
also shown to predict scores on the Neuro-Item Score. For the mCHI subjects only,
higher scores on the Neuro-Item Sum were associated with lower scores on scales
reflecting positive impression management and defensiveness. As expected, higher
overall MCELEV consistently predicted higher scores on the Neuro-Item Sum. In
interpreting these correlations, it is important to consider the limited range for some PAI
variables (i.e., MAL and DEF) and the exclusion of subjects with extreme scores on other
PAI variables (i.e., NIM, MAL, and RDF).
Because there were extreme outliers for time since injury, the correlation between
the Neuro-Item Sum and months since injury was re-calculated using only subjects who
had sustained their injuries less than 60 months prior to the evaluation. For the mCHI
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Table 12
Correlations Between the Neuro-Item Sum and Select PAI Variables for the Combined
Sample (n = 98), the Mild CHI (mCHI) Group (n = 60) and the Moderate to Severe CHI
(sCHI) Group (n = 38).

Combined Sample

mCHI

sCHI

PAI Variable

rip)

rip)

rip)

RDF

-.001 (.992)

.057 (.667)

.189 (.256)

CDF

-.155 (.128)

-.279 (.031)*

-.053 (.750)

NIM

.634 (.000) **

.687 (.000) **

.462 (.003) **

PIM

-.352 (.000) **

-.443 (.000) **

-.213 (.200)

DEP

.758 (.000) **

.773 (.000) **

.713 (.000) **

MAL

.187 (.065)

.227 (.081)

-.002 (.990)

DEF

-.305 (.002) **

-.431 (.001)**

-.131 (.433)

MCELEV

.621 (.0 0 0 ) **

.682 (.0 0 0 ) **

.471 (.003) **

*/?<0.05. **p<0.01
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group (n = 56), the computed correlation failed to reach significance, r2 = 0.065, p =
0.636. For the sCHI group (n = 33), time since injury appeared unrelated to the NeuroItem Sum, r2 = 0.269, p = 0.131. Likewise, there was no relationship between chronicity
and endorsement of the neurological items in the combined sample (n = 89), r2= 0.113,/?
= 0.292. These re-analyses seem to confirm the absence of a simple, obvious
correspondence between time since injury and endorsement of these neurologically
relevant items.
Hence, the strongest observed correlates of the Neuro-Item Sum on the PAI were
MCELEV, DEP, and NIM. The strongest correlate of the Neuro-Item Sum in the
cognitive domain was Coding, but this finding was only apparent for the mCHI group
when analyses were stratified by injury severity. Significant correlations were similarly
obtained for the Neuro-Item Sum and the APR in the mCHI group. Therefore,
hierarchical regression analyses were used in an attempt to disentangle contributions from
DEP, NIM, MCELEV, and cognitive variables in predicting scores on the Neuro-Item
Sum. Given the widespread correlations observed between the Neuro-Item Sum and
cognitive scores in those who had sustained mCHI, as well as the relationship of this sum
to FSIQ, an independent contribution from any given cognitive variable could merely
reflect the confounding of overall or premorbid intellectual functioning. Hence, the
decision was made to include cognitive scores sensitive to CHI in regression analyses
only after accounting for premorbid intellectual functioning in a prior step. The Verbal
Comprehension Index (VCI) was selected as such as a measure, in part because it does
not include subtests reflecting processing speed and is known to be relatively resistant to
the effects of CHI. Inclusion of VCI as an independent predictor has the net effect of
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better isolating cognitive inefficiencies plausibly related to CHI, as would ostensibly be
tapped by Coding, the Processing Speed Index, or the APR. Overall, a series of
hierarchical regression analyses were utilized to evaluate independent contributions of
NIM, DEP, MCELEV, and cognitive variables putatively reflecting decreased cognitive
efficiency secondary to CHI.
Initial regression analyses showed that MCELEV did not improve prediction of
Neuro-Item Scores after accounting for NIM and DEP. Specifically, for the mCHI group,
MCELEV failed to improve prediction of the Neuro-Item Sum, A F (1,56) = 0.130,/? =
0.720, but NIM, t = 2.274,p = 0.027, and DEP, t = 3.858,p = 0.000, independently
contributed to the prediction of the Neuro-Item Sum. For the sCHI group, MCELEV
failed to improve prediction of the Neuro-Item Sum, A F (1,34) = 1.375,/? = 0.249. DEP
scores independently contributed to the prediction of the Neuro-Item Sum, t = 4.346,/? =
0.000, but NIM did not, t = 0.112, p =0.446. Consequently, DEP and NIM were included
in subsequent regression analyses, but MCELEV was omitted from further analyses.
For the initial regression analysis, NIM was entered first. DEP was entered
second to determine whether addition of depression contributed to prediction after
controlling for NIM. VCI was entered third to control for premorbid intellectual ability,
preceding entry of APR. Finally, APR was entered fourth to determine whether the
neuropsychological composite score improved prediction, after accounting for negative
response bias, depression, and premorbid intellectual functioning.
Results of the first regression analysis are shown in Table 13. It is noteworthy
that DEP improved prediction of Neuro-Item Scores, independently from NIM, for the
mCHI subjects, as well as the sCHI subjects. For those who had sustained sCHI, NIM
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Table 13

Hierarchical Regressions Evaluating Independent Contributions of NIM, DEP, VCI, and APR to the NeuroItem Sum in the Mild CHI Group (n - 60) and the Moderate to Severe CHI Group (n = 38)

Step
#

d F (p)

NIM

DEP

VCI

APR

Overall

f i l (p)

P'(P)

0'<P)

P l ip)

F(P)

Mild CHI
1.

.683 (.00)**

49.815 (.000) **
48.359 (.000) **

2 .25.495(.045)* .291 (.012)*

.573 (.000)**

3. 0.045(.833)

.292 (.013)*

.573 (.000)**

.019 (.833)

4. 6.40(.014)*

.267 (.017)*

.581 (.000)**

.167 (.110)

31.704 (.000) **
-.250 (.014)*

27.713 (.000) **

Moderate to Severe CHI
1.

.442 (.006) **

8.505 (.006) **

2. 19.720(.000)**.057 (.704)

.666 (.000) **

3. 3.371(.075)

-.015 (.920)

.707 (.000) **

-.225 (.075)

4. 0.231(.634)

-0.012 (.940)

.709 (.000) **

-.206 (.123)

16.387 (.000) **
12.81 (.000) **
-.061 (.634)

9.442 (.000) **

* p < 0.05. **/><0.01.
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was no longer a significant independent predictor of Neuro-Item Scores after adding DEP
as a predictor. After controlling for DEP, NIM, and VCI, APR scores independently
contributed to prediction of Neuro-Item Scores only in those who had sustained mCHI.
Since VCI is the IQ Index Score most resistant to effects of CHI and PSI is the
Index Score most vulnerable to the effects of CHI, the difference between these scores
(VCI - PSI) was computed and served as an index of cognitive decline potentially
attributable to CHI. Note that larger values on this difference score presumably reflect
decreased cognitive efficiency, particularly in the domain of speed of information
processing, that could be secondary to CHI. A second set of hierarchical regressions was
conducted to determine whether this putative measure of cognitive decline independently
contributed to Neuro-Item Sums, after controlling for depression and negative impression
management. In these regression analyses, NIM and DEP were entered together in the
first step and the difference score was entered in the second step. For the mCHI group,
addition of the difference score to NIM and DEP significantly improved prediction of the
Neuro-Item Sum, A F (1,55) = 4.203 ,p = 0.045, producing an overall solution that was
statistically significant, F (3,55) = 35.484, p = 0.000. Review of the standardized
coefficients in the final solution indicated independent contributions from NIM, P =
0.295,/? = 0.009, DEP, p = 0.583,/? = 0.000, and VCI - PSI, p = 0.163,/? = 0.045, in

predicting the Neuro-Item Sum. For the sCHI group, the overall solution including NIM,
DEP, and VCI - PSI was statistically significant, F (3,35) = 11.989,/? = 0.000, but
addition of VCI - PSI to the model had not improved prediction of Neuro-Item Scores, A
F (1,34) = 0.225,/? = 0.638. Standardized coefficients suggested an independent
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contribution from DEP, P = 0.686,/? = 0.000, in the prediction of neuro-item sums, but
not NIM, p = 0.049,/? = 0.747, or VCI - PSI, P = 0.058,/? = 0.638.
Goal 3: The Relationship of Objective Neuropsychological Performance to
Cognitive Complaints on the PAI
Correlation coefficients between elevations on cognitively loaded scales of the
PAI (i.e., SCZ and SCZ-T) and scores obtained on objective neuropsychological
measures are listed in Table 14. For the subjects who had sustained sCHI, the only
significant correlations to emerge were between elevations on SCZ-T and scores achieved
on the CVLT-II (i.e., total learning and delayed free recall). There was a wider range of
significant correlations for the mild CHI group. The APR composite score correlated
negatively with SCZ-T elevations. Interestingly, however, the magnitude of this
correlation was somewhat smaller than that between SCZ-T and FSIQ. Small to
moderate correlations were also noted between elevations on SCZ-T and scores on the
following neuropsychological measures: Verbal Fluency (FAS), Longest Spatial Span
Backwards, and Long Delay Free Recall on the CVLT-II.
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Table 14
Correlations Between Cognitively Loaded PAI Scales and Neuropsychological
Performance in Mild CHI and Moderate to Severe CHI

Mild CHI

Moderate to Severe CHI

SCZ

SCZ-T

n

r(p)

r(p)

n

-.069 (.603)

60

.000 (.998)

-.163 (.334)

37

-.124 (.340)

-.198 (.127)

61

.070 (.674)

-.018 (.914)

38

LDSF

-.223 (.084)

-.201 (.120)

61

.144 (.387)

.066 (.694)

38

LDSB

-.241 (.706)

-.205 (.112)

61

-.016 (.923)

-.081 (.630)

38

LNS

-.124 (.368)

-.207 (.130)

55

-.094 (.602)

-.153 (.396)

33

Spatial Span -.059 (.667)

-.176 (.200)

55

-.073 (.679)

-.110 (.528)

35

LSSF

-.059 (.669)

-.143 (.297)

55

.128 (.455)

.062 (.720)

36

LSSB

-.241 (.076)

-.293 (0.03)* 55

.071 (.683)

.052 (.765)

36

CT

.110 (.455)

-.120 (.418)

48

.074 (.708)

.218 (.265)

28

LDFR

-.221 (.096)

-.259 (.049)* 58

-.326 (.064)

-.361 (.039)* 33

Trials 1-5

-.028 (.834)

-.174 (.192)

58

-.275 (.122)

-.384 (.028)* 33

FAS

-.229 (.075)

-.299 (.019)* 61

.213 (.205)

.261 (.119)

37

Trails B

-.110 (.418)

-.160 (.240)

56

.209 (.259)

.074 (.691)

31

Coding

-.211 (.102)

-.231 (.074)

61

.013 (.938)

.118 (.481)

38

APR

-.203 (.117)

-.316 (.013)* 61

.034 (.842)

-.014 (.935)

37

FSIQ

-.381 (.002)

-.400 (.001)* 61

.225 (.180)

.153 (.366)

37

Cognitive

SCZ

SCZ-T

Measure

r(p)

r(p)

Arithmetic

-.093 (.479)

Digit Span
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Note. LDSF = Longest Digit Span Forward; LDSB = Longest Digit Span Backwards;
LNS = Letter-Number Sequencing; LSSF = Longest Spatial Span Forward; LSSB =
Longest Spatial Span Backwards; CT = Consonant Trigrams Total; LDFR = Long
Delay Free Recall; FAS = Verbal Fluency (FAS); FSIQ = Full Scale IQ.
*p< 0.05. **^<0.01.
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Chapter IV
Discussion
Goal 1: Describing the PAI Profiles of the Sample

Symptomatic Report in the Combined Sample
The first goal of the current study was to describe the personality profiles
generated by a compensation-seeking CHI sample, without the explicit goal of attributing
observed elevations to causes of a neurological, medical, psychosocial, or emotional
nature, whether premorbid or reactive. It was hypothesized that mean elevations in the
clinically significant range would be observed on PAI scales and subscales reflecting
common presenting complaints following CHI, particularly those associated with
depression (i.e., DEP), somatic dysfunction (i.e., SOM), and cognitive disturbance (i.e.,
SCZ-T). However, the only mean PAI scale to exceed a T score of 65 in the combined
severity CHI sample was SCZ-T, the Schizophrenia subscale tapping complaints of
cognitive disturbance. Review of score distributions nonetheless indicated that a
considerable minority of this sample (i.e., at least 25%) did present with the anticipated
complaints of somatic dysfunction (SOM: SOM-C, SOM-S, and SOM-H) and depression
(DEP: DEP-C, DEP-A, and DEP-P), even in the absence of prominently elevated mean
scores on these scales for the group.
Data analyses also showed that at least 25% of the sample generated PAI profiles
with scores of at least 65T on scales representing anxiety (ANX: ANX-C, ANX-A, and
ANX-P), affective instability (BOR-A), and identity problems (BOR-I), as well as
anxiety-related disorders, particularly those related to traumatic stressors (ARD: ARD-T).
In addition, a smaller proportion (i.e., at least 10%) of this sample reported clinically
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significant degrees of symptomatology germane to aggression (AGG: AGG-A, AGG-V,
and AGG-P), obsessive-compulsive tendencies (ARD-O), phobias (ARD-P), irritability
(MAN-I), social detachment (SCZ-S), negative relationships (BOR-N), antisocial
attitudes (ANT-A), suicidal ideation (SUI), recent life stressors (STR), and-inadequate
social support (NON), in addition to resentment and hypervigilance potentially associated
with paranoia (PAR: PAR-R, PAR-H). It was anticipated a priori that some proportion
of the CHI sample would show high scores on the majority of these scales. Elevations
above a T score of 65 in at least 10% of the sample had not been specifically
hypothesized for the following scales: AGG-A, ARD-O, SCZ-S, BOR-N, ANT-A, SUI,
STR, NON, PAR, PAR-R, PAR-H.
The fact that elevations were observed across such a variety of scales for a small
proportion of the sample is not inherently unexpected, given the heterogeneity of
emotional and behavioral issues seen in this population. The majority of the PAI
elevations documented herein bear an obvious relationship to the common post-TBI
emotional and motivational disturbances listed by Prigatano (1992). In particular,
Prigatano cited irritability, agitation, belligerence, anger, abrupt / unexpected acts of
violence, impulsiveness, impatience, restlessness, inappropriate social responses,
emotional lability, anxiety, suspiciousness, delusions, paranoia, manic symptoms, loss of
interest, loss of initiative, tiring easily, depression, childishness, helplessness, and lack of
insight.
Several of the PAI elevations documented in the current study could plausibly
represent direct sequelae of the injury. In particular, elevations on all three of the somatic
subscales (and, therefore, the composite SOM score) could be due to direct physiological

105

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

effects of neurological injury. For example, sensorimotor aberrations such as blurred
vision, weakness, and hemiparesis may contribute to elevations on SOM-C, while
malaise, pain, and headaches may contribute to elevations on SOM-S in some patients.
High scores on SOM-H generally reflect complaints of poor health and medical problems
that have proven difficult to treat, potentially including ones arising from the injury.
Affective lability and irritability, not uncommon in this patient population, could inflate
scores on BOR-A and MAN-I, respectively. Affective lability and irritability can be
associated with incidents of aggression (such as losing one’s temper, yelling, or smashing
things), particularly in the context of disinhibition secondary to frontal lobe dysfunction.
Despite the plausibility of organic contributions to these symptoms in some cases, one
should not minimize the importance of environmental, emotional, and psychosocial
influences on the development, maintenance, and exacerbation of symptoms in many
cases. In a similar vein, Prigatano (1992) notes the complexity in dissociating the direct
physiological impact of neurological injury on emotional / behavioural status from
indirect emotional sequelae and psychosocial responses.
It must also be borne in mind that circumstances surrounding the brain injury (and
extraneous comorbidities) could also be expected to impact item endorsement on the PAI
and, therefore, affect scale scores. For example, the majority of the current sample
sustained their injuries during motor vehicle accidents, a mechanism of injury itself
associated with orthopaedic / musculoskeletal injuries and psychological responses to
traumatic stressors (Blanchard, Hickling, Freidenberg, Malta, Kuhn, & Sykes, 2004;
Duckworth, & Iezzi, 2005; Ehlers, Mayou, & Bryant, 1998; Mayou, Bryant, & Ehlers,
2001; Miller, 1998). Chronic pain secondary to whiplash-associated disorder and
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orthopaedic injury could account for or inflate scores on all three SOM subscales, while
post-traumatic stress disorder and specific phobia could contribute to scores on ARD-T,
ARD-P, and all ANX scales. Despite some debate about the likelihood of psychological
responses to stressors for which the patient is amnestic, post-traumatic stress disorder and
phobia have been noted in 19% and 10% of a TBI sample, respectively, in one study
using the Structured Clinical Interview for DSM-IV Diagnoses (Hibbard, Uysal, Kepler,
Bogdany, & Silver, 1998).
Elevations on other PAI scales might best be characterized as encompassing
indirect sequelae of the injury, including emotional responses to injury and ensuing
disability, as well as psychosocial consequences indirectly arising from the injury.
Symptoms of depression (Dikmen, Bombardier, Machamer, Fann, & Temkin, 2004;
Kreutzer, Seel, & Gourley, 2001) and anxiety (Hibbard et al., 1998) are prevalent
following TBI; the bona fide presence of these disorders following CHI may well account
for the observation of high scores on the DEP and ANX scales. The astute reader may
note that several items included in the DEP-P scale could reflect direct physiological
sequelae of brain injury (e.g., items related to anergia, sleep disturbance, psychomotor
retardation). While it seems reasonable to surmise that these physiological effects could
inflate scores on DEP-P in some individuals, elevations on all three subscales composing
the DEP scale in a considerable minority of the subjects suggests the presence of a
depressive disorder in at least some proportion of them. Depression may develop as
individuals become increasingly aware of their deficits, as they fail to meet aspirations
for recovery, or as they experience losses in the occupational and interpersonal domains
over time, hypotheses consistent with prior literature demonstrating more marked
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depressive symptoms in more chronic cases (Cullum & Bigler, 1988; Fordyce et al.,
1983).
It is also important to note that some individuals who are left with significant
residual symptoms that are not easily overcome with compensatory strategies experience
challenges, if not incapacity, in performing their customary occupational, familial, and
social roles. Clinically significant scores on BOR-I, a scale that includes items such as “I
wonder what I should do with my life”, “I worry about people leaving me”, and “my
attitude about myself changes a lot”, are occasionally seen in patients struggling with
these issues. Experiences of this nature may account for the elevations on BOR-I seen in
a small proportion of the CHI sample in the current study.
In a similar vein, a myriad of interpersonal changes can become manifest in the
lives of a subset of individuals who have sustained brain injury. The nature and quality
of interactions with peers may be impacted if significant deficits in physical, intellectual,
and/or emotional domains persist, with some friendships altogether dissolving. If
occupational functioning is hindered, contacts with colleagues may be limited or entirely
discontinued. Relationships with family members may be altered, if not strained, as a
result of cognitive and personality changes. These types of interpersonal changes have
implications for the interpretation of observed elevations on several PAI scales, including
NON, SCZ-S, and BOR-N. High scores on NON reflect a lack of perceived social
supports, whether due to limited quantity of relationships with significant others or
inadequate quality of available supportive relationships. Review of items on SCZ-S (i.e.,
social detachment) suggests that this scale may be sensitive to the social alienation and
isolation experienced by some individuals who have sustained TBI; it is probably not
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specific to the lack of interest in interpersonal engagements sometimes associated with
schizophrenia or schizoid personality disorder. Although BOR-N (i.e., negative
relationships) includes several items with content relevant to intense and unstable
relationships characteristic of borderline personality disorder, some items pertain to
loneliness and disappointment in interpersonal relationships. Neither volatile nor
disappointing relationships would be entirely uncommon in patients with significant
residual deficits. Scores on STR represent recent life stressors in financial, marital, and
occupational domains, also not surprisingly common in individuals with significant life
changes secondary to injury.
The finding that a small proportion of individuals in the combined CHI sample
produced elevations on remaining scales (i.e., ARD-O and ANT-A) is more difficult to
explain, although speculative explanations can be entertained. High scores on ARD-O in
a small subset of the sample, for example, are not obviously the result of brain injury,
since the traditional interpretation suggests a meticulous, perfectionistic individual who
attempts to exert control over themselves and their environment. They may, however,
reflect an attempt to compensate for cognitive inefficiencies arising from milder injuries.
Indeed, the authors of one epidemiologic study reported a 14% rate of obsessivecompulsive disorder onset following TBI and speculated that compensatory strategies
were contributory (Hibbard et al., 1998). Alternately, one might suppose that an
abundance of these characteristics premorbidly could predispose an individual to
emotional distress in response to mild cognitive decline or physiological symptoms (and
perhaps even keen sensitivity to these symptoms), thereby increasing the likelihood they
might present for neuropsychological evaluation following injury. High scores on ANT-
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A could be due to premorbid characteristics, since several items represent past history of
rule-breaking behaviour and potentially reflect a risk factor for brain injury.
Finally, from a statistical perspective, it is important to acknowledge that a small
proportion of individuals in any sample randomly drawn from a non-clinical population
could be anticipated to produce scores that deviate from the mean on any given scale.
Therefore, it is possible that some of the clinical scales for which at least 10% of the CHI
sample produced scores at or above a T score of 65 were identified merely as the result of
normal inter-individual variability that bears no relationship whatsoever to their brain
injury. Indeed, they may merely reflect sampling of premorbid characteristics.
The most robust finding arising from description of PAI profiles is that a
considerable minority (at least 25%) of the combined CHI sample generated clinically
significant scores on scales relevant to somatic dysfunction, depression, anxiety, and
thought disturbance. When clinically significant elevations on the MMPI have been
described for TBI samples, they have tended to be observed on the Hs, D, and Hy scales,
and less consistently on the Pt and Sc scales (Berry et al., 1995; Cattelani et al., 1996;
Cicerone & Kalmar, 1997; Cripe, 1999; Diamond et al., 1988; Gass & Russell, 1991;
Hoffman et al., 1999; Leininger et al., 1991; Novack et al., 1984; Suhr et al., 1997;
Youngjohn et al., 1997).
Observed elevations on the DEP and SCZ scales of the PAI, as described herein,
can broadly be construed as analogous to elevations on the D and Sc scales of the MMPI,
with elevations on the Sc and SCZ scales perhaps tapping elements of social alienation
and cognitive dysregulation, rather than positive symptoms secondary to primary
psychotic disorder per se. Observed elevations on the SOM scale of the PAI presumably
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incorporate elements of the Hs and Hy scales of the MMPI, with the subsumed SOM-C
(Conversion) subscale most closely reflecting the “hard neurological signs” such as
paralysis and weakness included in Hy and the subsumed SOM-S (Somatization)
subscale reflecting the vague somatic symptoms such as fatigue and malaise included in
Hs.
At first blush, it might appear that the observed elevations on ANX and ARD in
the current study are analogous to the high scores on Pt documented in the MMPI
literature. Some caution is warranted in making this inferential leap, however, given the
less than perfect conceptual relationship between Pt and the PAI scales germane to
anxiety. Although Pt includes many items that might be construed as sensitive to anxiety,
insecurity, and generalized distress, there is considerable item overlap with other clinical
scales on the MMPI including D, Sc, Hs, and Hy (Greene, 2000). The PAI scales
germane to anxiety were devised with far more homogeneous content, without item
overlap, to isolate and quantify constructs more closely related to diagnostic criteria for
anxiety disorders, including specific phobias and post-traumatic stress disorder (Morey,
1991).
Since this dissertation was submitted for review, two studies describing PAI
profiles in TBI samples have surfaced in the peer-reviewed literature (i.e., Demakis et al.,
2007; Kurtz, Shealey, Putnam, 2007). Unfortunately, scores on symptom validity
measures were not administered and/or evaluated in either study. Therefore, it is possible
that some proportion of individuals who were feigning or exaggerating symptoms of TBI
were inadvertently included in the samples. Additionally, scores on the clinical subscales
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were not reported in either study. Nonetheless, the results of both studies are summarized
herein to compare and contrast the results of analogous analyses in independent samples.
In their study, Demakis and colleagues (2007) found that the five highest
elevations in their mixed-severity TBI sample were on SOM, DEP, BOR, PAR, and SCZ.
The relatively higher scores observed on SOM, DEP, and SCZ are consistent with the
findings described herein. However, mild elevations on BOR and PAR were not found in
the current study, a discrepancy which may be attributable to differences in sample
characteristics. In particular, the TBI sample culled by Demakis and colleagues included
both rehabilitation patients and military personnel, some of whom had sustained blast
injuries. This difference in sample composition may account for mild elevations on the
PAR and BOR scales in the Demakis study, but not in this one.

Interpretive Conundrums and Strategies
Although the earlier discussion lists potential attributions for observed elevations
on various scales that should be entertained when evaluating individuals who have
sustained CHI, it cannot be emphasized enough that the mere presence of these elevations
cannot conclusively be attributed to causes related to the brain injury on the basis of the
scores alone. As Cripe (1999) described with regard to the MMPI, if multiple underlying
causes for item endorsement in a given direction can be posited, the total score on any
given scale is unlikely to accurately discern the cause amongst several plausible
alternatives. Indeed, scores on various scales could be due to direct neurophysiological
effects of the injury, emotional sequelae in response to perceived losses, and premorbid
characteristics, as well as symptom exaggeration. Attempts at discerning the relative
importance of contributory factors should entail a detailed multi-method evaluation that
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relies on clinical expertise and judgment. Following suit with Cripe’s recommendation to
inspect responses to individual items of the MMPI (particularly items with neurological
content), the clinician should review responses to specific items on the PAI. The clinical
neuropsychologist can then begin to consider the most likely causes for item endorsement
(and associated scale elevations), given information culled during the clinical interview,
informant report, review of records (preferably including pre-injury and post-injury
medical, educational, and employment records), current neuropsychological performance,
scores on symptom validity tests, and known brain-behaviour relationships. In some
cases, clinical differentiation will be feasible; in others, it will not.
Inspection of scores on subscales with relatively homogeneous content may prove
a useful heuristic for identifying content areas that could be informed by review of
individual items. For example, if review of the SCZ subscales reveals a high score on
SCZ-T concomitant to normal scores on SCZ-S and SCZ-P, the clinician should
hypothesize that a slightly elevated score on SCZ could be due to endorsement of items
tapping cognitive disturbance secondary to neurological impairment, rather than a
primary psychotic disorder. Review of scores on single items from the SCZ-T subscale
may then shed light on this hypothesis. Whether endorsement of these items reflects
exaggeration, bona fide neurological sequelae, or the confounding effects of
psychopathology, however, must draw upon the clinician’s knowledge of the patient’s
history and plausible sequelae of the injury in question.
Given the frequency of high scores on depression scales following TBI, routine
inspection of depression subscales on the PAI is also recommended. Particular attention
should be given to scores on DEP-A, considering the central role of depressed mood and
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anhedonia to diagnoses of depression. Low scores on DEP-A reduce the probability that
formal diagnosis of depressive disorder is warranted, even if accompanied by higher
scores on DEP-P and DEP-C. This recommendation is akin to Gass and Russell’s (1991)
remark that depression is most likely to be present when D1 (subjective depression) in
particular is elevated. In this sense, the PAI subscales are quick and readily available
cues that serve to alert the clinician to the possibility of spurious elevations owing to
neurological symptoms. The reliance on subscales with more homogeneous content as an
interpretive aid suggested herein receives some corroborating support from prior work
demonstrating the incremental validity of MMPI Content Scales in predicting patient
complaints (Palav et al., 2001).

PAI Profiles According to Injury Severity
An ancillary goal of the current study was to compare PAI profiles generated by
individuals who had sustained mCHI and sCHI. Profile analyses showed that the
personality profiles were neither flat nor parallel. Visual inspection of mean scores on
the PAI scales revealed a distinct configural pattern on the PAI in association with lesser
injury severity. In particular, the mean PAI profile for the mCHI group revealed T scores
above 60 on SOM, ANX, ARD, and SCZ, presumably reflecting increased self-reporting
of symptomatology germane to somatic dysfunction, anxiety (including trauma-related
disorders), and cognitive disturbance. This contrasted with the absence of elevations
above a T score of 60 for the sCHI group. Consistent with this observation, follow-up
ANOVA analyses indicated higher scores on SOM, ANX, ARD, and SCZ in mCHI than
sCHI, even after covarying for higher MCELEV scores in the mCHI group.
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These findings are generally consistent with expectations derived from the
literature on MMPI profiles following CHI. For example, higher scores on a variety of
MMPI scales in association with lesser injury severity have been reported in several
studies (Hoffman et al., 1999; Leininger et al., 1991; Novack et al., 1984). This
counterintuitive phenomenon has been referred to as the “paradoxical severity effect”
(Youngjohn et al., 1997).
Several factors could be hypothesized to contribute to the higher elevations in
mCHI relative to sCHI described in the current study. First, individuals who present for
neuropsychological evaluation during the course of compensation-related matters
following mild head trauma, particularly in the chronic phases of recovery, often
simultaneously present with complaints of pain syndromes (whether secondary to
whiplash associated disorders, orthopedic injuries, or post-concussion headaches) and/or
anxiety disorders (e.g., post-traumatic stress disorder, specific phobias, anxiety
surrounding perceived cognitive decline or functional limitations). The higher scores on
the SOM, ANX, and ARD scales could be an artifact arising from the greater prevalence
of these complicating issues in mCHI patients than sCHI patients that present for
neuropsychological assessment, ultimately falling within the purview of
neuropsychological studies derived from convenience samples. Second, individuals who
have sustained severe CHI may present with attenuated elevations on a variety of scales
as a result of limited awareness and insight, regardless of the nature and degree of
dysfunction that would be reported by an objective observer (cf. Cullum & Bigler, 1988;
Fordyce et al., 1983; Youngjohn et al., 1997). Third, the injury severity groups in the
current study did differ significantly with regard to scores on validity scales of the PAI,

115

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

despite the a priori exclusion of individuals who generated profiles with extreme scores
on these scales. It is certainly possible that the mCHI group included individuals who
responded to the PAI with a mild degree of negative response bias while evading
detection of response bias, thereby inflating mean scores on scales laden with somatic,
affective, and cognitive sequelae of TBI. This possibility cannot be dismissed easily,
particularly considering the lack of empirical data in peer-reviewed literature
documenting the sensitivity of the response bias indicators on the PAI to the feigning of
common TBI sequelae.
When interpreting the clinical significance of group differences on the validity
scales, one might infer some degree of symptom amplification in the mCHI group, and
this hypothesis is warranted. However, it must be borne in mind that depression predicts
high scores on NIM (Morey, 1996). Depression per se is associated with a pervasively
negative view of one’s self, one’s circumstances, and one’s future; this depressogenic
lens can translate to a negative impression response bias that manifests as a mild to
moderate elevation on NIM. Consequently, it is important to note that malingering,
independent of psychopathology, does not necessarily explain the greater NIM scores in
mCHI than sCHI.
Comparison of the injury severity groups on demographic variables also showed
that the females were over-represented in the mCHI group and under-represented in the
sCHI group. From an epidemiologic perspective, adult males are more likely to sustain
TBI than are adult females, but women have been over-represented in mild TBI groups
amassed via neuropsychological convenience samples (e.g., Leininger et al., 1991). In
fact, some authors have commented that the “female sex could be associated with the
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presence of persistent symptoms” following “the slightest of all cranial traumas”
(Cattelani et al., 1996, p. 194). Therefore, it was of interest to determine whether the
higher scores on the PAI in the mCHI than in the sCHI group were merely artifacts of the
higher proportion of women in the former group.
Consequently, one-way ANOVA analyses were repeated separately for each
gender, for each of the PAI variables for which severity-related differences had been
identified by earlier ANOVA analyses. Significant differences, in the same direction,
were replicated for the majority of the scales when the data were stratified by gender. For
males, there were no statistically significant differences on NIM, ARD, DEP, ARD-T,
and BOR-A across the injury severity groups. It should be noted that the failure to
achieve significant differences on DEP and BOR-A were not due to the absence of
elevations on these scales in the males with mCHI. The scales that did not differ
significantly between females with mCHI and females with sCHI were RDF, ANX, and
ANX-A. It is not entirely clear whether the failure to find statistically significant
differences by injury severity on select PAI scales, when the data were stratified by
gender, reflects true gender differences or the lack of statistical power secondary to
reduced sample sizes. Whether gender differences impact PAI profiles following CHI
warrants further investigation, particularly since qualitatively distinct profiles have also
been described for the MMPI (Alfano, Neilson, Paniak, & Finlayson, 1992). Despite this,
the results of follow-up analyses suggest that the general trend towards higher PAI scores
in mCHI than sCHI are not entirely due to inclusion of a higher proportion of women in
the mCHI group.
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In contrast to the findings herein documenting differences in overall elevation and
profile configuration according to injury severity, Demakis and colleagues (2007) did not
find any significant differences between the PAI profiles of subjects who had sustained
milder brain injuries and those who had sustained more severe brain injuries. It should be
noted, however, that the mild group included primarily military personnel, while the
moderate to severe group included mostly patients from a rehabilitation hospital. This
raises some methodological concerns about this specific comparison. Some military
personnel present as highly-motivated and minimize psychological distress, perhaps
obscuring prominent elevations on some scales in Demakis’ sample of individuals with
mild TBI. Furthermore, the compensation-seeking status of the Demakis sample was not
known. Consequently, the impact of litigation or other forms of compensation-seeking
on the observed PAI profiles could not be evaluated in their study. It is possible that
higher scores for the mCHI group were obtained in the current study due to a higher
proportion of litigating patients.
The results of univariate analyses reported by Kurtz, Shealy, and Putnam (2007)
were more consistent with the injury severity effects described in this dissertation.
Specifically, the authors found higher scores on SOM and DEP in their mild TBI group
than in their moderate to severe TBI group, akin to group differences identified in the
current study. However, Kurtz and colleagues also found that their mild TBI subjects
generated lower scores on ANT and ALC than their more severely injured counterparts;
scores on these scales were indeed below average. Although mean scores on these scales
were lower in mCHI than sCHI in the current study and were below average in the mCHI
group, these differences did not reach statistical significance. Kurtz and colleagues
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suggested that the below average scores on ANT and ALC may be due to timid and
conforming individuals in their mild TBI group. An alternative explanation is that some
individuals in their mild CHI sample were selectively minimizing these traits and
difficulties. Surprisingly, there were no main effects of injury severity or compensation
status in the multivariate analyses of PAI profiles in the Kurtz and colleagues study. The
reasons for the failure to find these expected effects remain unclear.
Goal 2: Evaluating Neurological Content of Individual PAI Items
Broadly speaking, the second goal of the current study was to address the issue of
neurological content at the item level by using a rational-empirical method to identify
items with content germane to traumatic brain injury. Furthermore, it was hoped that
determining the correlates of the sum of neurological items so identified would shed light
on the underlying constructs influencing endorsement of these items.
As anticipated, the majority of expert raters (i.e., at least 5 of 9) selected several
(precisely 24) items for which endorsement in the pathological direction could reflect
common sequelae of sCHI. As hypothesized, the selected items were represented on
scales tapping somatic complaints, depression, affective instability, aggression,
irritability, and thought disturbance. Contrary to expectations, none of the items on the
anxiety scales were selected by the expert raters. One selected item was from BOR-S and
another was from NIM, neither of which had been predicted a priori. The selection of
this set of PAI items by a majority of raters confirms the suggestion that particular items
on the PAI plausibly represent neurological content applicable to TBI, at least from the
perspective of face validity.
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Of the 24 neurologically relevant items selected by the expert raters, it was
hypothesized that only a subset would be found to empirically discriminate between the
sCHI group and a normal control group derived from the standardization sample. Indeed,
the sCHI group obtained significantly higher scores than the control group for 11 of the
24 selected items. The mCHI group also obtained higher scores on these 11 items than
the control group. The neurologically relevant items that discriminated between the sCHI
and control groups were endorsed by a significant proportion of the CHI samples.
Overall, the employed rational-empirical methodology resulted in the identification of 11
neurologically relevant items, endorsed fairly frequently in the CHI sample, that
potentially inflated scores on the somatic, depression, and cognitive disturbance scales of
the PAI. These analyses appear to lend credence to the notion that spurious elevations on
select scales of the PAI may occur as a result of CHI sequelae in some individuals.
It was hoped that factors influencing endorsement of the identified neurologically
relevant items would be clarified by considering correlates of the sum of the items.
Specifically, it was hypothesized that the nature of the Neuro-Item Sum would be
clarified by its pattern of associations with demographic variables, injury parameters,
objective cognitive performance, scores on response bias indicators of the PAI, and
depression scores. Data analyses showed the Neuro-Item Sum to be unrelated to
demographic variables such as age, education, and gender. Time since injury did not
predict the sum, but the mCHI group obtained higher scores than the sCHI group, even
after controlling for the higher MCELEV scores in the mCHI group. The latter finding is
not entirely unexpected, given the higher scores on scales reflecting somatic and
emotional dysfunction noted in this study of the PAI and other studies of the MMPI
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(Hoffman et al., 1999; Leininger et al., 1991; Novack et al., 1984; Youngjohn et al.,
1997) and the higher rates of symptom complaints in mTBI relative to sTBI and other
medical conditions (Gordon, Haddad, Brown, Hibbard, & Sliwinski, 2000). Nonetheless,
it does provide evidence that endorsement of the neurologically relevant items does not
directly and accurately measure the sustained neurological injury or resulting
neurological dysfunction. The notion that bona fide neurological symptoms are
artificially inflating select PAI scores, in a dose-response relationship commensurate with
the actual severity of the injury, receives little support and must be revisited. At a
minimum, the influence of supplementary factors such as depression, impression
management, and insight must be taken into account.
The influence of psychological factors, particularly depression and response bias,
on endorsement of the neurologically relevant items was addressed by computing
correlations between the Neuro-Item Sum and various PAI scores (i.e., DEP, NIM, MAL,
DEP, RDF, CDF, PIM). The pattern of computed correlations suggested a strong
relationship between scores on the Neuro-Item Sum and depression regardless of injury
severity. On the other hand, the association between the Neuro-Item Sum and response
bias was attenuated in the sCHI group relative to the mCHI group. More specifically, for
the mCHI group, there were negative correlations of moderate magnitude between the
Neuro-Item Sum and positive response bias indicators (i.e., PIM and DEF) in the context
of a strong negative correlation between the Neuro-Item Sum and NIM. By contrast,
only NIM predicted the Neuro-Item Sum for the sCHI group, with the magnitude of the
correlation coefficient being weaker than in mCHI. Hence, the strongest predictors of the
Neuro-Item Sum, in both injury severity groups, were DEP and NIM.
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Given the inherent correlation between DEP and NIM, hierarchical regression
analyses were utilized in an attempt to disentangle independent contributions of these
factors on endorsement of items with neurological content. For the sCHI subjects,
depression emerged as the most potent predictor (and, indeed, the only independent
predictor) o f the total score on the neurologically relevant items. Negative impression
management did not contribute to prediction of the Neuro-Item Sum, after depression
scores were accounted for. In contrast, both depression and negative impression
management emerged as independent predictors of the Neuro-Item Sum for the mCHI
subjects.
When interpreting the significance of the latter finding, one certainly needs to
consider the possibility that deliberate deceit to secure secondary gain could be
contributory in some cases. In this context, it must be borne in mind that the subjects
included in the mCHI sample achieved adequate scores on all administered measures of
neurocognitive effort. The sample was also screened for extreme scores on indices of
response bias on the PAI. Therefore, flagrant dissimulation of severe cognitive or
psychiatric symptoms appears unlikely in this mCHI sample. The possibility that a small
proportion of the sample presented with distorted or “amplified” self-report of cognitive
or psychiatric sequelae, while evading detection, cannot be dismissed, however. It may
be the case that individuals involved in civil litigation or other forms of compensationseeking following mCHI are more likely to emphasize or “embellish” symptomatic report
during forensic evaluations than are individuals following sCHI, ultimately producing
higher scores on the Neuro-Item Sum than their more severely injured counterparts. In
protracted mCHI litigation, the legitimacy and seriousness of symptoms is more likely to
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have been questioned in prior evaluations; patients may come to expect skepticism from
evaluators they hope to convince of their debilitation. Attorneys may encourage such
symptomatic emphasis, consistent with legal objectives and securing treatment for their
clients. Indeed, the notion that individuals with mCHI would present with embellished
report during the course of forensic evaluations is generally consistent with the
adaptational model of malingering devised by Rogers (1990).
It is perhaps not surprising that a correlation between depression and the NeuroItem Sum was obtained in the current study, since depression has been shown to be
associated with increased symptomatic report following concussion (Gunstad & Suhr,
2004; Iverson & Lange, 2003). Furthermore, prior studies have demonstrated that scores
on MMPI neurocorrection factors were correlated with depression (Brulot et al., 1997)
and showed poor discrimination between CHI and psychiatric disorders (Glassmire et al.,
2003). Likewise, endorsement of CNS items on the MMPI appears to be similar in
neurological, psychiatric, and chronic pain samples (Cripe et al., 1995).
Unfortunately, a mixed psychiatric sample was not available to extend these
findings to the PAI by demonstrating similar scores on the Neuro-Item Sum in CHI and
psychiatric samples. Nonetheless, some insight into this issue can be gleaned by
examining scores on the neurologically relevant items for the mixed clinical sample listed
in the technical manual (Morey, 1991). Although scores on the individual items were
higher in the sCHI group than a control group derived from the standardization sample,
inspection of the scores for the mixed clinical sample (shown in Table 8) reveals them to
be similar to those produced by the sCHI sample. Indeed, mean scores on neurologically
relevant items for the sCHI and mixed clinical samples never differed by more than one
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standard deviation. This observation further supports the suggestion that psychological
factors may contribute to endorsement of items putatively representing neurological
content on self-report measures of psychopathology, a phenomenon that extends to the
PAI. Considering the similarity of scores on these individual items for sCHI and mixed
psychiatric samples, the goal of discriminating between neurological and psychiatric
samples on the basis of the Neuro-Item Sum, while maintaining adequate specificity,
appears less than promising.
Data analyses in the current study also showed objective cognitive performance to
be related to endorsement of the neurologically relevant items. In particular, lower scores
for APR, PSI, and Coding (reflecting greater neuropsychological compromise) were
associated with higher scores on the Neuro-Item Sum (reflecting more numerous
complaints on the neurologically relevant items) in the mixed-severity CHI sample, in the
absence of a correlation between the Neuro-Item Sum and FSIQ. This finding is
noteworthy, particularly since the APR was designed to be sensitive to the cognitive
sequelae of CHI and measures of processing speed (i.e., PSI and Coding) are known to be
vulnerable to CHI (Fisher, Ledbetter, Cohen, Marmor, & Tulsky, 2000; Martin, Donders,
& Thompson, 2000). A wider range of cognitive scores correlated with the Neuro-Item
Sum when analyses were restricted to those with mCHI. The latter finding is unlike the
failure to identify significant correlations between cognitive performance and MMPI
neurocorrection scores in a sample with predominantly mild TBI (Brulot et al., 1997).
No significant relationships were observed between Neuro-Item Scores and objective
cognitive performance in the sCHI group.
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Hierarchical regression analyses were used to determine whether surrogate scores
for cognitive compromise (or decline) secondary to CHI would contribute to the
prediction of the Neuro-Item Sum, after accounting for NIM and DEP. These regression
analyses incorporated performance on measures sensitive to CHI (i.e., APR and PSI) and
measures that are relatively resistant to deterioration secondary to CHI (i.e., VCI) to
control for premorbid intellectual functioning, in an attempt to gauge the degree of
cognitive decline putatively secondary to CHI. Overall, regression analyses showed that
putative indicators of cognitive compromise (i.e., APR and PSI) contributed significantly
to the prediction of the Neuro-Item Sum, after controlling for DEP and NIM, but only for
the mCHI sample. In conjunction with the aforementioned inverse relationship between
the Neuro-Item Sum and cognitive scores in mCHI, the results of these regression
analyses suggest that cognitive inefficiency plausibly attributable to CHI could be
associated with endorsement of PAI items with neurological content. This would appear
to hold only for those who have sustained mCHI.
For the sCHI sample, depression was the only significant independent predictor of
the Neuro-Item Sum to emerge in analogous regression analyses. It is particularly
noteworthy that NIM did not contribute significantly to the prediction of the Neuro-Item
Sum, after controlling for depression scores. However, due to the small number of
subjects relative to the number of independent variables included in analyses, some
caution is warranted in relying on the results of the hierarchical regression analyses for
the sCHI sample (particularly with regard to regression coefficients for individual
predictors). Despite this statistical limitation, there is reasonable confidence in the
overarching conclusion that depression is the most potent predictor of endorsement to
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neurologically relevant items following sCHI. That this is the case is apparent in the
magnitude of the correlation coefficients presented earlier, demonstrating a strong
positive relationship between depression scores and the Neuro-Item Sum.
In these hierarchical regression analyses, the difference score between VCI and
PSI was utilized as an index of cognitive inefficiency plausibly attributable to the
sequelae of CHI. However, it should be understood that VCI-PSI is not an accurate
measure of cognitive compromise secondary to CHI for all individual patients. In
particular, some patients with verbal impairment secondary to severe CHI impacting left
hemispheric systems can experience declines on VCI due to their injuries. VCI may also
underestimate premorbid intellectual functioning in individuals with pre-existing verbal
learning disabilities. Nonetheless, it is believed that use of the difference score
reasonably achieved the intended purpose (i.e., indexing cognitive inefficiency arising
from the sequelae of CHI) across the entire sample for the aforementioned hierarchical
regression analyses.
Collectively, the findings in this study provide evidence that endorsement of
neurologically relevant items identified by a rational-empirical method is multi-factorial
in nature. In the terminology of item-response theory, the endorsement of given items
appears to be influenced by multiple latent variables, including injury severity, response
bias, depression, and cognitive functioning. The sum of the neurologically relevant items
was not directly proportional to the magnitude of neurological injury; indeed, patients
who had sustained mCHI produced higher sums than those with sCHI. Depression was a
potent predictor of endorsement, regardless of injury severity. Cognitive functioning and
negative response bias appeared to contribute to item endorsement only in mCHI. Since
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endorsement of items with neurological content appears multi-factorial and substantially
influenced by psychiatric comorbidities, neurocorrection (or deletion) of items cannot be
recommended. This is particularly true, given the lack of external validation of
incremental validity or improved diagnostic efficiency of the resulting neurocorrected
profile (see Arbisi & Ben-Porath, 1999; Greene, 2000 for analogous comments regarding
neurocorrection of the MMPI).
Goal 3: The Relationship of Objective Neuropsychological Performance to Cognitive
Complaints on the PAI
The third goal of this study was to determine whether PAI scales comprised of
items reflecting cognitive complaints (i.e., SCZ and SCZ-T) would be associated with
performance on objective measures of cognitive functioning. It was tentatively
hypothesized that scores on these PAI scales would be negatively correlated with scores
reflecting working memory, memory, and set-shifting, as well as other measures sensitive
to CHI. Data analyses showed that scores on the overall SCZ scale were unrelated to
performance on a variety of administered neuropsychological measures. In contrast,
several significant correlations were obtained for SCZ-T, which differed depending on
injury severity. For the subjects who had sustained sCHI, the only significant
correlations to emerge were between elevations on SCZ-T and scores achieved on the
CVLT-II (i.e., total learning and delayed free recall), suggesting that memory deficits
were associated with increased cognitive complaints in this group. Indeed, subjects with
reasonably intact insight into their cognitive abilities following moderate to severe CHI
may endorse cognitive complaints, if they are experiencing difficulties with verbal
memory.
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There was a wider range of significant correlations for the mCHI group.
Specifically, there was an inverse relationship between verbal fluency and SCZ-T
elevations, but scores on individual measures that composed the APR were not otherwise
predictive of elevations on SCZ-T. On the other hand, the APR composite score per se
did correlate negatively with SCZ-T elevations. Small to moderate correlations were also
noted between elevations on SCZ-T and scores on the following neuropsychological
measures: Longest Spatial Span Backwards and Long Delay Free Recall on the CVLT-II.
Interestingly, however, the strongest predictor of SCZ-T was FSIQ. The latter finding
casts doubt on any hypothesis that elevations on SCZ-T are entirely attributable to
cognitive sequelae of mCHI.
Although speculative in nature and requiring further empirical validation, one
plausible rationale for the observed correlations between SCZ-T and objective cognitive
performance can be posited. First, it is important to concede that select mCHI patients
who genuinely experience some limitations in cognitive functioning (whether due to
mCHI or other factors) might be producing mild to moderate elevations on SCZ-T as a
result of the cognitive complaints endorsed on the PAI inventory, consequently
contributing to observed correlations. On the other hand, inaccurate responses on SCZ-T,
inflating SCZ-T scores in select individuals, may also have contributed to the observed
correlations. Review of individual items represented on SCZ-T indicates that several
could legitimately be endorsed following TBI (e.g., confused thinking, poor
concentration), while others are extremely unlikely to accurately depict the mental state
of an individual in the chronic phases following mCHI. For example, “sometimes I have
trouble keeping different thoughts separate”, “sometimes it feels as if somebody is
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blocking my thoughts”, and “sometimes I wonder if my thoughts are being taken away”,
likely do not represent bona fide cognitive experiences secondary to mCHI. There is,
however, the possibility that unsophisticated patients with cognitive limitations could
respond to these statements in an idiosyncratic fashion, whether due to genuine
misunderstanding (e.g., unusually concrete interpretations) or an attempt to “convey” the
magnitude of their deficits, thereby inflating their scores on SCZ-T and creating spurious
correlations with objective cognitive performance.
Review of individual items loading on SCZ-T also generally leads one to
tentatively hypothesize that mild to moderate elevations on SCZ-T could be observed in
CHI, chronic pain, depression, or any other condition associated with cognitive
complaints. However, extreme elevations should lead the clinician to question the
accuracy of responses in the absence of severe cognitive dysfunction (e.g., secondary to
psychosis) that is apparent to the objective examiner. This caveat applies primarily when
evaluating outpatients, residing independently without supervision, in whom there is no
known psychotic disorder, particularly in the chronic phases of recovery from milder
injuries. The notion that extreme scores on SCZ-T can be observed in the context of
neurocognitive malingering gamers some support from preliminary findings that
analogue TBI simulators produce extreme scores on this scale (Keiski, Miskovic, Shore,
& Hamilton, 2007).
The aforementioned correlations between cognitively loaded subscales of the PAI
and objective performance on neuropsychological measures are somewhat analogous to
the inverse relationships between MMPI variables (e.g., D, Sc, BIZ) and scores on
measures of attention and list learning in TBI reported by Ross, Putnam, Gass, Bailey,
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and Adams (2003). In contrast, the findings are discrepant from those of Gass, Russell,
and Hamilton (1990), who failed to identify significant correlations between performance
on neuropsychological measures and cognitively loaded scales of the MMPI. It is
tempting to attribute these discrepant findings to differences in the scales used and infer
that the PAI SCZ-T scale and the MMPI scales are tapping qualitatively distinct elements
of self-reported cognitive complaints. However, other methodological differences
between the studies could account for the discrepant findings. These include the failure
of Gass and colleagues to screen for poor effort on neurocognitive measures, common to
that era, and perhaps differences in sample composition (since injury severity was not
clearly specified in the study by Gass and colleagues).
In any event, scores on SCZ-T should not be construed as accurate representations
of cognitive efficiency, particularly given the higher SCZ-T scores for mCHI than sCHI
described herein, dramatic SCZ-T elevations observed in analogue simulators (Keiski et
al., 2007), and the reality that some patients with severe TBI will provide poor estimates
of their actual cognitive functioning due to limited insight. Finally, it should be noted
that the mCHI group was larger than the sCHI group. Furthermore, the range of SCZ-T
scores was wider for the mCHI group than the sCHI group. Therefore, the possibility that
a wider range of correlations between SCZ-T and cognitive scores were observed for the
mCHI group than for the sCHI group merely as a result of differential statistical power
cannot be entirely ruled out.
Concluding Remarks
The current study has provided empirical data that begins to address issues
germane to the use of the PAI in neurological populations, particularly CHI, via analysis
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of profiles yielded during consecutive neuropsychological assessments following alleged
CHI of varying severities. Importantly, the sample included only subjects for whom
performance on measures of neurocognitive effort was adequate. Noteworthy findings in
the study included the demonstration that a considerable minority of the CHI sample
produced clinically significant scores on scales relevant to somatic dysfunction,
depression, anxiety, and thought disturbance. Potential attributions for these elevations
were addressed in the text, although it was emphasized that the mere presence of these
elevations could not conclusively be attributed to causes related to the brain injury on the
basis of the scores alone. The recommended interpretive strategy includes examination
of subscales with more homogeneous content and review of responses to individual
items, while integrating information from the clinical history, collateral information,
scores on various psychological and neuropsychological instruments, and known brainbehavior relationships.
The study also demonstrated distinct PAI profiles in association with injury
severity, with more prominent elevations on various scales (particularly SOM, ANX,
ARD, and SCZ) consequent to injury of lesser severity. This finding did not appear to be
entirely attributable to the over-representation of females in the mCHI group. On the
other hand, the higher scores on these scales following mCHI could be due to
comorbidities such as chronic pain and anxiety disorders in this population. Limited
insight consequent to sCHI and response bias consequent mCHI were also deemed
potentially contributory to these group differences.
The issue of neurological content at the item level was addressed via rationalempirical selection of a subset of PAI items representing neurological content that were
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endorsed more frequently in sCHI than in a normal comparison group. Endorsement of
these neurologically relevant items, however, was not directly proportional to the
magnitude of the sustained neurological injury. To the contrary, endorsement of these
items appeared to be influenced by a host of factors, such as response bias, depression,
and cognitive functioning. Depression was the most potent predictor of the sum of scores
on these items, regardless of injury severity. Consequently, neurocorrection was not
recommended.
The current study also explored potential relationships between objective
cognitive performance and scores on cognitively loaded subscales of the PAI, particularly
SCZ-T. Inverse relationships were noted between verbal learning / memory and
cognitive complaints for individuals who had sustained moderate to severe brain injuries.
Although several correlations were obtained between SCZ-T elevations and cognitive
scores following mCHI, the strongest correlation was with overall intellectual
functioning, which argues against any hypothesis that elevations on SCZ-T are primarily
attributable to cognitive sequelae of mCHI.
Several overarching limitations of the current study, and directions for future
research, warrant mention. First, several hypotheses were advanced regarding underlying
causes for the distinct PAI profiles observed in mCHI relative to sCHI. For example, the
possibility that elevations on ARD and SOM were higher following mCHI than sCHI was
deemed potentially attributable to a higher proportion of individuals presenting with
comorbid post-traumatic stress disorder and chronic pain conditions following mCHI.
While this seems to be a reasonable hypothesis, empirical demonstration of a relationship
between observed scores on these scales to external criteria (e.g., independent diagnosis
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of post-traumatic stress disorder via APA criteria, presence of known orthopaedic
injuries, and prescription of analgesics) would be required to confirm this possibility.
Similarly, potential alternative interpretations consequent to TBI described in the text
should be subjected to further empirical scrutiny. In general, it can be said that empirical
demonstration o f the relationship between various PAI scores to external criteria in CHI
would be very useful to the field.
Another consideration when evaluating data yielded by the current study involves
the cut-off scores on PAI response bias indicators that were selected for inclusion in this
study. There is a paucity of information in peer-reviewed literature regarding the
sensitivity and specificity of the PAI validity scores in TBI. As a result, it remains
possible that the selected cut-off scores were not sufficiently sensitive to the subtle and/or
qualitatively distinct forms of exaggeration seen in this population, thereby inflating the
proportion of mCHI subjects endorsing PAI items plausibly representing affliction by
psychiatric and/or neurological ailments. Note that such a tendency could lead to
inflation of both the Neuro-Item Sum and various PAI scales / subscales in the mCHI
sample. Further research addressing the utility and limitations of the PAI validity scales
for use in forensic evaluations consequent to CHI clearly represents a research priority.
Indeed, since implementation of the current project, preliminary evidence from an
analogue study of TBI malingering suggests that a lower cut-off score on NIM might
have been more sensitive to this type of dissimulation, without compromising specificity
(Keiski et al., 2007).
The scores achieved on various PAI validity scales for the mCHI and sCHI in the
current study may also shed some light on their value in evaluations consequent to
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alleged TBI. In particular, the fact that the mCHI group obtained higher scores on NIM
(suggestive of symptomatic exaggeration) than the sCHI group may provide some
preliminary evidence regarding its sensitivity to symptom amplification / dissimulation in
this context. Conversely, the fact that the sCHI group obtained higher scores on RDF
(suggestive of symptomatic exaggeration) than the mCHI group raises some concerns
about the use of this score in TBI populations.
The representativeness of the current sample and the generalizability of the
current findings also warrant explicit mention. First, the retrospective data described
herein represents a series of consecutive referrals to a private practice in
neuropsychology, typically for the purpose of evaluating potential sequelae of CHI due to
ongoing litigation or persistent cognitive complaints. It must, therefore, be understood
that the results are not representative of the much larger segment of individuals who
sustain CHI and do not present for neuropsychological evaluation at a secondary or
tertiary level of care (cf. Dikmen, Reitan, Temkin, & Machamer, 1992).
Second, inclusion in this study required completion of the PAI and various
neuropsychological measures, likely narrowing the characteristics of the culled sample by
virtue of study design. For example, subjects with inadequate facility with the English
language and/or grossly limited literacy skills were not administered the PAI and were
consequently not included in the current sample. Likewise, individuals with very severe
cognitive deficits following CHI who were deemed incapable of validly completing the
PAI were not included in the current study. Hence, it should be understood that
individuals with limited literacy skills or severe cognitive deficits were not represented in
the current sample.
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Third, the current sample was comprised entirely of outpatients. There is no
legitimate reason to infer that the findings described herein would generalize to an
inpatient population, particularly in the acute or post-acute phases of recovery. Overall,
the instant findings appear most pertinent to comprehensive neuropsychological
evaluations undertaken on an outpatient basis at the request of a third party to evaluate
potential sequelae arising from putative CHI during the course of compensation-seeking.
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Appendix A. Neurological correction factors identified for the MMPI-2 in TBI (up to item #370) - adapted
from Greene (2000)

Method of Identification
Empirical

Item

Rational

Gass (1991) Alfano (1993) Artzy(1994)' Gass & Russell (1991)

3 False

X

5 True

X

8 True

X

10 False

X

X

12 False

X

X

20 True
31 True

X

X

X

X

X

X

35 True

X

38 True

X

X

40 True

X

45F False

X

47 True

X

53 True
X

X

X

X

x

X

116 True

X
X

119 True

X

137 True

X

141 False

X

143 True
146 True

X

X

33 True

106 False

Van Balen (1997)

X
X

X
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Item

Gass (1991) Alfano (1993) Artzy(1994)

147 True

X

X

X

X

X

164 False

X
X

X

X

X

166 True
X

168 True
170 True

X

172 True

X

X

X

173 False
175 True

X

X

152 False

165 False

X

X
X

176 False
177 False

X

X

X

X

179 False

X

X

X

X

180 True

X

X

X

X

204 True

X

208 True

X

213 True

X

224 False
229 True

Van Balen (1997)

X

148 True
149 True

Gass & Russell (1991)

X
X

247 True
249 False

X

252 True

X

253 True

X

255 False

X

258 True

X
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Item

Gass (1991) Alfano (1993) Artzy (1994)

Van Balen (1997)

X

266 False
295 False

Gass & Russell (1991)

X

X
X

299 True

X

X

X

X

X

308 True

X

X

309 True

X

X

325 True

X

X

X

X

341 True

X
X

N.B. Items identified by 3 of the 5 studies are bolded.
1as provided in Greene (2000)
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Appendix B. PAI Items that Plausibly Contain Neurological and/or Medical Content

Item

Scale

3.

SOM-C

7.

MAN-A

12.

SOM-H

14.

BOR-A

21.

AGG-P

32.

SOM-S

38.

SCZ-T

43.

SOM-C

45.

ARD-0

47.

MAN-A

52.

SOM-H

72.

SOM-S

75.

DEP-P

78.

SCZ-T

83.

SOM-C

86.

DEP-A

87.

MAN-A

92.

SOM-H

94.

BOR-A

107.

DEP-C

112.

SOM-S

137.

BOR-I

141.

AGG-P

147.

DEP-C

155.

DEP-P

195.

DEP-P
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198.

SCZ-T

223.

BOR-S

272.

SOM-S

283.

SOM-C

318.

SCZ-T

323.

STR

326.

STR

329.

NIM
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Appendix C. Data Exploration and Statistical Disclaimers
Goal 1: Describing the PAI Profiles of the Sample
All scores derived from the PAI were explored for normality and univariate
outliers within the respective injury severity groups. Slightly elevated kurtosis and
positive skew were noted for the following PAI scores: ALC (more so for the moderate to
severe CHI group than die mild CHI group), DRG (for both groups), SUI (for both
groups), PAR-P (for both groups), and AGG-P (for the moderate to severe CHI group
only). Visual inspection of the MAL scores showed a limited range of scores (raw scores
of 0,1,2, or 3), with the distributions appearing relatively flat. Univariate outliers were
identified for four of the PAI scales. For the mild CHI group, there was one outiier
reflecting a high score on DRG and two outliers reflecting high scores on SUI. For the
moderate to severe CHI group, there was one outiier reflecting an elevation on DEP-C
and two outliers reflecting high scores on ARD-T. The outliers did not appear to be
extreme values relative to the total sample and were reasonably close to the next value
within their respective groups. Means and 5% trimmed means never differed by more
than 2 points. Therefore, all outliers were tentatively retained without modification,
although their influence was considered when relevant to subsequent analyses.
As discussed in Tabachnick and Fidell (2001), consideration of several statistical
assumptions and constraints was necessary prior to implementation of profile analyses
comparing the mCHI and sCHI groups. Clinical subscales were analyzed separately from
the clinical scales they compose to avoid singularity and to ensure there would be more
subjects in the smallest group than there were dependent variables. Unequal sample sizes
are not problematic in profile analyses with only one between-subjects independent
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variable. With regard to the assumption of multivariate normality, the normality of
sampling distributions could be assumed, since group sizes were not substantially
divergent, there were more dependent variables than cases in the smallest group, and
distributions of the dependent variables were not markedly skewed. Linearity amongst
the dependent variables was assumed, with reduced power for the test of parallelism
being the consequence for failure to meet this assumption. Multicollinearity did not
appear problematic, since tolerance never approached 0.001. (Additionally, univariate
correlations were less than 0.8.) Univariate homogeneity of variance was tenable
(variance ratio < 10:1), as was homogeneity of variance-covariance matrices (Box’s M <
0.001; Pallant, 2001).
Given the sensitivity of profile analysis to univariate and multivariate outliers
(Tabachnick & Fidell, 2001), both profile analyses were repeated without either type of
outlier to replicate significant findings. Univariate outliers that were excluded from re
analyses were identified by SPSS as extremes during production of boxplots, indicating
that scores on a given PAI scale were more than three box lengths from the edge of the
box, where the box length is equal to the interquartile range. By this criterion, six
individuals were excluded from subsequent profile analyses.
For the ANOVA and ANCOVA analyses comparing PAI scores between injury
severity groups, homogeneity of variances appeared tenable, as indicated by variance
ratios that never exceeded 4:1. Accuracy of additional assumptions was confirmed for
ANCOVA analyses using MCELEV as the covariate. In particular, MCELEV showed
moderate to strong positive correlations (range: 0.411 to 0.833) with PAI scores, with
most correlations being greater than 0.6. Linearity of relationships between MCELEV
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and the PAI variables was confirmed via visual examination of scatterplots.
Homogeneity of regression slopes also appeared tenable, since there were no noticeable
discrepancies in the slopes of the lines of best fit shown in the generated scatterplots.
With regard to the ANOVA analyses comparing select PAI scores for those
following mCHI and sCHI conducted separately for each gender, the assumption of
homogeneity of variances was tenable. On the other hand, statistics such as Shapiro-Wilk
identified deviations from normality in these smaller groups, as did visual inspection of
histograms. However, deviations were believed to reflect the effects of small sample
selection and were not deemed extreme enough to invalidate the use of ANOVA, which
tends to be relatively robust to minor violations of assumptions.
Goal 2: Evaluating Neurological Content of Individual PAI Items
Since the scale of measurement for responses at the item level is ordinal and
distributions were markedly skewed for many of the selected neurological items, nonparametric statistics were utilized for analyses comparing scores on neurologically
relevant items in the control group and CHI groups. Non-normality and outliers pose no
issues for the statistical methods employed for this purpose.
For t-tests comparing die Neuro-Item Sum between injury severity groups and
genders, the assumptions of normality and homogeneity of variance were tenable. For
ANCOVA analyses comparing Neuro-Item Sums for the mCHI and sCHI groups after
covarying for MCELEV, the relationship between MCELEV and the Neuro-Item Sum
appeared linear and slopes appeared equivalent in both groups, as determined by visual
inspection of scatterplots.
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As pertains to computations evaluating correlates of the Neuro-Item Sum, there
were extreme outliers for time since injury. Therefore, supplementary analyses restricted
to the subsample that had sustained their injuries in the prior 60 months were conducted,
with these correlation coefficients being reported in the text. All correlation coefficients
reported were subsequently subjected to regression diagnostics. One outlier, with a
standardized residual of -3.027, was identified for the correlation between the Neuro-Item
Sum and DEP in the mCHI sample. This case was not identified during regression
diagnostics using the combined sample. Visual examination of the relevant scatterplot
for the mCHI group failed to reveal any influential data points that would skew the
determined correlation value. Otherwise, no outliers were identified via regression
diagnostics; no standardized residual exceeded an absolute value of 3.0. All significant
correlations were plotted, and none of the correlations were judged to be the result of
influential data points. None of the cognitive variables used in this section were
markedly skewed, and no extreme outliers were identified.
With regard to hierarchical regression analyses used to consider independent
contributions of various correlates to the Neuro-Item Sum, it is important to note that
Variance Inflation Factors never exceeded 3.5. In fact, the Variance Inflation Factors that
were this elevated were for the analyses that excluded MCELEV from further
consideration. For the other models provided, the Variance Inflation Factors never
exceeded 2.1. Therefore, multicollinearity did not appear to pose a substantial problem,
despite known correlations amongst the predictors. Furthermore, standardized residuals
were consistently below an absolute value of 3.0, with no outliers being detected via
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SPSS casewise diagnostics. Visual inspection of residuals plots failed to suggest
heteroscedasticity.
Goal 3:The Relationship of Objective Neuropsychological Performance to
Cognitive Complaints on the PAI
Data screening for PAI variables was described earlier; univariate non-normality
and extreme outliers were not noted for the SCZ or SCZ-T scales. Serious violation of
normality was not noted for any of the objective neuropsychological measures included
herein, nor were there any extreme outliers. All computed correlation coefficients were
subsequently subjected to regression diagnostics. No standardized residuals exceeded an
absolute value of 3.3. All statistically significant correlations were inspected visually via
scatterplots, and none were judged to have been significant due to a limited set of
influential data points.
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